..,.
and
Stephen K. Lwanga
World Health Organization
Table of Contents
Preface
Introduction
Part I
ix
xi
9
11
16
16
19
21
21
22
24
29
36
36
41
42
38
44
vi
Part II
The population
49
Elementary units
Population parameters
50
50
The sample
52
52
52
53
54
55
57
61
Hypothesis testing
64
68
71
71
74
79
79
80
82
83
Sampling distribution
Bibliography
77
87
Part Ill
vii
Table 1
94
Table 2
97
Table 3
100
Table 4
109
Table 5
118
Table 6
122
Table 7
131
TableS
140
Table 9
149
Table 10
161
Table 11
170
Table 12
182
Table 13
191
Table 14
206
Table 15
215
Table 16
216
Table 17
225
Index
235
Preface
The World Health Organization (WHO) Expert Committee on Health Statistics, in its tenth
report (Technical Report Series, number 336 of 1966), concluded that in view of the
important role played by sampling in many types of public health investigations and the
shortage of experts in the theory and practice of sampling, epidemiologists and other health
workers should be provided with facilities for obtaining a basic knowledge of sampling
principles and methods and acquainted with their potential applications in the medical field.
The Committee therefore recommended that a manual dealing with the general principles of
sampling and describing in some detail the special problems and opportunities in the
medical field would be a useful guide for many workers in public health. The manual
would assist the statistician or sampling expert with no previous experience of medical
applications, and would also prove valuable for training courses.
In 1973 a document: Adequacy of sample size (HSM/73.1) was issued by WHO's
Statistical Methodology Unit, as a second edition of a 1961 document (MHO/PA/220.63)
with reconstructed tables. Since then the document has been in steady demand. The 1973
document was issued by the then Health Statistical Methodology Unit of WHO in Geneva
because "WHO (was) sponsoring a major program in medical research and workers
engaged in it needed to have at their elbow a document answering questions on the
adequacy of sample size". The current emphasis of the Organization's activities is different
to that in 1973. While the tables in HSM/73.1 are still adequate for most purposes of
experimental research, they do not cover important areas of case-control type studies and
cluster sampling. These approaches are the most likely to be adopted by health managers in
evaluating and monitoring their health programs.
WHO's Unit of Epidemiological and Statistical Methodology (ESM), in collaboration with
the Organization's programs of: Diarrhoeal Disease Control (CDD), Expanded
Immunization (EPI) and Research and Training in Tropical Diseases (TDR), sponsored the
preparation of this book on the determination of adequate sample sizes under different
situations. A number of "typical" questions which health workers pose to the statisticians
concerning the size of the sample of subjects they should study are covered in this book. It
is hoped that the book will meet the needs of health workers and managers faced with the
problem of deciding how large a sample to survey or study, and that it will provide insight
into the methodology of solving the most common problems of sample size needs.
The authors would like to acknowledge the editorial assistance of James L.
Duppenthaler, World Health Organization, in the preparation of this work.
IX
Introduction
The role of sampling in the health field
For most studies, especially those of human populations, all the people cannot be studied.
This may be because the population is too large and therefore impossible to study every
person due to time, fmancial and other resource constraints, or because it cannot be defined
uniquely in either time or space. In such situations only a part of the population, a sample,
would be studied and the results generalized to cover the whole population. It is the need
to generalize the results based on the sample to the population that dictates the use of
appropriate sampling techniques. Different samples drawn from the same population
would give different results if the population elements are not identical. The variability of
the sample results depends directly on the variability of the population elements and
inversely on the size of the sample. Since human populations are so variable, sampling
errors must be accepted as part of the study outcome.
A conscientious health worker planning a survey or a study will ask an apparently
straightforward question: How large a sample do I need? Very often an immediate answer
will be expected without realizing that a realistic answer has to be computed based on the
specific aims of the survey or study. Additional information is therefore always required.
A reasonable guess the expected result is usually a prerequisite for arriving at a satisfactory
estimate of sample size. The health worker also has to indicate the required precision and
the confidence with which the results are to be established, the operational constraints and
any available information on the expected outcome.
The adequacy of any sample size is judged according to the scope of the survey or study
results. For example, the question of sample size might not arise if one wants to study the
efficacy of a rabies treatment drug, but it would be important to have an 'adequate' sample
when one is testing a new anti-malaria drug. In the first example a positive result based
even on a single case would be important since there is as yet no known cure for the
disease. In the second example since there are known efficacious preventive measures the
results of the new drug have to be based on a sufficiently large number of responses.
The size of the survey or study will naturally depend on the subject matter and the aims of
the exercise, the desired precision etc. The collected information on the outcome can,
however, be classified into different categories. Firstly, the outcome may be split into two
categories; for example, disabled/not disabled, vaccinated/not vaccinated, existence of a
health committee/lack of a health committee, etc. Secondly, the outcome may have a
number of mutually exclusive and exhaustive possibilities; for example, attitudes, religious
beliefs, blood groups, etc. In these two cases the data are generally summarized by
percentages or rates. Thirdly, for each respondent (study subject) some numerical
measurement may be recorded; for example, weight, age, height, blood pressure, body
temperature etc. In this case the data are summarized by means (averages) and variances or
their derivatives. Determination of sample size has to take into account the category into
which the outcome falls.
When deciding on the size of the sample to use it should be realized that absolute sample
size is more important than sample size relative to the whole population, in reducing
sample variances when one is not dealing with very small populations. It is therefore very
often better not to aim at, for example, increasing the sample from 5% of the population to
say 10% but rather think in terms of absolute increments.
xi
xii
When data are to be analyzed in subgroups, for example by regions, the sampling errors of
the subgroups are likely to be larger than the estimated errors for the whole sample since,
by definition, subgroups are smaller. The larger the number of subdivisions, the smaller
the sample sizes would be for the individual subgroups and hence the larger the sampling
variations are likely to become, leading to less reliable population subgroup estimates.
The second part of the book givesthe theoretical background to sample size determination
covering populations, samples and their sampling distributions. It also covers
characteristics of estimates of population parameters, hypothesis testing and two-sample
confidence intervals, epidemiological study designs, basic sampling concepts and lot
quality assurance sampling strategies. Sample size needs for measurements are given with
the relevant formulae.
Methods of sample size determination which do not use the normal approximation to the
exact distribution can be extremely complex, and are thus beyond the mathematical level of
the proposed users of this book. Uses of the normal approximation in those instances in
this book, when an exact analysis would theoretically be appropriate, are few in number
and the resultant error in sample size arising from use of the normal approximation will be
small. For these reasons no material which uses exact distributions is included.
Illustrative examples have been kept as simple as possible so as to be readily
understandable by all users of the book.
This is a book on sample size determination, not a book on epidemiology. Many
interesting epidemiological aspects of the illustrative examples are, therefore, not
discussed.
Part I
P+Z1-a/2-J(P(1-P)/n]
Fig. 1 Sampling distribution of the sample proportion
The quantity d denotes the distance, in either direction, from the population proportion
and may be expressed as
d = z1-a/2,l[P(1-P)/n]
The quantity z represents the number of standard errors away from the mean. The
quantity d is termed the precisiond and can be made as small as desired by simply
increasing the sample size n. Specifically, if z is chosen to be 1.960, then 95% of all
sample proportions will fall within 1.960 standard errors of the population proportion P,
where a standard error equals ,IP(1-P)/n. Unfortunately, this standard error is a function of
the unknown population parameter P. Solving the above expression for n gives:
z~-a~2 P(1-P)
n=--~--
d2
(1 )
However, it should be notethat P(1-P) takes on the following values for different choices
ofP:
0.5
0.4
0.3
0.2
0.1
P(1-P)
0.25
0.24
0.21
0.16
0.09
The sample size selected will be largest when P equals 0.5, which is not an unreasonable
level to use since P(1-P) decreases rather slowly as the difference between P and 0.5
increases.
Hence, it is recommended that when the researcher has no idea as to what the level of P is
in the population, choosing 0.5 for P in the formula for sample size will always provide
enough observations, irrespective of the actual value of the true proportion. In such
circumstances, the following formula should be used in order to estimate the population
proportion to within d percentage points of the true P:
n = z~-a/.2 [0.25]fd2
(1a)
Tables 1a-lc present sample sizes for z = 1.645 (90% confidence), 1.960 (95%
confidence), and 2.576 (99% confidence) for d ranging from 0.01 to 0.25, and for P
ranging from 0.05 to 0.90 in increments of 0.05. These alternative levels are presented
for P since there are some situations where the researcher has a reasonable idea as to the
actual value. For example, if the rate to be estimated is the infant death rate, using P=0.5
would clearly yield much too large a sample size.
Example 1.1.1
A district medical officer seeks to estimate the proportion of children in the district
receiving appropriate childhood vaccinations. Assuming a simple random
sample of a community is to be selected, how many children must be studied if
the resulting estimate is to fall within 10 percentage points of the true proportion
with 95% confidence?
Solution
Using formula (1 a), n = (1.960)2(0.25)/(0.1 0)2 = 96.04 and rounding up to the
nearest integer, a sample of 97 children would be needed in order to be 95%
confident of estimating the population proportion of children appropriately
vaccinated. This value may also be found in Table 1b under the column headed
0.50 and in the row headed 0.1 0. As can be seen in that table, any value for the
population proportion other than 0.5 would have required a smaller sample size.
Hence, use of 0.5 as the value of P in the formula provides a conservative
estimate of the required sample size. As can be seen from Tables 1a-1 c, as the
desired confidence increases, the required sample size also increases (a
minimum sample size 167 would be required for 99% confidence).
Example 1.1.2
A local health department wishes to estimate the prevalence rate of tuberculosis
among children under five years of age in its locality. How many children should
be included in the sample so that the rate may be estimated to within 5
percentage points of the true value with 99% confidence?
Solution
From Table 1a with P=0.5 and d=0.05, it can be seen that a sample of 666
children should be studied. If, however, the health department knows that the
rate does not exceed 20%, a sample of size 427 would be necessary. If studying
this many children is unrealistic with respect to time and money, the investigators
should lower their requirements of confidence to, perhaps, 90% . In this case
Table 1c shows that for d=0.05 and P=0.20, a sample size of only 174 is
necessary.
Example 1.1.3
A new treatment has cured three out of ten cases of a previously fatal disease.
How many cases must be treated in order to be 95% confident that the recovery
rate with the new treatment lies between 25% and 35%?
Solution
In Table 1b, using the column headed 0.30 and the row headed 0.05 it can be
seen that the necessary sample size is 323 cases.
=19--alta
In the present example it follows that
IP - P I = z1-a12
JP(1-P)
,[;
and, dividing both sides by P, we obtain an expression similar to the one presented above
for E is obtained. That is,
lp-PI
= --P- = Z1-a12
~
r-:::
"'nP
tsee page 86
9 See pages 84-86
(2)
Tables 2a- 2c present values ofn from formula (2) fore= 0.01, 0.02, 0.03, 0.04, 0.05,
0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40, and 0.50, and proportions ranging from 0.05 to
0.95 in increments of 0.05. Tables are presented for 99%, 95%, and 90% confidence.
Example 1.1.4
Consider the information given in Example 1.1.1, only this time we will determine
the sample size necessary to estimate the proportion vaccinated in the
population to within 10% (not 10 percentage points) of the true value.
Solution
In the present example, assuming P=0.5, and using formula (2),
n = ((1.960)2 (0.5) ]/[ (0.1 0)2 (0.5)] = 384.16.
Hence 385 individuals should be sampled in order to be 95% confident that the
resulting estimate will fall between 0.45 and 0.55. This value can also be found
in Table 2b in the column headed 0.50 and the row headed 0.1 0. Notice that a
much larger sample size of 385 is necessary to estimate P to within 10% of the
true value than that of 97 which was necessary previously to estimate P to within
10 percentage points.
Example 1.1.5
How large a sample would be required to estimate the proportion of pregnant
women in the population who seek prenatal care within the first trimester of
pregnancy to within 5% of the true value with 95% confidence. It is estimated
that the proportion of women seeking such care will be somewhere between 25%
and 40%.
Solution
Using Table 2b it can be seen that if P=0.25, 461 0 women would have to be
sampled to estimate P to within 5% of P with 95% confidence; if P=0.30, in Table
2b shows that 3586 would be necessary; if P=0.35, n=2854; and if P were as
large as 0.40, 2305 women would have to be studied. Therefore, a study might
be planned with roughly n=461 0 women to satisfy the objectives of the study. If,
however, this number is too large then a smaller sample size might be used with
a loss of either precision or confidence or both.
In the above situations, the primary aim was to estimate the population proportion. We
now consider sample size determination where there is an underlying hypothesis which is
to be tested.
and we would like to fix the level of the type I error to equal a and the type II error to
h See pages 64-67
equal ~- That is, we want the power of the test i to equal 1-~. Without loss of generality,
we will denote the actual Pin the population asP a This may be represented graphically
as shown in Fig. 2:
Distribution under Ho
Distribution under Ha
Type I error
probability
Type II error
probability
....
Region where we
fail to reject HO
Region where we
reject Ho
In this figure the point "c" represents, for the sampling distribution centered at Po (i.e., the
distribution which would result if the null hypothesis were true), the upper lOO(cx)tt
percent point of the distribution of p:
c = Po+ z1-av'[Po(1-Po)/n]
and, for the sampling distribution centered at Pa (i.e., the distribution which would result
if the alternate hypothesis were true), the lower 100(~) tt percent point of the distribution
ofp:
c = Pa- Z1-~v'[Pa(1-Pa)/n]
In order to find n we set the two expressions equal to each other and solve for n. From
The necessary sample size, for this single sample hypothesis testing situation, is therefore
given by the formula:
z1~ +Z1~Pa(1-Pa)}
{
2
n = ...;;__ _ _ _ _ _ _2_ _ _ _ _...;_
(3)
(Pa -Po)
Formula (3) has been criticized for providing underestimates of the sample size necessary
to achieve the stated level of power. As a result, various adjustments to this formula have
been proposed in the statistical literature which adjust the sample sizes to make them
achieve the stated goals for type-! and type-II errors more accurately. Tables 3a-3i
present sample sizes corresponding to the uncorrected values computed using the above
formula since we believe that researchers using this formula will certainly achieve close
approximations to the desired goals, and that adding a level of precision to a process
which relies heavily upon specifying levels of unknown parameters (e.g., P a), would be of
questionable value. (See Fleiss IS for the modification of the sample size formula based
on the continuity correction.)
Example 1.1.6
During a virulent outbreak of neonatal tetanus, health workers wish to determine
whether the rate is decreasing after a period during which it had risen to a level of
150 cases per thousand live births. What sample size is necessary to test
Ho:P=0.15 at the 0.05 level if it is desired to have a 90% probability of detecting a
rate of 100 per thousand if that were the true proportion?
Solution
Using formula (3), it follows that
n = {1.645,1[(0.15)(0.85)] + 1.282,1[(0.1 0)(0.90)]}2/(0.05)2 = 377.90.
So, a total sample size of 378 live births would be necessary. An alternative to
performing this computation would be to look up the sample size directly in Table
3d with Po=0.15, P a=0.1 0, a=0.05, and P=0.1 0 (since the desired power is 90%).
In that table we find again that a sample of size 378 would be required. Notice
that as Pa gets further and further away from P0 , the necessary sample size
decreases.
Note that when using Tables 3a-3i, the values of Po and Pa are not
interchangeable. Columns are headed by values of P 0 and rows by values of
Pa. Entering the table in an inappropriate manner will result in wrong sample size
determination.
Example 1.1.7
Previous surveys have demonstrated that the usual rate of dental caries among
school children in a particular community is about 25%. How many children
should be studied in a new survey if it is desired to be 80% sure of detecting a
level of 20% or less at the 0.05 level of significance?
Solution
Using Table 3e, using the row headed 0.20, and moving to the column headed
0.25, it can be seen that a sample of 441 children must be studied.
Note that in order to calculate n, a, p, Po and Pa must be specified A similar approach is
followed when the alternative is two-sided. That is, suppose we wish to test
Ho: P =Po
versus
Distribution under Ha
Type I error
probability
Type II error
probability
U/2
Po
Fall
to rnject H 0
Reject Ho
From this figure we see that the null hypothesis is rejected if p, the observed proportion,
is too large or too small. We assign area a/2 to each tail of the sampling distribution
under Ho. The power of the test is the area under the distribution centered at P a which
falls in the rejection region. However, it should be noted that if P a is greater than P0 , the
probability of a proportion sampled from the distribution centered at P a falling into the
lower portion of the critical region of the sampling distribution centered at Po will be very
small. On the other hand, if the picture were reversed, and P a was smaller than P0 , then
the probability of a proportion sampled from the distribution centered at P a falling into
the upper portion of the critical region of the sampling distribution centered at P 0 will be
very small.
The only adjustment to the sample size formula (3) presented for the one-tailed test is that
z1-a12will be used in place of z1_a This can be derived by noting that "c" represents, for
the sampling distribution centered at P 0 (i.e., the distribution which would result if the
null hypothesis were true), the upper 100(a/2)th percent point of the distribution of p:
c = Po+ Z1.aJ2"[Po(1-Po)/n]
and, for the sampling distribution centered at Pa (i.e., the distribution which would result
if the alternate hypothesis were true), the lower 1OO(~Jh percent point:
C
Pa- Z1-~"[Pa(1-Pa)/n]
Then, setting the two expressions equal to each other and solving for n, it follows that:
2
{ z1-.af2../P 0(1-P 0) +Z ~Pa(1-Pa)}
n=
(4)
2
(Pa-Pa)
In determining sample size for this one-sample, two-sided hypothesis testing situation,
the problem is that we cannot be sure whether Pa was larger than or smaller than P 0
Hence, to determine adequate sample size, it is necessary to compute n twice; once with
Pa larger by a stated amount than P0 and again with Pa less than P0 by that stated amount.
The appropriate sample size is the larger of these two numbers.
Tables 4a-4i present sample sizes corresponding to formula (4) for a range of values of
P0, Pa, a and [3. These tables are accessed by selecting the column corresponding to Po (or
1- P0 if P0 >0.5) and the row corresponding to the absolute value of the difference between
Po and P a (I Po- Pal).
Example 1.1.8
Suppose the success rate for surgical treatment of a particular heart condition is
widely reported in the literature to be 0.70. A new medical treatment has been
proposed which is alleged to offer equivalent treatment success. A hospital
without the necessary surgical facilities or staff has decided to use the new
medical treatment on all new patients presenting with this condition. How many
patients must be studied to test H0 :P=0.70 versus Ha:P;e0.70 at the 0.05 level if it
is desired to have 90% power of detecting a difference in proportion of success of
10 percentage points or greater?
Solution
Using formula {4) we first consider Pa greater than Po by 10% (i.e., P a =0.8).
n = [1.960-Y{(O. 7){0.3}} + 1.282-Y{(0.8)(0.2)}]2/[0.1]2 = 199.09.
Hence, a total sample size of 200 patients would be necessary. Similarly, since
Pa may be less than P 0 by 10 percentage points, the computations are performed
again using P a =0.6.
n = [1.960.Y{(0.7}(0.3}} + 1.282-Y{(0.6}{0.4)}]2/[0.1]2 = 232.94.
Hence, taking the larger of the two sample size determinations, we would require
233 patients to be studied using the new medical treatment. This number may
be found directly by entering Table 4d in the column corresponding to 1-Po=0.3
and the row corresponding to IPo-P al=0.1 0.
Example 1.1.9
The proportion of patients seeking prenatal care in the first trimester of
pregnancy is estimated to be 40% according to figures released by a local
department of health. Health officials in another county are interested in
comparing their success at providing prenatal care with the published data. How
many women should be sampled in order to test H0 :P=0.40 versus Ha:P;e0.40 in
order to be 80% confident of detecting a difference of as much as 5 percentage
points with a=0.05?
Solution
Using formula (4) we first consider Pa to be 5 percentage points greater than Po
(i.e., P a=0.45).
n = [1.960-Y{{0.4)(0.6}} + 0.842.Y{{0.45){0.55)}]2/[0.05]2 = 760.76.
Hence, a total sample size of 761 patients would be necessary. Similarly, since
Pa may be less than P 0 by 5 percentage points, the computations are performed
again using P a =0.35.
n = [1.960-Y{{0.4)(0.6}} + 0.842.Y{(0.35)(0.65)}]2![0.05]2 = 741.81.
Hence, taking the larger of the two sample size determinations, we would require
761 patients to be studied in the community. This number may be found directly
by entering Table 4e in the column corresponding to Po=0.40 and the row
corresponding to !Po-P al=0.05.
Since the values of P1 and P 2 are unknown population parameters, replacing them with
the values of p 1 and p2 provides an estimate of the variance which can be used for the
purpose of constructing a confidence interval estimate of the risk difference, P 1-P 2 That
is, the upper and lower bounds on the confidence interval are given by
Example 1.2.1
Suppose two drugs are available for the treatment of a particular type of intestinal
parasite. One hundred patients entering a clinic for treatment for this parasite are
randomized to one of the two drugs; fifty receiving the standard drug A and fifty
receiving drug B. Of the patients receiving drug A, 64% responded favorably;
82% of the patients receiving drug B responded favorably. Estimate the
difference between the proportions responding favorably to the two drugs with a
95% confidence interval.
Solution
The end points of the 95% confidence interval estimate for the difference are as
follows:
(p 1-p2) z1-a.2.Y[p 1{1-p 1)/n 1+P2(1-p2)/n2]
(0.64-0.82) 1.960'1'[(0.64)(0.36)/50+(0.82)(0.18)/50]
-0.18 1.960(0.0869) = -0.18 0.17.
The resulting 95% confidence interval for P 1-P 2 is
The fact that zero does not fall in this interval suggests that the two drugs may
/see pages 71-78
ksee page 57
10
(1/n)(0.5)
1/2n .
Now, following the same logic as was used in estimating a single population proportion,
the quantity d denotes the distance, in either direction, from the population risk difference
and may be expressed as
(5)
Tables are provided for determining the sample size of formula (5) in a two-stage
process. First Table 5a is used to obtain the value of "V" given by:
P 1(1-P 1) + P2 (1-P2 )
(P 1 and P 2 may be interchanged for the purpose of obtaining the value of V from this
table. When P 1 and P2 are unknown, the table is entered at P 1 == 0.5, and P 2 == 0.5 which
yields the value of V== 0.5.) Then once V has been detennined from Table 5a, we
determine the required sample size using Table 5b, 5c, or 5d (corresponding to a==O.Ol,
0.05 and 0.10, respectively), by looking up the intersection of the row corresponding to V
and the column corresponding to d%. When the precise values cannot be located in these
tables, estimates may be obtained by interpolation.
Example 1.2.2
11
Solution
Here d=0.05, so using formula (5), it follows that
n = 1.9602[0.5(0.5)+0.5(0.5)]/(0.05)2 = 768.32.
Hence, a study with 769 subjects in each of two groups would be required. This
same value may be found in the tables by first looking up V in Table 5a,
(P t=P2=0.50, so V=0.50) and then going to the column corresponding to d%=5 in
Table 5c, and the row corresponding to V=0.5.
Example 1.2.3
Suppose that in a pilot study using 50 patients in each of two groups it was
observed that p 1=0.40 and p2=0.32. The estimated risk difference is p 1-p 2 =
0.08. If we would like to estimate the population risk difference to within 5
percentage points of the true value with 95% confidence, how many additional
patients must be studied?
Solution
Using the sample proportions as estimates of the population parameters it follows
that
Var(p1-p2) = 2[P(1-P)/n] .
Clearly, this variance involves the population parameter, P, which we have no way of
I See pages 64-67
12
knowing. This parameter may be estimated as the average of the two-sample proportions
from the pilot study. That is,
Fig 4 displays a graphical representation of the two sample hypothesis testing situation
for two proportions.
Distribution under H0
Distribution under H a
II
0
Fail to reject H 0
Type I error
probability
Type II error
probability
c
Reject Ho
Example 1.2.4
Consider the data of Example 1.2.1. One hundred patients entered a clinic for
treatment of a particular parasite and participated in a randomized trial of the two
drugs; fifty received drug A which is the standard treatment and fifty received a
new drug, drug B. This new drug will be adopted if it can be demonstrated, at
the a= 0.05 level, that it is more effective than the standard treatment. Of the
patients receiving drug A, 64% responded favorably; 82% of the patients
receiving drug 8 responded favorably. Is drug 8 significantly more effective than
drug A? In other words, is the observed difference too large to be due to chance
alone?
Solution
Using a=0.05, the decision rule is to reject Ho if P1- p 2 is greater than
0+ 1.64..J2(0. 73)(0.27)/50 = 0.146. The value 0. 73 is the average of the
proportions responding in each group (previously denoted p). In the actual trial,
letting P1 and p 2 denote the proportion with a favorable response with drugs B
and A respectively, p 1- pz = 0.82 - 0.64 = 0.18. Therefore, since this falls in the
rejection region, the null hypothesis is rejected in favor of the alternative that drug
B is more effective than drug A.
Now, suppose we would like to consider the previously described trial as a pilot study,
and assuming that a difference in proportions of 0.18 is considered clinically significant,
how many patients should be studied in order to be 90% confident of rejecting H0 when,
in fact the true difference between the population proportions is 0.18?
As is seen in Fig. 4, under H0 the point c is defined as
13
and, assuming n 1=n 2=n, equating these equations and solving for n we obtain
(6)
Tables 6a-6i give, for various choices of a and ~. the sample sizes of formula (6).
Example 1.2.5
Suppose it has been estimated that the rate of caries is 800 per 1000 school
children in one district and 600 per 1000 in another district. How large a sample
of children from each district is required to determine whether this difference is
significant at the10% level if we wish to have an 80% chance of detecting the
difference if it is real?
Solution
Using formula (6) with P = (0 .80+0.60)/2=0.70, it follows that
n = {1.282--.1[2(0.70){0.30)]+0.842--.1[(0.80)(0.20}+(0.60}(0.40)]}2/(0.80-0.60)2
= 46.47.
Hence, a sample of 47 children from each district would be required. Using
Table 6h it can be seen from the intersection of the column headed 0.60 and the
row headed 0.80 that n = 47.
A similar approach is followed when the alternative is two-sided. That is, suppose we
wish to test H0:P 1-P 2=0 versus Ha:P 1-P 2;e0. Fig. 5 presents the sampling distributions for
this situation.
Distribution under Ho
Distribution under Ha
Type I error
probability
Type II error
probability
0
Reject H
0
Fail to reject H
Reject H
0
Note that H0 is rejected if p1-p 2 > Cz or if p 1-p 2 < c 1 If H0 is false, and if P 1-Pz > 0, it will
14
be a very rare event for PrP 2 to be less than c 1 With that in mind, note that c2 may be
defmed with respect to either distribution. For the distribution centered at 0,
and, for the sampling distribution centered at P 1-P 2 (i.e., the distribution which would
result if the alternative hypothesis were true):
C2 = PrP2- z1.~v'[P 1(1-P 1)/n+P2{1-P2)/n] .
Then, setting the two expressions equal to each other and solving for n it follows that
{
n=
2
(7)
Tables 7a-7i present, for various choices of a and~. the sample sizes based on fonnula
(7). The necessary sample size is found at the intersection of the column corresponding
to the smaller of P 1 and P 2 , and if neither of these proportions is less than 0.5, then the
smaller of 1-P 1 and 1-P 2 is used as the column in which to enter the table. The
appropriate row corresponds to the absolute value of the difference between P 1 and P 2 ,
i.e., IP rP 21.
Example 1.2.6
An epidemiologist compared, in a pilot survey, a sample of 50 adult subjects
suffering from a certain neurologic disease to a sample of 50 comparable control
subjects who were free of the disease. Thirty of the subjects with the disease
(60%) and 25 of the controls (50%) were involved in industries using a specific
chemical. Assuming that the proportion employed in these industries in the entire
population is similar to that observed in the pilot survey, how many additional
subjects should be studied in each of the two groups to have 90% confidence of
detecting the true difference between the groups if the hypothesis is tested at the
5% level?
Solution
Using formula (7), assuming P 1=0.60, P2=0.50, a=0.05, and
that
~=0.10,
it follows
It should be noted that the above method is just an approximation since several
distributional assumptions were made. Fleiss 18 presents tables for sample size in the twogroup problem for a two-sided alternative. These tables are based upon an adjustment
originally proposed by Casagrande, Pike and Smith 6 which modifies the sample size as
given by fonnula (7) in the following manner:
In the situation where the underlying rate is very rare (e.g. in a disease such as cancer
having an underlying probability of occurrence of 50 per 100,000 or 0.0005), neither of
15
the above methods may be appropriate. Lemeshow, Hosmer and Stewart4t demonstrated
that for diseases whose occurrence is rare, the arcsin formula performed best. That is,
(8)
Sample sizes based on formula (8) are given in Tables 8a-8i for various choices of a,
and P 2
Example 1.2.7
Two communities are to be identified to participate in a study to evaluate
widescale use of a new screening program for early identification of a particular
type of cancer. In one community, the screening program will be used on all
adults over the age of 35, while in the second community it will not be used at all.
The annual incidence rate of this type of cancer is 50/1 00,000=0.0005 in an
unscreened population. A drop in the rate to 20/1 00,000=0.0002 would justify
using the procedure on a widespread basis. How many adults should be
followed in each of the two communities to have an 80% probability of detecting a
drop in the rate this large if the hypothesis test will be performed at the 5% level
of significance?
Solution
Using formula (8):
n
= (1.645+0.84)2/{2(arcsinv'0.0005- arcsinv'0.0002)2}
= (1.645+0.84) 2/{2(0.0223625432- 0.014142607) 2}
= 45770.39
~.
P1
OR .
Following exponentiation of the end points, the resulting confidence interval will be
asymmetric, the direction of the skew depending upon whether the end points of the
confidence interval for In( OR) are greater or less than one.
For a case-control study denoting the probabilities of exposure given disease presence or
absence by P1* and P2 * respectively, the variance of the sampling distribution of ln(OR),
for n 1 = n2 = n, is approximated as:
Var[ln(OR)]
We would like to know what sample size, n, is necessary to estimate the OR to within e of
OR with probability 1-a. Fig. 6 depicts the use of the ln(OR) and the relationship
between the end points of the confidence intervals as defined on two scales.
17
Disease
{E)
{E)
Total
Present
(D)
n1
(D)
n2
Total
m1
m2
Absent
t------:::;;or~
1\
0.0 +----.,c---_,..a.----L-------'------1~ OR
o"RL
OR
L.wJ
Fig. 6 Plot of confidence interval for ln{OR) vs. confidence interval for OR
We know that, based on the log scale, with 100(1-a)% confidence, the value of ln(OR)
falls somewhere between ln(ORu) and ln(ORL) in Fig. 6. Note that whereas the interval
established for ln(OR) is symmetric, when the values are exponentiated they yield an
asymmetric interval on the OR scale.
We wish to determine the number of study subjects, n, required in each of the case and
control groups so that the width of the stated portion of the interval be of length w, with
probability 1-a.
A number of assumptions are made at this point. First we assume that the OR > 1. If this
is not the case, the reader may proceed simply by interchanging the definition of
"exposed" and "unexposed". Second, we wish to control the width of the left half of the
confidence interval ("w" in Fig. 6) since controlling the distance between ORu and OR
would usually result in unrealistically large sample size requirements. It will be useful to
define the width w as a function of the odds ratio so we choose n to estimate the OR to
within e of its true value. We do this via the equation w=eOR, where e=l ORL-ORVOR. It
18
Note that in solving these problems there are three parameters (P 1*, P 2* and OR) but only
two need be specified since any two determine the third. For example, if P 2 * and OR are
given then
p1 =
(OR)P;
Tables 9a-91 present the sample sizes for 99%, 95%, and 90% confidence intervals, E =
0.10, 0.20, 0.25 and 0.50, odds ratios ranging from 1.25 to 4.0 and P 2 * ranging from 0.01
to 0.90.
Example 1.3.1
What sample size would be needed in each of two groups for a case-control
study to be 95% confident of estimating the population odds ratio to within 25% of
the true value if this true value is believed to be in the vicinity of 2, and the
exposure rate among the controls is estimated to be 0.30?
Solution
The proportion exposed among the cases is
P1* = ORP2*/[0RP2*+(1-P2*)]
= 2x0.3/[2x0.3 +0.7] = 0.46
Evaluating the required sample size from formula (9) it follows that
n = (1.960)2[1/{0.46x0.54} + 1/{0.3x0.7}]/[ln(1-0.25)]2 = 407.91.
Hence, 408 subjects would be required in each of the case and control groups in
order to assure, with 95% confidence, that the estimate of the odds ratio will not
underestimate the true OR by more than 25% of its true value. Using Table 9g
the same result is obtained. The table is entered in the column for 0R=2.00 and
the row for P2*=0.30. At the intersection of this row and column it can be seen
that n=408.
Example 1.3.2
If, in Example 1.3.1, we want the estimate to be within 50% of the true odds ratio,
what should be the minimum sample size for each study group?
Solution
The calculations for sample size in this example are as follows:
n = (1.960)2 [1/{0.46x0.54} + 1/{0.3x0.7}]/[ln(1-0.5)]2 = 70.26.
19
Hence, only 71 subjects would be required in each of the two groups. This value
may be looked up directly in Table 9h.
The above example demonstrates an important point relevant to sample size for
estimating the population odds ratio. Specifically, estimation of the odds ratio with a
level of precision commonly used with such other population parameters as proportions
or means, requires very large samples. (Had we required the estimate to be within 10%
of the true value, a sample size of 3041 would have been required in each group.)
p1 =
(OR)P;
(OR)P 2 +(1-P~
and the null and alternative hypotheses expressed in terms of proportions are
versus
where P 1* is given above and P2* is known.
The sample size needed to test these null and alternative hypotheses has already been
presented in the discussion of two-sample hypothesis testing of proportions. The
formula, similar to formula (7), is repeated below with minor modifications.
{
n=
(P 1 -P~
(10)
Note that in the above formula we have used 2P 2*(1-P 2 *) in place of 2 P. (1- P.) as was
used previously (where P. = (P 1*+P 2 *)/2). The rationale for this modification is that it is
likely that the population is made up of many more individuals without the condition
(controls) than it is of individuals with the condition (cases). Often the exposure rate
among the controls will be known with a high degree of precision and, under the null
hypothesis, this is the exposure rate for the cases as well. Thus it seems logical to use ~ 2 *
as the population proportion for each group. The use of 2 P(1- P) in the formula in the
earlier development was to provide a method of expressing uncertainty with respect to the
common proportion of the two groups. If one is not sure of the exposure rate among the
controls then one should use 2 p (1- p) with formula (10).
20
Tables 10a-10i present sample sizes corresponding to formula (10). The table is accessed
by specifying a (0.01, 0.05 or 0.10), ~ (0.10, 0.20 or 0.50), OR (ranging from 0.25 to 4.00)
and P 2 * (ranging from O.Ql to 0.90).
The following example will illustrate the use of P 2 * versus
Fi*.
Example 1.3.3
The efficacy of BCG vaccine in preventing childhood tuberculosis is in doubt and
a study is designed to compare the immunization coverage rates in a group of
tuberculosis cases compared to a group of controls. Available information
indicates that roughly 30% of the controls are not vaccinated, and we wish to
have an 80% chance of detecting whether the odds ratio is significantly different
from 1 at the 5% level. If an odds ratio of 2 would be considered an important
difference between the two groups, how large a sample should be included in
each study group?
Solution
The exposure rate (proportion unvaccinated) among the cases which yields an
odds ratio of 2 is
P 1* = 2x0.3/[2x0.3+0.7]
= 0.4615
n=~------------------------,_---------------2
(0.4615 -0.3)
129.79
Thus 130 cases and 130 controls would be necessary. This value may be found
in Table 1Oe at the intersection of the column headed 2.00 and the row headed
0.30. The sample size obtained using f)* = [0.3+0.46]/2 = 0.38 is as follows:
n=--------------------------~~---------------2
(0.4615 -0.3)
140.69
Hence 141 cases and 141 controls would be required. Which of these two
sample size formulae would be used depends upon how firmly it is believed that
the rate of nonvaccination among the controls, which is by far the larger group in
the population, is actually 0.3.
true population value. Thus, the necessary precision must first be derived using the
natural logarithm (ln) scale as shown in Fig. 7.
ln(RR)
ln(RRu
)=ln(~R)+z~[ln(~)]l---------------==-r-~
ln(RR) 1--------=..,--
Fig.7 Plot of confidence interval for ln(RR) vs. confidence interval for RR
Tables 11a-111 present these sample sizes for 99%, 95%, and 90% confidence intervals,
E =0.10, 0.20, 0.25, and 0.50; RR ranging from 0.025 to 4.0, and P2 *ranging from 0.01 to
0.90.
Example 1.4.1
Suppose an outcome is present in 20% of the unexposed group of a cohort
study, how large a sample would be needed in each of the exposed and
unexposed study groups to estimate the relative risk to within 10% of the true
value, which is believed to be approximately 1. 75, with 95% confidence?
o See pages 71-74
22
Solution
It follows from the given information that
P1 = (RR) P2 = 0.35
and
m = (1.960)2[(0.65/0.35) + (0.8/0.2)]/(ln(1-0.1 )]2 = 2026.95
Hence a sample size of 2027 would be needed in each of the two exposure
groups. This value may be located in Table 11 e at the intersection of the column
corresponding to RR=1.75 and the row corresponding to P2* =0.20.
n=~----------------~----------~-
(12)
(p1 -p2J2
where p = (p 1+p 2 )/2 = p 2(RR+l)/2. Note that once p 2 is specified the value of RR is
bounded by
This inequality places constraints on what sample sizes are possible for a given value of
P2
Suppose, for example, it is thought that approximately 30% of all unexposed persons may
be expected to develop the disease during the time frame of the study. Then the possible
Hence, the alternative of Ha:RR=4 does not make sense. This is to be contrasted with the
case control study where it is possible to have any value for the odds ratio for a given
exposure probability for the control group. The resulting calculation for the second
population given an OR and P 1* guarantees that 0<P 2*<1 for any OR.
Tables 12a-12i present sample sizes based on formula (12). The tables are accessed by
specifying a (0.01, 0.05, or 0.10), ~ (0.10, 0.20, or 0.50), RR (ranging from 0.25 to 4.00)
= ----------------------------------------(0.175-0.35)2
= 130.79
This suggests that the study be performed with 131 patients in each arm of the
trial. This same sample size value may be found in Table 12d at the intersection
of the column corresponding to RR=0.5 and the row corresponding to P2=0.35.
23
versus
Ha: P <Po (i.e., proportion of nonimmunized children less than Po).
The four-celled table presented in Fig. 8 describes the consequences of the testing
procedure.
Actual
Population
c::
0
Adequately vaccinated
1-a.
sensitivity
~
false positive rate
(test recognizes
adequate coverage)
G>
1-~
c
false negative rate
specificity
Note that in Fig. 8, because the test is set up as one-sided, and because it is assumed the
population is not adequately covered unless Ho is rejected, the type I error, i.e., accepting
the lot when it is defective (false negative), whose probability can be controlled, is the
most serious error. That is, the "cost" of declaring that the population is adequately
25
immunized, when in fact it is not, is concidered to be very high. On the other hand, the
type II error, rejection of an acceptable lot, is judged not to be as serious since the result
of this false-positive decision would be to take steps to improve on the immunization
coverage of an already adequately immunized population.
The fundamental problem in LQAS sampling is not so much one of simply determining
sample size, but of choosing an appropriate balance between sample size and critical
region. The computation of~ will, in all cases, depend upon what the correct value of P
is when it is assumed to be different from P 0 Because LQAS surveys often use small
samples, evaluation of the procedure is accomplished using the binomial distribution.
The binomial distribution is the statistical distribution which describes the probability of a
particular configuration of dichotomous outcomes when the total number is finite (e.g.,
the number of times a "head" appears in 7 tosses of a coin"). If P denotes the probability
of observing an event, then the probability of having exactly d individuals with the event
in a sample of size n is given by :
Prob{d) = [nCctl Pd (1-P)n-d ;
where ned= n!/[d!(n-d)!], a!= a(a-1)(a-2)21 and, by definition, 0! = 1. Thus, if 50% of
the children under 2 years of age in a particular community are not immunized, the
chance that we would find only 1 child who is not immunized in a random sample of 7
children in the community is:
Prob(1) = [7C1] (0.5)1 (1-0.5)6 = 0.0547 .
Similarly, the chance of finding exactly 1 nonimmunized child in a sample of 7 children
if 70% of the children are not immunized is:
Prob(1) = [7C1] (0.7)1 (1-0.7)6 = 0.0036.
Suppose we decide that 7 is the sample size we wish to use. The rejection region for the
test states that we should reject H 0 (and "accept the lot" as adequately immunized) if d :s;
d* (i.e., if the number of subjects in the sample found to be nonimmunized is less than or
equal to the critical value, d *). We first consider whether there is a value of d * such that
the probability that d :s; d* when Ho is true is exactly equal to a=0.05. The probability of d
:s; d *, for a specified sample size n, probability P0 , and number d * is given by the
expression
l'
(13)
d=Q
fo establish the existence of ad* such that Prob(ds;d*)=a, we must compute Prob(ds;d*)
for a number of values of d*. In the example where n=7 and P=0.5, these values are
presented in Fig. 9:
d*
0
Prob{d:s;d*}
0.0078
0.0625
0.2266
0.5000
0.7734
0.9375
0.9922
Fig. 9 Actual probability of a type I error for possible values of d*, n=7, P=0.5
1.0000
26
From Fig. 9 it can be seen that choosing d *=0 would yield an a. = 0.0078 level test and
choosing d *=1 would yield an a.=0.0625 level test. If it was decided to take n=7 subjects,
then choosing d*=1 would probably be safe; but only d *=0 results in a value of a. less
than or equal to 0.05. That is, in a sample of 7 children, none must be nonimmunized in
order for us to reject H0, thereby accepting the lot as having an immunization rate of at
least 50%.
Now, if we decide to use d*=1 (a.=0.0625), what is the power of the test if 70% of the
population is actually nonimmunized? The probability of rejecting H0 (i.e., accepting the
lot or declaring it to have an acceptable vaccination level) is the chance that dS";d*=1,
given P=0.7, and is computed as follows:
I
Prob{d~1} =
L [7Cd]{0.7)d (1-0.7)7-d
0.0039.
d=O
For each value of n there will be only one value of d * at or about the chosen value of a.. It
is not usually possible to attain the level a. exactly. Thus one choice ford* will have the
type I error less than a. and d *+ 1 will have type I error greater than a.. The investigator
will usually choose the value of d * yielding the type I error less than a.. Sometimes this
strategy results in an extremely conservative test such as the one illustrated in the
example above where, with n=7, d*=O and P 0=0.5, a. equalled 0.0078. Here the use of
d*=1 with a.=0.0625 might seem justified. Tables 13a-13o give sample sizes such that a.
will not exceed the stated type I error probability of 0.01, 0.05 or 0.10 for various
populations (100- oo), d* (0- 4) and P 0 (0.8- 0.1).
Example 1.5.1
Given a population of size 15000 what is the minimum sample size which should
be taken so that if no more that 2 cases of malnourished children are found in the
sample we can confidently say (with a probability of 95%) that the prevalence of
malnutrition in the population is not more than 10%?
Solution
The general solution is to determine the value of n for which the probability of
finding 2 cases in a randomly selected sample of size n given a population of
size 15000, with 1500 malnourished children, is less than 0.05.
This gives n = 61. Alternatively the sample size may be read from Table 13h in
the row headed 15000 and column headed by 10.
The results of a particular choice of n and d * can be shown graphically using what is
called an operating characteristic (OC) curve where the variable on the horizontal axis is
the proportion, P, in the population who have not been immunized. The vertical axis
presents the probability of rejecting the null hypothesis H0 : P=Po and concluding that the
vaccination coverage in the population is greater than P 0 Each combination of n and d *
will generate a unique curve. We know that if no one in the population is immunized
then P=1 and there will be no chance of rejecting H0 . On the other hand, if everyone in
the population is immunized then P=O and we would always reject H0 We look for rules
which give us a very high probability of rejecting H0 when there is a high coverage, i.e., P
small. Fig. 10 presents a typical OC curve for n=7, d*=l.
27
1.0
0.9
0.8
0.7
........
0.6
~
'C 0.5
'i:""
ll.
0.4
0.3
0.2
0.1
0.0
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Additional curves can be constructed by varying n and d *. The power of the test is
reflected in how steeply the curve rises to 1.0 in the region Q::;p::;pO
The choice of the fmal rule then comes down to one of combining the desired power, 1-~.
with the desired a level. Rather than providing curves which are difficult to read
precisely, Tables 14a-14i, which present the values of (n,d*) pairs for chosen values of
a, ~. p 0 and p a have been developed.
In these tables, (n,d*) are chosen so that Prob(d::;d* I n,P 0)::; a and Prob(d::;d*+1 I n,P 0) >
a. The LQAS survey problem is a one-sided test of H0 :P=Po versus Ha:P=Pa where
Pa<P 0 , (i.e., it is a test of the hypothesis that the proportion nonimmunized is a specified
level, versus the alternative that the proportion nonimmunized is less than the specified
level). We first choose that sample size which will yield a test with stated a and~ errors
for the particular null and alternative hypothesis specified using formula (3) of Chapter 1.
Use of this formula is based on the assumption that the normal approximation to the
binomial is valid. The value of d* for the necessary n is determined by using the formula
(14)
d={)
where values of d* are always rounded down (e.g. [5.3] = 5; [6.8] = 6). When n::;20, d*
is determined by exact computations with the binomial distribution.
Example 1.5.1
A child-health program in a large refugee camp aims at reaching at least 70% of
the children but it is feared that probably no more than 40% are being reached.
How many children should be sampled to monitor the program's activities, and
what should be the maximum acceptable number of children in the sample not
reached by the program so as to test for the program's performance target, at the
5% level with a power of 80%?
Solution
The null hypothesis is: P0 = 0.70 and the alternative is: Pa= 0.40 with a 5% level
of significance and a power of 80% using formula (3), in Section 1, gives:
28
=8.2
Out of the 16 children if 8 or more children are found not to have been reached
by the program then the null hypothesis would be rejected and the conclusion
would be that the program is behind its original target.
Alternatively, the values of n and d* may be read from Table 14e in the row
headed 40% and column headed 70%. Discrepancies between Table 14e and
the results obtained with formula (14) are due to the more appropriate use of
exact binomial calculations in Table 14e.
These tables clearly demonstrate the trade off one must make between power and sample
size in LQAS surveys. It is essentially impossible to have a=O.OS, 13=0.2 and use n=5
unless Pa under the alternative was actually close to 0. Hence investigators with limited
resources must be ready to compromise on the value of J3 or the difference between P 0 and
Pa. The more serious error of concluding that an inadequately immunized population has
adequate coverage is being guarded against by the value of a which can always be
controlled.
expresses the number of observed events relative to something other than the total
number of persons at risk of the event. The most common of these alternative measures
is the incidence rate. This measure has been called the incidence density, the persontime incidence rate, the instantaneous incidence rate, the force of morbidity, and the
hazard by various authors. The measure expresses the number of events relative to the
time over which they occur. It is an especially useful measure when one is interested in
expressing the risk of disease relative to some unit of time.
The following example illustrates the calculation of the incidence rate, "A.", which is a
population parameter and its estimate ");.".
Suppose we have 5 individuals who are followed up for 5 years and 2 develop the event
of interest, for example cardio-vascular disease (CVD), after 2 and 3 years of follow-up.
Since the total number of events is 2 and the total person-years of risk is 5+5+5+2+3=20,
the estimated incidence rate is
);.=2/20=0.1.
This estimated rate is typically expressed in some multiple of persons per year. In this
example the incidence rate can be expressed as 1 CVD case per 10 people per year. In
other words, if we were to follow up 10 people for 1 year we would expect one of them
to develop CVD.
The goals of a study using A. as the measure of interest might include estimating it to
within a stated precision and/or testing whether it was equal to some specific value A.0
These would be single-sample studies. Alternatively one may wish to test whether the
incidence rates for two different populations are the same versus some specific alternative
hypothesis.
Development of the sample size determination methods for the incidence rate studies is
based on "survival analysis" based, in tum, on the hazard function. The methods of this
field are extensive and include many different models. The reader is referred to the texts
by Gross and Clark26, Lee39, Millers!, and Kalbfleisch and Prentice34 for a treatment of
this field with health related applications. The hazard function gives the conditional
probability that the event will occur in the next "instant" given that the event has not yet
occurred. Expressing the hazard in different mathematical forms yields different survival
distributions. For example, the probability that a 42 year old male will develop CVD in
the next year given that he is free of the disease at his 42nd birthday is the hazard or
incidence density for 42-year-old males. The notion of "an instant" may be as long as a
year for some chronic diseases and as short as a day for some highly infectious diseases.
To develop the expressions needed for ascertainment of sample size, a model with the
statistical distribution of survival times in the population following an exponential
distribution, will be assumed. Under this model, the probability that an individual will
survive for more than t time units is
S(t) = e-A.t
30
P(t)
= 1 - e-AI = 1 - S(t) _
The conditional probability that the individual will develop CVD in the forthcoming
interval of unit length, given that the event has not yet occurred prior to that interval, is
constant and equal to A.. In other words the hazard function for this model is constant and
equal to A.. This assumption of constant success rate may not be appropriate for certain
diseases or for large groups of individuals, but may be realistic for certain age-, sex- or
race-specific groups. For example, the risk of CVD does not change dramatically for
white males, in the USA., during the years 40-45. If J..L denotes the mean survival time,
then A. = 1/J..L.
If we consider the information on follow-up of the five individuals discussed in an earlier
example, we note that two of these persons had developed CVD, by the end of the study.
This type of observation, or in fact any observation of follow-up which is terminated
before the event has occurred, is said to be censored. Under the assumption of
exponential survival the maximum likelihood estimate of the hazard function is
~=d/F
(see Gross and Clark26 Chapter 3) where d is the number of events and F is the total
follow-up time. In the previous example, d = 2, F = 20 and ~ = 0.1. Thus, the incidence
density is the estimate of the hazard under exponential survival. This result will provide
the basis for development of formulae to determine necessary sample size. In many
epidemiologic studies the hazard rate may change considerably with age although the
assumption of a constant hazard may be approximately true during the time period
considered in most studies.
Suppose we are planning an experiment which involves observing experimental subjects
from the time they receive a "treatment" until a "success" occurs. (For example, the
experimental subject may be a human, the treatment may be an analgesic, and success
might be the end of a headache.) The subject is observed until "success" occurs; thus
there is no censoring. Let tJ, ... ,tn represent the observed success times for then subjects.
In this case ~ = 1/t, where
t=(1/n)Lti.
~1
It follows from the theory of maximum likelihood estimation that where n is sufficiently
large, ~is normally distributed with mean A. and variance A.2/n. This information may be
used in the same way that similar information was used to develop sample size formulae
for estimation and tests about proportions. The sample size which is necessary to
estimate A. to within E of its true value with probability (1- a) is given by the formula
(15)
from I~-A.I = z1--12 [AtJ n] withe= 1~-AJ/A. These values of n may be looked up directly in
Table 15.
Example 1.6.1
How many people should be followed-up to estimate the hazard (incidence rate)
to within 10% of the true value with 95% confidence?
31
Solution
indicating that we would need to follow-up 385 individuals until the "success" time
of each individual was known. This value may be found by using Table 15, at the
intersection of the row corresponding to e=0.1 0 and the column corresponding to
the 95% confidence level.
In order to test a hypothesis about the hazard (incidence rate), we must consider
formulation of the alternative hypothesis. The incidence rate expresses risk on the basis
of events per so many persons per time unit. We may wish to state the null and
alternative hypotheses directly. For example, H0 : A= 0.1 versus Ha: A= 0.05. Under Ha
we have 5 events per 100 persons per time unit or 1/2 the incidence rate under Ho.
Alternatively, the null and alternative hypothesis may be expressed in terms of the mean
length of time to failure, Jl, through the relationship Jl = 1/A. For example, when A = 0.1,
Jl = 1/0.1 = 10. In the alternative we might express our belief that the mean length of
time to failure will be 15 (this would correspond to A = 1/15 = 0.06667). Since the
expression ofthe null and alternative hypothesis in terms of Jl or A is equally satisfactory,
the decision should be based on whichever is most biologically meaningful for the
problem at hand. This will depend on the available data. If incidence data are available,
'Ao and 'Aa should be specified directly; otherwise A.o and Aa should be specified indirectly
through Jlo and lla The test statistic for H0: A='Ao is
z = (~-'Ao)(,ln)/'J...o
which is distributed N(0,1) under the null hypothesis. To obtain an expression for the
necessary sample size which will detect the two-sided alternative Ha: A ::;:. Ao with stated
power, we must find that value of n such that
Using a strategy similar to the one used in developing the formula for the sample size for
hypothesis testing for a single population proportion, Fig. 3 and equation (4), gives:
n=
('J...o-J...a)2
Tables 16a-16i provide sample sizes based on formula (16). The appropriate sample size
is located in the table, for specified a and ~ levels, at the intersection of the row
representing 'Aa and the column representing Ao
Example 1.6.2
Suppose it is widely reported that the hazard due to a certain chemical exposure
in a particular industry had always been 0.20, but, recently with the introduction
of new production techniques the hazard has been changed by 25%. How many
people should be followed-up to test H0 : A.o = 0.20 versus 'Aa = 0.15 or 0.25 at the
5% level of significance and with 80% power?
Solution
32
In the above example, under the null hypothesis the average time to follow-up is
J.!o=l/A.0 =5 "years" and under the alternative it is lla=l/A,.=4 or 6.7 "years" depending on
whether \>A.0 or \ <A.0 Thus the study could take up to nearly 7 "years" to complete if
the unit of time for the study is in years. This points out the problem of not allowing for
censoring. We need few subjects but it requires a long time to complete. Modifications
in the study design based on control of the follow-up period will now be presented for the
two-sample problem.
where X = (~ 1 + ~i)/2 assuming equal group sizes. We must find that value of n such
that
Prob{ z > z 1.a12l Ha} = 1-~.
Using the same method as was used in developing formula (7) for the sample size for
hypothesis testing for two population proportions, and Fig. 4 (replacing P 1-P 2 with A. 1-A.z)
gives:
{z1-a!2,1[2A. ] + Z1-~,I[A.14A.z2JF
(17)
n=
(A.rA.z)2
Tables 17a-17i provide sample sizes based on formula (17). The appropriate sample size
is located in the table, for specified a and ~ levels, at the intersection of the row
representing A.z and the column representing A. 1
33
If there are to be unequal sample sizes, n 1 and n 2, from the two populations, then formula
(17) generalizes to:
n1=-----------------------
(17a)
with X=(~1 + !&2)/(1+k) where k = n2/n1. Tables 17a-17i cover the most common
situation of k= 1.
Example 1.6.3
Suppose that a disease hazard due to a certain chemical exposure in a particular
industry is believed to be roughly 0.1 0 and a competing industry uses techniques
with a disease hazard believed to be roughly 0.05, how many people would be
needed to be followed-up in each industrial exposure to test, at the 5% level of
significance with a power of 80%, whether there is a difference in the disease
hazards in the two industries?
Solution
Using formula (17) with X= (0.1+ 0.05)/2 = 0.075 yields
n=
(0.1 -0 .05)
2
=36.49
Hence, at least 37 subjects would have to be followed-up in each group until the
event/failure occurs. This value may be found as the first entry in Table 17e.
An alternative strategy is to begin the study on a fixed date, allow patients to enroll in the
study throughout the period, and terminate enrollment and follow up for "T" years. This
controls the time duration of the study but we must worry about how to account for the
censored observations which are bound to occur. The mathematical details of the
necessary modifications to formula (17) are sketched in the papers by Donneri2 and
Lachin37 and developed more fully in Gross and Clark26. The modification of formula
(17) requires that we evaluate
f(A.) =
~vs
T/( n
- 1 + e- A.T)
Example 1.6.4
Consider the data in Example I. 6.3 with the additional limitation that the study
will terminate in 5 years. We wish to test H0 : A.1 = A.2 = 0.1 versus the alternative
that Ha: A.1 = 0.1, A.2= 0.05 with a = 0.05, ~ = 0.2. How many people should be
followed up?
Solution
Using the formula for f(A.):
f(X = o.o75) = o.o339
(18)
34
f(A.t = 0.1)
= 0.0469
f(~ = 0.05) = 0.0217
and
n = {1.960 v'[2(0.0339)] + 0.8416 v'[0.0469 + 0.0217]}2/(0.1-0.05)2
= 213.7
By restricting the study duration to 5 years we need many more subjects (214) in each
group than was previously the case. The reason for this is that the average time to failure
is 10 years under H0 and 20 years under Ha. . The survival rates are too high to be
realistic for a 5 year study.
Example 1.6.5
Suppose that the average survival for patients suffering from a specific disease
and receiving a standard treatment is 2 years but there is a new treatment which
will receive approval for marketing if it can be demonstrated that it would
increase the patients' survival, on average, by at least 1 year; how many
subjects would a 5 -year study require?
Solution
In this example "-1
and
n = {1.645v'[2(0.2995)] + 0.842v'[0.3950 + 0.2164]}2/(0.5 - 0.33)2
=163.74
Thus 164 subjects would be needed in each group. If, however, the follow-up
was uncensored 100 subjects would be needed in each group.
Examples 1.6.4 and 1.6.5 illustrate that the proposed length of the study cannot
be chosen with total disregard to the survival times that are likely to be observed.
Using the results presented in Gross and Clark26, Lachin37 has extended formula (18) to
cover the situation in which subjects are enrolled for T1 years and the total duration of the
study is T years ..
The following formula is used for n:
n=
{z1-CXJ2v'[2g(X,)] + z 1 _~v'[g(A.t)+g(A.z)]}2
(A.t-A.z)2
where
Example 1.6.6
Suppose, in Example 1.6.5, that subjects are to be enrolled in the study for 2.5
years and then continue the follow-up for another 2.5 years, how many people
would have to be included in the study?
Solution
With T 1 = 2.5, T = 5, "-1 = 0.5, A.2 = 0.3333 and
g (X. = 0.4167) = 0.2224
X. = 0.4167 yields
(19)
35
g (1..2 = 0.3333)
Thus only 100 subjects would be needed in each group if the design allowed for 2.5 years
of follow-up after an enrollment period of 2.5 years. The saving of subjects occurs
because all subjects are being followed for at least 2.5 years, which is the average
survival time under H0 and Ha. Thus we expect to observe many more failures/events.
The precision of the study depends on the expected number of events. The design which
generates the greatest number of events over the shortest enrollment and follow-up period
will require the fewest overall number of participants.
The development of formulae for sample size involving incidence rates was framed
entirely in the domain of survival studies. Examples of these in health research include
most clinical trials of cancer therapies. The results are easily interpreted in this context.
The extension to other types of studies comes from the observation that the measure,
incidence density, or person-years incidence, is an estimate of a hazard function under
exponential survival. This assumption will be approximately valid for relatively
homogeneous groups of subjects.
Finally, the use of the incidence density ratio (IDR) as a measure of comparing two
populations will, under certain conditions, be as an approximation to the relative risk. In
the notation of this Chapter, the test of the hypothesis that A. 1 = A.2 is fully equivalent to a
test that the IDR = A.JIA.2 = 1. Direct tests about the ratio would be based on ln(IDR) =
ln(A.1)-ln(A.2). Sample sizes based on the distribution theory ofln(A.1)-ln(A.2) will not differ
significantly from the sample sizes obtained from equations (17), (18), and (19), which
are likely to be accurate enough for most purposes.
where z 1 -a~2 represents the number of standard errors from the mean. As before, d is the
precision of the estimate and can be made as small as desired by increasing the sample
size n. Specifically, if z1-a12 is chosen to be 1.960, then 95% of all sample means will fall
within 1.960 standard errors of the population mean Jl, where a standard error equals
...J( a2/n ). Solving the above expression for n it follows that
(20)
This expression depends upon the unknown population parameter a2 which could be
estimated from a pilot sample or other available sources.
Example 1.7.1
Suppose an estimate is desired of the average retail price of twenty tablets of a
commonly used tranquilizer. A random sample of retail pharmacies is to be
selected. The estimate is required to be within 10 cents of the true average price
with 95% confidence. Based on a small pilot study, the standard deviation in
price, a, can be estimated as 85 cents. How many pharmacies should be
randomly selected?
Solution
Using the above formula, it follows that
n = [(1.960)2(0.85)2]/{0.1 0) 2 = 277.56.
As a result, a sample of 278 pharmacies should be taken.
In this example, it might seem more reasonable to require that the estimate of Jl fall
within 10% of Jl rather than to within a specified number of units of Jl. The formula used
for this purpose is:
(21)
37
Example 1.7.2
Consider the data in Example 1.7.1, but this time we will determine the sample
size necessary to be 95% confident of estimating the average retail price of
twenty tablets of the tranquilizer in the population of all pharmacies to within 5%
(not 10 cents) of the true value, if, based on the pilot survey data, we believe that
the true price should be about $1.00.
Solution
Assuming cr2=(0.85)2, and using formula (21) above,
n = [(1.960)2(0.85)2]/[(0.05)2(1.00)2] = 1110.22.
Hence 1111 pharmacies should be sampled in order to be 95% confident that the
resulting estimate will fall between $0.95 and $1.05 if the true average price is
$1.00.
In the above situations, our primary aim was estimation of the population mean. We now
consider sample size determination when there is an underlying hypothesis which is to be
tested.
n=
Example 1.7.3
A survey had indicated that the average weight of men over 55 years of age
with newly diagnosed heart disease was 90 kg. However, it is suspected that the
average weight of such men is now somewhat lower. How large a sample would
be necessary to test, at the 5% level of significance with a power of 90%,
whether the average weight is unchanged versus the alternative that it has
decreased from 90 to 85 kg with an estimated standard deviation of 20 kg?
Solution
Using formula (22):
n = 202(1.645+ 1.282)2/(90-85)2 = 137.08.
Therefore, a sample of 138 men over 55 years of age with newly diagnosed heart
disease would be required.
Note that, as was the case for population proportions, in order to calculate n, a,
~.
!lo and
38
lla must be specified. A similar approach is followed when the alternative is two-sided.
That is, when we wish to test
versus
In this situation, the null hypothesis is rejected if x is too large or too small. We assign
area a/2 to each tail of the sampling distribution under H0 . The only adjustment to
formula (22) is that z1-w2 is used in place of z 1-<X resulting in
n=
(23)
Example 1.7.4
A two-sided test of Example 1.7.3 could be designed to test the hypothesis that
the average weight has not changed versus the alternative that the average
weight has changed, and that a difference of 5 kg would be considered important.
Solution
Using formula {23) with z1_a/2 = 1.960,
z 1 _~
Thus, 169 men would be required for the sample if the alternative were twosided.
For simplicity, we will assume that cr 12=cr22=cr2. Under this assumption we say the
variances are said to be homoskedastic and the formula for the variance of the difference
can be simplified to
The value cr2 is an unknown population parameter, which can be estimated from sample
or pilot data by pooling the individual sample variances, s~ and s~, to form the pooled
variance, s~, where
39
s2 _ _ _ _ _ _ __
p-
Following the same logic used in estimating a single population mean, the quantity d
denotes the distance, in either direction, from the population difference, fl d..lz, and may
be expressed as
d = Z1-aQ-,I[2cr2/n].
(24)
Example 1.7.5
Nutritionists wish to estimate the difference in caloric intake at lunch between
children in a school offering a hot school lunch program and children in a school
which does not. From other nutrition studies, they estimate that the standard
deviation in caloric intake among elementary school children is 75 calories, and
they wish to make their estimate to within 20 calories of the true difference with
95% confidence.
Solution
Using formula (24) ,
n=(1.960)2[2(752)]/202=108.05.
Thus, 109 children from each school should be studied.
Now, suppose we would like to know how many observations to take in order to be
100( 1-a.)% confident of rejecting H0 when, in fact, the true difference between the
population means is (f.l 1-f.l 2) = 8.
Following a strategy similar to that employed in developing formula (7), it follows that
n=-----
(25)
40
Since the value of cr2 would not ordinarily be known, it could be estimated from a pilot
study using s~. The quantity 11 dlz represents that difference considered to be of
sufficient practical significance to warrant detection.
Example 1.7.6
Suppose a study is being designed to measure the effect, on systolic blood
pressure, of lowering sodium in the diet. From a pilot study it is obseNed that the
standard deviation of systolic blood pressure in a community with a high sodium
diet is 12 mmHg while that in a group with a low sodium diet is 10.3 mmHg. If
a=0.05 and ~=0.1 0, how large a sample from each community should be
selected if we want to be able to detect a 2 mmHg difference in blood pressure
between the two communities?
Solution
Pooling the two variances, s~ = [ s~ + s~]/2 = [144.0+ 106.1]/2 = 125.05. {This
computation assumes that the pilot study used equal sample sizes, otherwise a
weighted average would be used.) This value is used in place of cr2 in formula
(25) to test
versus
A similar approach is followed when the alternative is one-sided. That is, testing Ho:ll 1llz=O versus Ha:ll 1-ll 2>0. The sample size necessary in this situation is
(26)
Example 1.7.7
A study is being planned to test whether a dietary supplement for pregnant
women will increase the birthweight of babies. One group of women will receive
the new supplement and the other group will receive the usual nutrition
consultation. From a pilot study, the standard deviation in birthweight is
estimated at 500 g and is assumed to be the same for both groups. The
hypothesis of no difference is to be tested at the 5% level of significance. It is
desired to have 80% power (~=0.20) of detecting an increase of 100 g.
Solution
Using formula (26) it follows that
n = 2(500) 2[1.645+0.842]2/(1 00)2 = 309.26.
Hence, a sample of 310 subjects should be studied in each of the two groups.
Because of the wide range of possible parameter values, it is not possible to present a
comprehensive set of sample size tables. Rather than provide a limited number of tables,
only the formulae are presented.
A sample survey generally has as its primary objective the estimation of an unknown
population parameter 9 with a given precision. A sample survey, irrespective of whether
it is a simple random, stratified or cluster sample, and irrespective of whether the
sampling takes place in one or multiple stages, produces an estimate e of 9 along with an
estimate of the variance of e, denoted by Var(e). There are two ways of expressing the
desired precision of the estimate. The first specifies that e should not differ from 9 by
more than "d" units with 100(1-a)% confidence. The second specifies that we wish to be
100(1-a)% confident that our estimate e will not differ, in absolute value, from the true
unknown population parameter, 9, by more than c:9. That is,
18-91/9 < c:.
Consider the case where 9 is a population proportion, P. By applying the central limit
theorem, and provided that the sample size is reasonably large, the sampling distribution
of P may be approximated by the normal distribution. This can be illustrated in the
following diagram:
'
To determine the required sample size, d is set equal to the desired precision. That is, d
may either be specified in terms of the number of percentage points or it may be specified
as a percentage of P, i.e., d=c:P.
Irrespective of which sampling scheme is used, Var(P) depends upon n, and
determination of sample size simply involves setting up the formula
42
P= }:Yi/n,
1
where Yl = 0 if the ith sampling unit does not have the characteristic,
or, Yl = 1 if the ith sampling unit does have the characteristicand the variance of
by
P(1-P)
P is given
N-n
Var(P)=--x-.
n
N-1
It should be noted that this expression incorporates the finite population correction ({Nn}/{N-1}), since, in most sample surveys, N is known and reflects the number of potential
sampling units. In practice, since n is usually small relative to N, the correction is close to
1. If the finite population correction is not used in the formula, the calculated variance
will be too large, yielding wider than necessary confidence intervals and/or larger than
necessary sample sizes.
n=--------
(27)
This formula may be simplified somewhat if we assume that the sample size n will be
small relative to a rather large population size N. Then the expression ( N-n)/(N-1) in the
formula for Var( p) may be considered equal to 1, the expression simplifies to
Var( p)
= P(1-P)/n ,
(28)
This expression is the same as formula (1) and, therefore, Tables 1a-1c present these
sample sizes. If the population size N is known (which it will be with simple random
sampling), the formula provides the correct sample size which often will not differ
appreciably from formula (1). Hence, Table 1 may often be used as a quick
q See pages 53-54
43
approximation for formula (27). No tables are presented corresponding to formula (27)
since the potential range of N is so great that it would not be possible to construct a
concise table.
Example 1.8.1
A preliminary random sample of 50 children is selected from 4000 children living
in a particular village and it is found that 30 of them have ascariasis. How large a
sample must be selected to be 95% confident that the estimate of P will not differ
from the true P by more that 5 percentage points?
Solution
Using the 50 children as a pilot sample in order to estimate P for use in formula
(27) it follows that
n = [4000(1.960)2(0.6)(0.4)]/[(0.05)2(3999)+(1.960)2(0.6)(0.4)] = 337.74.
Hence a simple random sample of 338 children should be selected, which means
that an additional 288 children should be studied. Alternatively, using the simpler
formula (1 ), it follows that
n
= (1.960)2(0.6)(0.4)/(0.05)2 = 368.79,
suggesting that a total sample of 369 children should be studied. This value may
also be found in Table 1b at the intersection of the column headed 0.40, and the
row headed 5%.
Estimating P to within
"~::"
of P
z~-a12N( 1-P)
n=~------~-----
e2P(n-1)
+ ~-wi 1-P)
(29)
If we assume that N is large and much greater than n, then the simplified expression for
the estimated variance results in the following expression for n
n=-------
(29a)
which may be recognized as formula (2) of this manual. The sample sizes based on this
simplified expression are given in Tables 2a-2c.
Example 1.8.2
Suppose, in Example 1.8.1, we wish to estimate the proportion of children in the
population with ascariasis to within 5% of the true value with 95% confidence,
how many children should be sampled?
Solution
Using formula (29), it follows that
44
P=LNhPt!N'
h=l
where Ph is the usual estimate of Ph based on the nh sampling units selected from the hth
stratum.
The variance of the estimated proportion is
L
Finally, if we assume that the Nh are large and much greater than nh, then this expression
simplifies to
L
Again, by applying the central limit theorem, the sampling distribution of P may be
approximated by the normal distribution and, as a result, the precision may be set to d
which again may be specified either in terms of a defined distance or as a percentage of
P.
45
z~--ai2LfN~Ph(1-Ph)/wh
h=1
n = _ __.:.;._;_____,L-----
(30)
N2d2 +Zf--a/2LNhPh(1-Ph)
h=1
where wh=nh/n. That is, wh is the fraction of observations allocated to stratum h and is
typically decided in advance of sampling by the particular allocation scheme used. Thus,
if equal allocation is used, then wh=11L for all strata. Alternatively, if proportional
allocation is used, then wh=NwN for the h1h stratum. Other types of allocation strategies
are commonly employed (for instance, the ones that incorporate such features as
variability in the strata and differential costs of sampling within the strata) but will not be
discussed further in this manual.
Using the simplified formula for Var( f>) results in a somewhat simpler formula for
sample size determination:
L
zta12L.[N~Ph( 1-Pt)/wh
n=--~~~1-~----
(30a)
N2d2
Proportion
City
A
8
2000
3000
5000
0.2
0.3
0.5
4000000
9000000
25000000
Total 10000
0.10
0.15
0.20
200
450
1000
180.0
382.5
800.0
1800000
3825000
8000000
1362.5
13625000
Solution
Using formula (30) it follows that
n = 1.9602[13625000]/{(1 0000)2(0.03)2+ 1.9602(1362.5)} = 549.61
Hence, a total sample of 550 families should be selected. With proportional
allocation, the sample would be distributed to the three strata as follows:
n1 = 550 x 2000/10000 = 110,
46
= 165,
= 275.
= 581.58
which suggests that a sample of size 582 be used. Hence by using formula (30)
which incorporates the finite population correction factors within each stratum, a
reduced estimate of sample size is obtained.
z~--a12L[N~Ph( 1-Pt.>twh
h=1
n=
{
E
)2
LNhPh
(31)
L
+ 4--a12LNhPh( 1-Pt.>
h=1
h=1
If we assume that Nh is large and much greater than n h then the simplified expression for
Var(P) may be used, giving rise to the following, less complicated, sample size formula:
L
zta12L[N~Ph( 1-Pt.>/wh
h=1
(31 a)
n=------.,...--
{t~Ph]'
Example 1.8.4
In Example 1.8.3, suppose that we wish to estimate P to within 5% of the true
value how large a sample should be used?
Solution
Using the calculations in Table 1.2 and formula (31):
n = 1.960 2[13625000]/{(0.05) 2(1650) 2+1.960 2(1362.5)}
= 4347.17.
47
In Example 1.8.1 when simple random sampling was used to estimate P to within
percentage points with 95% confidence, 338 children would have been needed.
If cluster sampling were to be used, how many clusters, and of what size, would
be needed for the same precision?
Solution
Cluster
size
68
45
34
27
23
The mix of number of clusters (m) and cluster sizes (ii) depends upon the degree of
heterogeneity of the clusters. When the variation between clusters is large, we would
choose ii small and m large. Alternatively, the closer the Pi in the clusters are to 0.5, the
larger will be the variability within the clusters. In this case, n should be large relative to
m. Another factor in determining the mix of m and n is cost. The total cost of selecting a
cluster sample can be expressed as
C=C1m+c2mn,
where c1 is the cost involved in selecting clusters (e.g., constructing frames, renting office
space, etc.), and c2 is the cost involved in selecting sampling units (e.g., travel expenses,
interviewer expenses, data processing costs). Common sense dictates that if c1 is large,
we would tend to take more sampling units and fewer clusters. However, if c2 is large,
we would take more clusters and fewer sampling units within each cluster.
ssee page 86
Part II
Foundations of Sampling
and Statistical Theory
1 The population
The population (or universe) is the entire set of individuals for which the findings of a
study are to be generalized. The individual members of the population whose
characteristics are to be measured are called the elementary units or elements of the
population.
For example, if we are conducting a survey , in a defmed area, to determine the proportion
of children vaccinated against polio, the universe includes all children living in the area and
each child living in that area is an elementary unit.
The primary purpose of almost every sample survey is to estimate certain values relating to
the distributions of specified characteristics of a population. These values are most often
means, totals, proportions or ratios. In this manual, we will concentrate on estimating the
proportion of individuals possessing a particular characteristic.
Sample surveys belong to a larger class of nonexperimental studies generally given the
name "observational studies", which include prospective cohort and retrospective casecontrol studies. In a cohort study, two or more groups of individuals are identified whose
members differ with respect to the presence or absence of a risk factor presumed to be
associated with the development of some outcome (for example some disease). All
individuals are studied over time to observe whether the incidence of the outcome is higher
in the exposed group than it is in the unexposed group. Estimates of the risk of
development of disease associated with levels of the risk factor are made through
computation of the relative risk and its associated confidence interval.
In case-control studies a group of persons with a disease or condition is identified as is a
group of individuals without the disease or condition. Individuals in both groups are
compared with respect to the presence or absence of characteristics thought to be associated
with the disease or condition. Potential risk factors may be identified and estimates of risk
are obtained through the computation of the odds ratio and its associated confidence
interval. Cohort and retrospective case control studies often involve specific hypotheses
concerning a set of dependent (or response) variables and another set of independent
(or explanatory) variables. To address these hypotheses, statistical tests may be
performed and the hypotheses will be either "rejected" or "not rejected", accordingly.
In contrast to observational studies, an "experimental study" is characterized by the
randomization of subjects to "treatments", and the observation of the subject's response to
the treatment assigned. Because of the interventional characteristic of experimental studies,
the experimenter plays a much more active role than is the case in an observational study.
The primary purpose of most experimental studies is to test some research hypothesis. In
an experimental study the subjects are usually not representative of the population as a
whole. Hence it is typically required that the experiment be repeated in a number of
different settings before the results can be thought to apply to a larger, untested group of
subjects. A common example of an experimental study is the randomization of patients
with a particular condition to one of two groups: (1) an "experimental" group receiving a
50
Elementary units
The total number of elementary units in the population is denoted in this manual by N, and
each elementary unit will be identified by a label in the form of a number from 1 to N. A
characteristic (or random variable) will be denoted by an upper case letter, such as V.
The value of the characteristic V in the ith elementary unit will be denoted by Vi.
Population parameters
The objectives of most sample surveys include estimating the values of certain
characteristics of the population from which the sample was selected. These population
values are called parameters, and for a given population the value of the parameter is
constant. Among the most commonly estimated population parameters are the mean and
the proportion which may be defmed as follows:
Population mean: The population mean of a characteristic X is denoted by "!!" and is
computed as:
N
ll=(Lx)IN.
i=l
Whenever the characteristic being measured represents the presence or absence of some
attribute, the variable is said to be dichotomous. In this case, the goal is to estimate the
proportion of elementary units in the population having the attribute. If the attribute is
N
denoted by V, then LVi is the total number of elements in the population having the
i=l
attribute. Let P denote the population proportion of elements having the attribute
where
N
P=(LYi)/N.
i=l
Population variance and standard deviation: The variance and the standard
deviation of the distribution of a characteristic in a population are important quantities
because they measure the spread or dispersion in the collection of all values. The
population variance of a characteristic X is denoted c;2. Its value is given by the following
expression:
N
c;2 =
L(Xj-j.1)2/N .
i=l
The population standard deviation, denoted by cr, is simply the positive square root of the
variance and is given by:
51
When the characteristic being considered is a dichotomous variable, it can be shown that
the population variance as defmed above reduces to the following expression:
cr2 = NP(1-P).
2 The sample
The primary objective of a sample survey is to estimate population parameters using data
from a sample.
53
contain one or more elementary units and can be identified prior to selecting the sample.
For example, in studying vaccination of children in a city, it is unlikely that an accurate and
up-to-date list of all children would be available or could be constructed at a reasonable cost
prior to sampling. However, it is conceivable that a list of all households is available or at
least could be obtained without great difficulty or expense. The households are the
enumeration units. If such a list is available, a sample of households can be drawn, and
those children residing in the sample households are taken as the elementary units.
x = LXjln.
i=l
P= LY/n
i=l
where the numerator is the number of sample elements having the attribute.
Sample variance and sample standard deviation: For any characteristic X the
sample variance is denoted by s2, and its value is given by
N
s2= L(Xj-x)2/(n-1).
i=l
When the characteristic is a dichotomous attribute, the sample variance s2 as defined above
reduces to
s2 = np(1-p)/(n-1).
The sample standard deviation, denoted by s, is simply the positive square root of the
sample variance.
54
3 Sampling distribution
Suppose that a particular sampling plan and estimation procedure could result in "T"
possible samples from a given population and that a particular sample results in an estimate,
of e. (The symbol e here represents any population parameter [e.g., !.!, p or cr2] while
the symbol erepresents an estimate of this parameter [e.g., x, p or s2]). The collection of
values of e over the T possible samples is called the sampling distribution of e with
respect to the specified sampling plan and estimation procedure.
e,
Village
Proportion
immunized
<50%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
yes
no
yes
yes
yes
no
no
no
yes
yes
yes
yes
no
yes
no
1
0
1
1
1
0
0
0
1
1
1
1
0
1
0
Village
Proportion
immunized
<50%
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
yes
yes
no
yes
no
yes
no
no
yes
no
no
yes
yes
yes
no
1
1
0
1
0
1
0
0
1
0
0
1
1
1
0
If a sampling plan is specified in which five villages are selected at a time at random
out of the thirty, such a procedure would yield 142 506 possible samples. Each
of these samples has the same chance of being selected. In terms of the
notation described in the definition of a sampling distribution, T = 142 506,
P=0.57, and each =p, where P and pare the population and estimated population proportion, respectively. The sampling distribution of the estimated proportion, p, is given in Table 11.2.
56
Frequency
Relative
frequency
0.0
0.2
1287
12155
38896
53040
30940
6188
0.009
0.085
0.273
0.372
0.217
0.043
0.4
0.6
0.8
1.0
The relative frequencies shown in the last column of Table 11.2 show the fraction
of all possible samples that can take on the corresponding values of p. These are
shown graphically in Fig. 12.
0.4
>-
()
0.3
CD
:I
0"
0.2
CD
>
as
Gi
:;::
a:
0.1
0
0.0
0.2
0.4
0.6
0.8
1.0
Estimated proportion of villages with inadequate
vaccination coverage
Sampling distributions have also certain characteristics associated with them. For our
purposes, the two most important of these are the mean and the variance (or its square root,
the standard deviation).
The mean of the sampling distribution of an estimated parameter e is also known as
its expected value, denoted by E(e), and is defmed by the equation
where T is the number of possible samples and ei is the sample statistic computed from the
ith possible sample selected from a population. Note that some of the values of ei may be
the same from sample to sample, but each one appears in the sum even if there is
duplication.
57
Using these general equations, it is possible to derive expressions for the mean (or
expected value), variance and standard error of the sampling distribution of any estimator
of interest. In particular, for the sample proportion, assuming simple random sampling of
elementary units,
E(p) = p
Var(p) = P(1-P)/n
and
SE(p) =-Y{P(1-P)/n}.
For the sample mean, x, the mean, variance and standard error of the sampling distribution
are E(x) = ~. Var(x) = cr2/n and SE(x) = cr/.Yn, respectively.
A very important theorem in statistics which concerns the sampling distributions of sample
proportions and means, is known as the central limit theorem. This theorem states, in
effect, that if the sample means and proportions are based on large enough sample sizes,
their sampling distributions tend to be normal, irrespective of the underlying distribution
of the original observations. (The normal distribution provides the foundation for much of
statistical theory. Readers unfamiliar with the normal distribution and its properties would
be advised to refer to Dixon and Masseyn or other basic statistics textbooks.) Hence
assuming the sample size is large, the sampling distribution of p may be represented as
follows:
P- zap
P+Z crp
Here z is the number of standard errors from the mean of the sampling distribution and crp=
SE(p). How large the sample size (n) must be for the central limit theorem to hold depends
on P. For practical purposes, n is sufficiently large if nP is greater than 5. At z equal to
1.96 in Fig. 13, the shaded area under the normal curve equals 95% of the total area. If
z=2.58, then the area equals 99%. Using the central limit theorem we can determine how
close a sample proportion p is likely to be to the true proportion P in the population from
which that sample was selected. This is discussed in greater detail in the following
sections.
58
m
p'
(MI(Nm)](LNi Pi),
i=1
where:
m
~
N
'
Pi =
LNiP i estimates the total number of individuals with the characteristic over all
i=1
L ~ p i/m estimates the mean number of individuals with the characteristic per
i=1
sample cluster;
m
i=1
the characteristic.
The variance of P is composed of two parts and is expressed as follows:
M
i=1
i=1
The first part of this expression represents the variation due to selecting m clusters, primary
sampling units (PSU's), from the M available clusters. The second part is the sum of the
sampling variation within clusters caused by selecting ni observations from the Ni which are
available.
Since the above expression is a population parameter depending upon knowledge
concerning all M population clusters, and true proportions within those clusters, it is
necessary to specify an estimate ofVar(P), which may be done as follows:
V~r(P) = [W(M-m)]/[N2m(m-1)]
m
l2
59
This expression is quite involved, incorporating Ni, ni and Pi for each of the m clusters
selected in the sample. From a sample size determination point of view this is a problem,
since different combinations of cluster sample sizes could be used in order to obtain some
pre-specified level of precision. A simplified formula may be obtained by specifying that
each population cluster be the same size (i.e., Ni = N) and that the sample size selected from
each cluster be the same (i.e., ni = ii). In that special case, it follows that
m
i=1
i=1
where P =
i=1
m n
P = (1/m) LPi=(1/mn)
i=1
LL>!.
i=1
~1
The advantage of the above formula is that once M, m and the Pi, i=1 ,... ,m are specified, it
would be possible to solve for n, the number of sampling units to select from each cluster.
However, it is rather unrealistic to assume that Ni=N for each of the clusters. A more
reasonable approach would therefore be to use probability proportionate to size (PPS)
cluster sampling. In this strategy, clusters are selected proportional to the number of listing
units in the cluster. In this way, clusters with large Ni have a greater chance of being
included in the sample than clusters having small Ni. In PPS sampling the same number, n,
of listing units is generally sampled from each cluster selected at the first stage. The
method is illustrated using the following example.
Example 11.3.2
Consider the population of ten villages along with the number of families living in
each village, as shown in Table 11.3.
Table 11.3 Distribution of families in ten hypothetical villages
Villages
(clusters)
Number of
families, Ni
Cumulative
LNi
1
2
3
4
5
6
7
8
9
10
4288
5036
1178
638
27010
1122
2134
1824
4672
2154
4288
9324
10502
11140
38150
39272
41406
43230
47902
50056
Random
numbers
Random Number
chosen
04285
00001-04288
04289-09324
09325-1 0502
10503-11140
11141-38150 11883;35700;36699
38151-39272
39273-41406
41407-43230
43231 -4 7902
47903-50056
60
ppps where
m n
i=1
It should be noted that the expected value of this estimate is the true population proportion.
Hence Ppps is an unbiased estimate" of P.
Also, the expression for the estimated variance of
ppps is
m
Comparing these formulae to the ones presented earlier for non-PPS cluster sampling, one
notes that the great advantage of using PPS cluster sampling is the resulting computational
simplicity.
The question of sample size is basic to the planning of any cluster sample. Decisions have
to be made on, first, the number of clusters, m, which should be selected from the M
available clusters and, second, the number of sampling units, ii, which should we select
from each cluster. We want to determine m and n so that
4 Characteristics of estimates of
population parameters
It would seem intuitively clear that a desirable property of a sampling plan and estimation
procedure is that it should yield estimates of population parameters for which the mean of
the sampling distribution is equal to, or at least close to, the true unknown population
parameter and for which the standard error is very small. In fact, the accuracy of an
estimated population parameter is evaluated in terms of these two characteristics.
The bias of an estimate !l of a population parameter 0 is defmed as the difference between
the mean, E(!l), of the sampling distribution of !l and the true value of the unknown
population parameter o,
Bias(!l) = E(!l)- 0 .
An estimate !l is said to be unbiased if Bias(!l) = 0, or, in other words, if the mean of the
sampling distribution of !l is equal to 0. The sample proportion and sample mean are
examples of unbiased estimates when we have random sampling. Recall that the
population variance is defmed as
N
crz = ,Lc~-fl) 2 JN
i=1
i=1
Hence, if is a biased estimate of a2. Alternatively, consider the sample variance presented
earlier as
n
s = ,Lcxi-x) /Cn-1).
i=1
62
study were carried out of every individual in the population of interest. In practice, of
course, this is never the case since populations are too large and are constantly changing; as
a result, a well-selected sample is the best one can hope for.
To illustrate sampling error, consider the following example.
Example 11.4.1
p = 0.28.
Using this notation, the sampling error is defined as
p- p = 0.28 - 0.23 = 0.05.
In this example, the value 0.28 is called a point estimate. In general, if e is some
population parameter, and if is an estimate of e, then
e is the sampling error.
e-
Note that sampling error refers to the relationship between an estimate resulting from a
single sample and a population parameter. To account for the existence of sampling error
confidence intervals are used rather than point estimates when making statements about
population parameters. A confidence interval has the general form:
and has the following interpretation. Suppose a sample of size n is selected from a
population with an unknown parameter e; the estimate 91 would not be expected to equal e
exactly . Suppose this process of selecting a sample of size n was performed many times
(say "k" times), each sample resulting in a new value of ei. i=1 ,... ,k. The collection of the k
estimates of e constitutes the sampling distribution which, as a result of the central limit
theorem, can be approximated by the normal distribution with mean E(e) and variance
Var(e). If the normal distribution adequately describes the sampling distribution, then 95%
of all values of 9 will fall in the interval:
e-1.96-v'Var(e) to 9+1.96-v'Var(a).
Only 5% of the time will the estimate fall more than 1.96v'Var(e) units away from the
mean, E(e). Since the value of Var(9) is a population parameter, it must be estimated from
the sample data. This quantity, denoted by Var(e), is used in the construction of
confidence intervals for e. For example the 95% confidence interval would take the form:
The interpretation of this interval is that if confidence intervals such as this were
constructed for each of all possible samples which could be selected from a population,
63
95% of all such intervals would include the true value of e in the population. Since any
particular interval either does or does not cover the mean, the "probability" of a particular
interval being correct is either 0 or 1. "Confidence" relates to the theoretical concept of
repeatedly sampling from the population. The value of 1.96 implies the inclusion of the
central 95% of the area under the normal curve (see Fig. 13). Other choices would be used
if different areas were desired (e.g., 2.58 would be used for a 99% confidence interval).
For some parameters, such as Jl, the t-distribution rather than the normal distribution,
would be used for the purpose of describing the confidence interval if the variance was
estimated from the data and if the sample size was small. (Readers unfamiliar with the tdistribution and its properties should refer to an appropriate basic textbook of statistics.)
The following example illustrates the construction of a confidence interval for a population
proportion.
Example 11.4.2
In order to estimate the proportion of children in a particular school vaccinated
against polio, a list of all students is assembled and a simple random sample of 25
of these students is selected. The proportion of students in the sample
vaccinated against polio is observed to be 44%. The 95% confidence interval
estimate of P, the true proportion vaccinated in the school, is
0.44-1.96~[0.44(1-0.44)/25] ~ p ~ 0.44+ 1.96~[0.44(1-0.44)/25]
or
0.25
0.63.
This states that if confidence intervals of this type were established for all possible
random samples of size 25 which could be selected from this population, 95% of
these would correctly incorporate the true proportion vaccinated in the
population. The interval 0.23 to 0.62 either does or does not include the true P
so in that sense, the "probability" of it being correct is either 0 or 1. We have
"confidence" in this interval because of our knowledge of the nature of the
sampling distribution as well as how such intervals perform upon repeated
sampling. (Since the population proportion P is unknown, p(1-p} is used as an
estimate of the variance of the sampling distribution, P(1-P).)
Precision relates to the confidence interval and is defined in terms of repeated sampling.
That is,
precision= [reliability coefficient] x [standard error]
where the reliability coefficient reflects the desired confidence and is represented by a zvalue if normality is assumed. For example, if the desired confidence is 95%, then the
reliability coefficient is the upper 97 .5th percentile of the normal distribution with mean 0,
and variance 1. This is represented by zo.975
5 Hypothesis testing
In the above discussion, our primary aim was estimating the unknown population
parameter. We now consider the situation where there is an underlying hypothesis which
is to be tested. A null hypothesis (H 0) is simply a statement concerning the value of the
population parameter. For example, the statement might be that the proportion of pregnant
women receiving adequate prenatal care in a particular city is 80%. This may be stated in
notational form as:
Ho: P = 0.8.
The statistician considers this statement as a possibility and, based on a knowledge of the
sampling distribution, decides which values of the sample statistic (in this case the sample
proportion, p) could reasonably be expected to occur if the hypothesized value was, in fact,
the actual population parameter. From the previous discussion regarding sampling
distributions we know that if a large number of random samples were selected from a
population, the sample statistic () would fall in the interval between e+ 1.96"Var(9) and e1.96"Var(()) 95% of the time. Hence, any value of() which falls in this interval would not
be considered an unlikely result of a random sample from the population with parameter e.
However, any value of () beyond 1.96 standard errors from e would be considered an
unlikely event if the population parameter was, in fact, e.
Every null hypothesis has an associated alternative. The alternative hypothesis is a
statement of what the value of the parameter is in the population if the null hypothesis is not
correct. The alternative hypothesis is denoted Ha. For example, if the null hypothesis is
that the population proportion is 0.8, the alternative could be that the population proportion
is something other than 0.8. This would be stated as
Ho: P = 0.8
versus
Ha: P'#-0.8.
H0 : P = 0.8
In this case, rejection of the null hypothesis in favor of Ha calls for action. Failure to reject
H0 would provide no evidence to suggest that the level of prenatal care in the community is
inadequate and no immediate action would be called for. The rejection region for the test
specifies, in advance of selecting the sample, those values of p which would result in the
rejection of the null hypothesis. If the sample yields a value of p which is not in the
rejection region, the appropriate conclusion is that there is no evidence to reject H0. The
null hypothesis is never "accepted" since a sample resulting in a particular value of p could
have been selected from many populations, and it is impossible to know exactly which one
it was.
65
A type I (or alpha [a]) error occurs whenever a null hypothesis which is true is
incorrectly rejected. The probability of making this type of error may be controlled by the
investigator and is denoted by a. This may be expressed by the following notation:
a= Prob{committing a type I error}= Prob{rejecting H0 [H 0 is true} .
Because of our understanding of the nature of the sampling distribution, the size of the aerror may be controlled by the investigator. For example, since it is known that only 5% of
sample proportions will differ from the true population proportion by more than 1.96
standard errors, a rejection region composed of all sample proportions above and below
1.96 standard errors from the mean would have an a-error of 5%. That is, 5% of all
possible samples which could be selected from a population would result in sample
proportions either above P+ 1.96cr P or below P-1.96cr p
On the other hand, if the null hypothesis is not rejected, there is a chance that it was, in
fact, false and should have been rejected. This type of error is termed the type II (or
beta [~])error. The probability of making a type IT-error is denoted~~= Prob{committing a type II error} = Prob{failing to reject Ho[Ho is false} .
Finally, the power of the test is defined as the probability of correctly rejecting Ho given
H0 is false. That is,
1-~ =
Actual
H0
1:
0
Ill
u
Q)
population
is true
Ho
is false
J:CI
-0
u
- G)
1-a
af&
...
()
.!.J:
c a:
G)
Cl
~
Type II error
a
Type I error
1-~
Power
From Fig. 14 we see that in any given hypothesis test only one type of error can be
committed. That is, if we reject H0 only an a-error could be made if H0 were actually true.
On the other hand, if we fail to reject H0 we could be inadvertently committing a ~ error if
H0 were actually false.
Figs 15 and 16 depict these concepts for a two-sided and a one-sided test respectively. In
Fig. 15, a statistical test is being performed concerning a population proportion. Under H0 ,
the population proportion equals Po while under Ha, the population proportion differs from
P0 That is
66
Since it is not known whether the true P in the population is actually above or below P0 ,
Fig. 15 shows the situation in which it is assumed that Pa>P0 A similar figure could have
been drawn for Pa< P0
Distribution under Ho
Distribution under Ha
..
Reject H
0
Po
Fail to reject H
Type I error
probability
Type II error
probability
~
0
Reject H
0
Distribution under H a
II
Fail to reject H
Type I error
probability
Type II error
probability
Reject Ho
As seen in Figs 15 and 16, the probability of making a type II error and the power of the
test vary according to the true P; the further the true P is from P0 , the smaller the type II
error (and the larger the power). In determining the sample size a suitable combination of
Pa and p is fixed together with the level of a. The way this is done is described in Part I.
Example 11.5.1
Suppose that as a method for screening a community to determine prenatal care
levels, 50 births are to be randomly selected and use of prenatal care by the
mother is assessed. If the results were to indicate that less than 80% of the
mothers had received "adequate" prenatal care then some appropriate action
would be initiated in the community. Suppose that 32 of the 50 mothers selected
are judged to have received "adequate" prenatal care, what conclusions can be
made about prenatal care in the community?
Solution
A one-sided rejection region is implied since action is to be taken only if the level
of care is less than 80%.
Therefore: H0 : P = 0.80 versus Ha: P < 0.80
Under the null hypothesis, and invoking the central limit theorem, the sampling
distribution of the sample proportion is normal with:
mean
standard error
= 0.80
=
"[(0.80 x 0.20/50)]
= 0.0566
(Note that 1.645 is the z-value corresponding to the number of standard errors to
the left of the mean of a normal distribution such that only 5% of the area under
the curve will be smaller.) Hence the decision rule is to reject the null hypothesis
if the sample proportion is less than:
0.80 - 1.645
0.0566
0.707
Since p = 32/50 = 0.64, the null hypothesis of "adequate" prenatal care should
be rejected. A corrective appropriate action should therefore be initiated.
67
and, assuming the two samples are independent, the variance of this distribution is
As a specific example, if the study is designed to test H 0 : P1 =P 2 then the mean of the
sampling distribution of p1-P2 under H0 is 0 and the variance is:
where n1 and n 2 are the number of observations selected from the first and second samples.
If the null hypothesis is true, P1=P2 =P. Hence it follows that
and if the sample sizes are equal, i.e., n1=n 2=n, then
Var(p1-P2) = 2[P(1-P)/n] .
This variance involves the unknown population parameter, P. As a result, this parameter is
usually estimated by the average of the two sample proportions. That is, assuming
69
Fail to reject H
Type I error
probability
Type II error
probability
~-~
Reject H
Distribution under Ha
Reject H
0
Example 11.6.1
Suppose two drugs are available for the treatment of a particular type of intestinal
parasite. One hundred patients entering a clinic for treatment for this parasite are
randomized to one of the two drugs; fifty receiving drug A and fifty receiving drug
B. Of the patients receiving drug A, 64% responded favorably; 82% of the
patients receiving drug B responded favorably. Are the drugs equally effective or
is the observed difference too large to be due to chance alone?
Solution
The problem is set up assuming the two drugs are equally effective and, so long
as there is no economic or other reason to prefer one drug over the other, the
test can be set up two-sided. That is,
An alternative approach for testing this hypothesis is to first establish a confidence interval
whose end points are given in the following expression:
and then determine whether or not the value 0, i.e., the value which would indicate no
difference between the population proportions, falls in the interval. If it does, the null
hypothesis is not rejected; if it does not, the null hypothesis is rejected.
Example 11.6.2
In Example 11.6.1, the end points of the confidence interval are:
(0.64-0.82)1.96v'[(0.64)(0.36)/50 + (0.82)(0.18)/50]
70
-0.181.96(0.0869)=-0.180.17,
yielding the 95% confidence interval,
Notice that 0 does not fall in this interval so that again we would conclude, using a
confidence interval approach, that the two drugs are not equally effective.
Note that when establishing a confidence interval the sample proportions are not pooled to
obtain an estimate of the variance of the difference since there is no underlying null
hypothesis stating that the population parameters are equal.
Confidence intervals have a major advantage over hypothesis tests - more information is
obtained about the population parameter than the simple rejection or acceptance of a
statement. When testing a null hypothesis we always run a risk of committing an error.
The type-I or a error is possible whenever the null hypothesis is rejected. Fortunately, the
magnitude of this error probability is fixed and may be stated in advance by the
investigator. Whenever the hypothesis cannot be rejected, there exists the possibility of
committing a type-IT or~ error. It is unfortunately true that one never knows how large the
~ error is since one never knows the actual condition of the population.
In a case-control design, subjects are selected on the basis of their outcome status (e.g.
patients with bladder cancer are enlisted into the study, as is a group of "controls" or noncancer patients) and all subjects are studied with respect to their prior and current exposure
to suspected risk factors. From a practical point of view, this type of study may be carried
out at relatively low cost and within a relatively short time frame since it is not necessary to
wait for the disease to develop in previously disease-free individuals.
There is a third type of epidemiologic study known as a prevalence study. In this type
of study, a representative sample is selected from the population in order to estimate the
proportion of individuals with a condition of interest at a specific point in time. This
condition can relate to either exposure or to disease and is typically presented as a
proportion. This proportion is termed the prevalence and represents an instantaneous
snapshot of the number of people with the condition at a specified point in time relative to
the total number of eligible individuals in the population. The concept of prevalence is
distinct from that of incidence which is a measure of the number of new cases occurring
in the population in a specified time period. Prevalence may be either greater than or less
than incidence depending upon the duration of the condition and the rate at which incident
cases die or leave the population. Hence one measure cannot be substituted for the other.
72
Disease
Present
(D)
Total
n1
(D)
n2
Total
m1
m2
Absent
In the cohort study, n individuals are enrolled in the study. All of these individuals are
disease-free at the beginning of the study and n1 of them are known to be subsequently
exposed to a suspected risk factor while n2 of them are not.
The relative risk, denoted "RR", is a population parameter defined as the ratio of the
probability of disease development among exposed individuals to the probability of disease
development among nonexposed individuals. The expression Prob{AIB} will denote the
probability of the event "A" among all individuals having the characteristic "8". Using this
notation, the relative risk is:
RR = Prob{DIE}/Prob{DIE}.
This parameter may be estimated directly only in a cohort study since in that type of study
the outcom~, presence or absence of disease, is the measured variable. In fact, Prob{DIE}
and Prob{DIE} may be estimated by a/n 1 and c/n 2 respectively. Thus, the relative risk may
be estimated as
A
RR = (a/m1)/(b/m2)
The remarkable feature of a case-control study is that it permits estimation of the relative
risk under certain conditions. This is accomplished via the odds ratio. The odds of an
event is defined as the ratio of the probability that the event will occur to the probability
that the event will not occur. For example, in the cohort study, let the odds in the
exposed group be denoted as "01 " where
-
01
= Prob{DIE}/Prob{DIE}.
Let the odds in the unexposed group be denoted as "02 " where
02 = Prob{DIE}/Prob{DIE}.
As its name implies, the odds ratio, denoted by "OR", is the ratio of 0 1 to 0 2 That is,
From Table II.4 it is clear that to estimate the odds ratio for a cohort study we compute
73
In a case-control study, the measured variable is the ex2osure status of the individual.
Thus, for the cases, the o~ds is d~fip.ed as Prob{EID}!Prob{E ID} while, for the controls, the
odds is given by Prob{EI D}/Prob{E ID}. Hence, the odds ratio for case-control studies is
-
The quantity ad/be is also called the cross product ratio in the literature of 2x2
contingency tables. We see that the odds ratio, as estimated by the cohort study, is
identical to the odds ratio as estimated by the case-control study. While odds ratios may be
estimated from either case-control or cohort studies, relative risks may only be estimated
directly from cohort studies.
In many, if not all, epidemiologic studies, the parameter of primary interest is the relative
risk, RR, since this parameter quantifies how much more (or less) likely an individual who
has been exposed is to develop the outcome than is an individual who has not been
exposed. In the epidemiologic literature, relative risks of order of magnitude 2 (providing
they are statistically significant) or larger are often considered important evidence of an
exposure effect.
In many epidemiologic studi~s the diseases being studied are relatively rare events and, as a
result, Prob{DIE} and Prob{DIE} are both small. The relative risk, as estimated from a cohort
study, is
A
RR
=
=
=
=
(a/m1)/(blm2)
[a/(a+e)]/[b/(b+d)]
(ab+ad)/(ab+bc)
(ad/be){[(b/d)+ 1]/[(a/e)+ 1]}
In the previous discussion of hypothesis testing and estimation of proportions the notation
P1 and P2 were used to denote the proportions with the condition in populations 1 and 2
respectively. Putting this into the framework of the cohort study, where the subscript 1
denotes the exposed cohort and the subscript 2 denotes the unexposed cohort, it follows
that
-
P1 = Prob{DIE},
P2 = Prob{DIE },
For the case-control study, similar notation may be defined for the probabilities of exposure
74
P2*=Prob{EID},
1-P2*=Prob{EID}.
It follows that
and that
In terms of the notation of the 2x2 table in Table 11.4 the parameters may be estimated as
follows:
P1 =alm1,
1-P1 =dm1
P2 = b/m 2,
1-P2 = d/m2
P1* = a/n1,
1-p1* = b/n1
P2* = ctn2,
1-p2* = d/n2
Estimates of the relative risk and odds ratio may be defined as:
RR = P1/P2 = (a/m1)/(b/m2) = am2/bm1
= OR .
Following exponentiation of the limits, the resulting confidence interval will not be
symmetric, the direction of the skew depending upon whether the odds ratio (OR) was
greater or less than one.
It follows, from statistical methods for determining the variance of a function of a random
variable, that the variance of the sampling distribution ofln(OR) is approximately
75
Since this expression involves unknown population parameters, an estimate of this quantity
may be obtained as
Var[ln(OR)] = 1/a + 1/b + 1/c + 1/d.
Fig. 18 shows the use of ln(OR) and the relationship between the confidence limits as
defmed on the two scales.
ln(<1Ru}=ln(OR)+zSE[In(dR)]
t----------------:=_,...---
1-------::::o..r
1\
0.0+-----::~~----:-L---....L..--------''----t~OR
O~L
OR
L.wJ
Fig. 18 Plot of confidence interval for ln(OR) versus confidence interval for OR
Fig. 18 shows that, whereas the confidence interval established for ln(OR) is symmetric,
when the limits are transformed into the original scale the transformed interval is not
symmetric about OR.
If a statistical test of the null hypothesis H0:0R=1 versus the alternative Ha:OR#1 is to be
performed, the usual chi-square (x 2 ) test based on the 2x2 table may be used. If the
resulting calculated value of xz is too large, the null hypothesis is rejected. (The previously
described test of the equality of two proportions is equivalent to this chi square test based
on the 2x2 table.)
Cancer status
Yes
No
Total
Yes
24
30
No
90
60
150
Total
114
66
180
76
For these data the estimated odds ratio is (24)(60)/[(90)(6)] = 2.67. To determine
whether 2.67 is significantly different from 1, test the hypothesis H0:0R=1 versus
Ha:OH;to1, by computing the usual chi-square test with one degree of freedom.
Here, 2=4.31 which is significant at the 5% level. [Note that the critical region is
reject Ho if x2 > x21-a(1 ).] Hence we reject H0.
A confidence interval estimate for the population odds ratio is obtained by first
taking the log 9 of the estimated odds ratio, utilizing the standard error of the
ln(OR) to construct a confidence interval for ln(OR), and finally exponentiating to
obtain a confidence interval for the odds ratio. In this example, the log odds is
ln(2.67)=0.981. The estimated variance of the log odds is:
Var[ln(OR)]=1 /24+ 1/90+ 1/6+ 1/60 = 0.236.
The 95% confidence interval for ln(OR) is:
0.981 - 1.96'11'0.236 ~ ln(OR) ~ 0.981 + 1.96'11'0.236
0.029 ~ ln(OR) ~ 1.93
Converting to original units it follows that
e0.029
~OR~
1.03 ~OR
e1.93
6.9 .
Since 1 does not fall in this interval, we again see that we would reject H0. This
may not always be the case since the chi-square test and the method for
confidence interval estimation are based on different distributional assumptions:
(P1-P2) and ln(OR), respectively. The reader should see Fleiss17 for a complete
discussion of the various methods for estimation and testing of the odds ratio.
The literature on estimation and hypothesis testing about odds ratios is very large and most
attention has focused on the situation where n1 , n2 , m1 and m2 (see Table II.4), are small.
Since the goal of this manual is sample size determination, and since these sample sizes will
tend to be large, the methods based on ln(OR) will be appropriate.
The sampling distribution of RR will, for extremely large samples, be approximated by a
normal distribution. However, for sample sizes typically employed in most epidemiologic
studies, the sampling distribution of RR will often not be normal, with considerable
skewness to the right (as was the case with OR). A logarithmic transformation is again
employed which induces more symmetry into the sampling distribution, allowing use of the
normal distribution to approximate the sampling distribution for smaller sample sizes.
Thus, as was the case with the odds ratio, confidence interval estimation of the RR is
usually performed by first obtaining a confidence interval for ln(RR) and later
exponentiating the confidence limits to obtain a confidence interval for the RR parameter.
Recall that the relative risk is estimated from a cohort study as
and it follows, from standard methods used to obtain the variance of a function of a random
variable, that:
Var[ln(RR )] = Var[ln(p1)-ln(P2)] = Var[ln(p1)l + Var[ln(P2)] .
77
Now, since the variance of the loge of any proportion p based on n observations is
Var[ln(p)]
=(1/n )[(1-P)/P]
This expression for the estimate of the variance of the lo& of the relative risk is then used in
precisely the same way as was the expression for the variance of the odds ratio for
construction of confidence intervals. Again, the limits of the symmetric confidence interval
for the ln(RR) must be exponentiated in order to obtain a confidence interval for the relative
risk. This interval will not be symmetric, as was illustrated in Fig. 18 for OR.
versus
Ha: Patient does not have cervical cancer
We will base our decision on a single screening test (PAP test) which will be used as a
diagnostic tool for early detection of cervical cancer. It is important to set up the screening
test such that the alternative is the disease-free condition. This allows one to take advantage
of the size of the type I error. By this we mean that if we reject H0, the only type of error
which could have occurred is a type I error, which we may make as small as we wish.
Consider the 2x2 table presented in Fig. 19 which relates to the decisions made on a
number of patients:
78
"CUI
CDCD
0-
asC')
.c
c:t:
OCD
CD
tna..
-()0
()
CD
cc:
0
~~~
Egl$
E
-~
:fi -~-~
n 11
1U >
n
1
12
Q)
a_<11a.
.c
(])
~~~
.!!l
......
True positives
False positives
gl ~
(/)-
55:ci
~0 ~
a.. .s
Total
n
21
False negatives
n
22
True negatives
n
1
n ..
Fig. 19 shows that a total of n patients have been screened. Of these, n1. had a positive
result and n2. had a negative result. Furthermore, we assume that all n patients were
studied in detail following the screening and n. 1 were determined to actually have the
disease while n.2 were determined to be free of the disease. Using these data, we may
estimate numerous quantities of interest.
True positive rate = n11 /n. 1 - This rate is also called the sensitivity of the test.
False negative rate = n21 /n. 1 - This rate is equivalent to the a error of the hypothesis test.
False positive rate = n1 2 /n.2 - This rate is equivalent to the ~ error of the hypothesis test.
True negative rate = n22 /n. 2 - This rate is also called the specificity of the test. It is
equivalent to the statistical power of the hypothesis test.
It should be noted that in any actual study, the values of n. 1 and n.2 would not be known.
The predictive value observed in any study depends upon the prevalence of the disease. If
the population being screened is a high risk population, there will be high prevalence and
the predictive value of a positive test will be higher than with a low risk population.
The proportion of these enumeration units which possess some characteristic, Y, is denoted
P, the mean level of some characteristic, X, over all N enumeration units is denoted ~. and
the variance of the N values of X is denoted o2. Because N may be very large or the time or
budget available to carry out the survey very limited, a sample of size "n" of the original N
enumeration units in the population must be selected. From the n selected enumeration
units in the sample, the population proportion, mean and variance may be estimated by p, x
and s2. If this sample is selected at random from the population, these estimates will be
"unbiased". That is,
E(p) = p
E(x)=~
E(s2)
= o2.
From the discussion of Chapter 4 of the second part of this book, this means that if many
80
(e.g., "k") random samples were selected from this population, and if p, X: and s2 were
computed for each of these samples, the average of the k sample proportions would equal
the population proportion, P, the average of the k sample means would equal l..l and the
average of the k sample variances would be o2. Unbiasedness is a desirable statistical
property since it assures that the sample values will, on average, be correct. However, it
must be stressed that an estimate computed from any one particular sample may be quite
different from the population parameter. The concept of unbiasedness relates to repeated
sampling and the corresponding averaging process.
In order to select a simple random sample it is necessary to:
Construct a list (or "frame") of the N enumeration units;
Use a random process (e.g., a random number table) to generate n numbers between 1
and N which identifies the n individuals in the sample.
Note that there are Ncn possible samples which can be selected from this population [where
NCn=N!/n!(N-n)! and a!=(a)(a-1 )(a-2) ... (1 )]. For example, if N=25 and a sample of size n=5 is
to be selected, there are 25 C5 = 53130 possible samples. A simple random sample may then
be formally defmed as follows:
Definition: A simple random sample is one in which each of the Ncn possible samples
has the same chance of being selected; i.e., 1/(NCn).
The advantages of simple random sampling may be stated as follows:
It is simple to conceptualize;
It provides the probabalistic foundation of much of statistical theory;
It provides a baseline to which other methods can be compared.
Systematic sampling
This method can save much time and effort and is more efficient in some situations than
simple random sampling. For example, suppose a sample, size n, of patients' records,
treated during the past year at a local health clinic, is needed for a survey of nutritional
intake. With systematic sampling, this is accomplished by creating n zones of k = N/n
records each. Within the first zone, a random number between 1 and k is selected,
representing the first chosen record. Subsequent records are identified by successively
81
adding the constant k to the starting random number i. Thus, the sample of size n is
composed of the ith, [i+k]lh, ... ,[i+(n-l)k]th records in the filing cabinet. This is represented
pictorially as follows:
f f f
k
i+k
i+2k
____..
i+3k
i+(n-1)k
random number
chosen between
1 and k
S M T W T F S I S M T W T F S /.. ./ S M T W T F S
82
Stratified sampling
Consider a study of all hospital beds in a particular geographic region. This population is
represented pictorially in Fig. 21 as follows:
Mid-sized hospitals
Fig. 21 Schematic representation of stratified sampling
If a simple random sample were selected from the N hospitals, the large hospitals could, by
chance alone, be either totally missed, oversampled or undersampled.
83
When proportional allocation is used, estimates of the population mean and proportion are
"self-weighting". This means that when estimating the population mean, proportion or
total, each sample element is multiplied by the same constant, 1/n, irrespective of the
stratum to which the element belongs.
The advantages of stratified random sampling may be summarized as follows:
A stratified random sample may provide increased precision (i.e., narrower confidence
intervals) over that which is possible with a simple random sample of the same size;
Information concerning estimates within each stratum is easily obtainable;
For either administrative or logistical reasons, it may be easier to select a stratified
sample than a simple random sample.
The major disadvantage of stratified sampling is, however, that it is no less expensive than
simple random sampling since detailed frames must be constructed for each stratum prior
to sampling. For this reason, despite the high level of precision possible with stratified
sampling, the most commonly employed sampling method in survey research is cluster
sampling.
Cluster sampling
Suppose a survey is being planned to study the prenatal care received by pregnant women
in a large city.
Among the numerous problems inherent in such a study are:
The population is very large and it might be impossible to construct an up-to-date and
accurate frame. Even if one could be set up, the costs involved in setting up a detailed
frame and later in attempting to contact individuals may be prohibitive;
The population is highly dispersed. This presents significant logistical problems if there
are restrictions on available time and travel expenses.
A solution to these problems is to use a cluster sampling strategy.
Sampling techniques such as simple random sampling and systematic sampling require that
the sampling frames be constructed which list the individual enumeration units (or listing
units).
Sometimes, however, especially in surveys of human populations, it is not feasible to
compile sampling frames of all enumeration units for the entire population. On the other
hand, sampling frames can often be constructed that identify groups or clusters of
enumeration units without listing explicitly the individual enumeration units.
Sampling can be performed from such frames by:
taking a sample of clusters;
obtaining a list of enumeration units only for those clusters which have been selected in
the sample;
selecting a sample of enumeration units.
84
Cluster sampling is a hierarchical kind of sampling in which the elementary units are at least
one step removed from the original sampling clusters, and often two steps (or more) are
involved.
The term "cluster", when used in sample survey methodology, can be defined as any
sampling unit with which one or more listing units can be associated. This unit can be
geographic or temporal in nature.
Definition: Cluster sampling can be defined as any sampling plan that uses a frame
consisting of clusters of enumeration units. Typically, the population is divided into "M"
mutually exclusive and exhaustive clusters. Unlike strata, clusters should be as
heterogeneous as possible.
The process by which a sample of listing units is selected is typically stepwise. For
example, if city blocks are clusters and households are listing units, there might be two
steps involved in selecting the sample households:
Step 1: Select a sample of blocks;
Step 2: Select a sample of households within each block selected at the first step.
In sampling terminology, these steps are called "stages", and sampling plans are often
categorized in terms of the number of stages involved. For example, a "single-stage cluster
sample" is one in which the sampling is done in only one step- i.e., once the sample of
clusters is selected, every enumeration unit within each of the selected clusters is included
in the sample. At the first stage, "m" clusters are selected from the Mavailable clusters. At
the second stage, all Nj listing units are studied in the jth selected cluster.
For a "two-stage sample" the "m" clusters are selected from theM available clusters at the
first stage. At the second stage, ni elementary units are selected, using simple random or
systematic sampling techniques, from the jth cluster, j=1 ,... ,m. Hence samples of size
n1 ,n2, ... ,nm are selected from the N1,N2, ... ,Nm elementary units comprising the frames of each
of the selected clusters.
85
Note that n=n1+n2+ ... +nm. Ifni= Ni. i=1, ... ,m, we have a "simple one-stage cluster sample".
On the other hand, if ni < Ni for some i, we have a two-stage cluster sample.
A "multistage cluster sample" is performed in two or more steps. For example, to carry out
an immunization survey of school children in a given province, the following steps might
be followed:
Step 1: Select m counties from the M mutually exclusive and exhaustive counties
composing the province;
Step 2". Select a sample of townships or other minor civil divisions within each of the
counties selected at the first step;
Step 3: Select a sample of school districts within each of the townships selected at the
second stage;
Step 4: Select a sample of schools within each of the school districts selected at the third
stage;
Step 5: Select a sample of classrooms within each of the schools selected at the fourth
stage;
Step 6: Take every child within the classrooms selected at the fifth stage.
In this example, the children are the "elementary units" and the classrooms are the "listing
units". In sampling involving more than two stages, the clusters used at the first stage of
sampling are generally referred to as "primary sampling units" or "PSUs".
With these multistaged designs, writing down precise expressions for parameter estimates
and associated standard errors can be difficult since each level. of sampling must be
accounted for. Variance estimation techniques such as jackknife, bootstrap, balanced
repeated replication and linearization are invaluable in these circumstances.
It should be noted that in the cluster sampling schemes described thus far, the m clusters
were selected at random from the M available clusters. (Without loss of generalizability,
this selection may be done systematically as well.) When clusters are selected with
"probability proportionate to size", denoted "PPS", selection is not random. This method
of selection has, however, a number of distinct advantages24.
The advantage of cluster sampling is that detailed frames need only be constructed for the m
clusters selected at the next-to-last stage. This represents great savings in time and
resources since frames need not be prepared for the entire population.
Cluster sampling generally will not produce as precise estimates as will simple random
sampling or stratified sampling if each method were to use the same total sample size, n.
However, due to the greatly reduced cost and administrative ease, a larger cluster sample
may be selected, for the same cost, than that which is possible using the other sampling
schemes discussed thus far. As a result of the larger sample size, a relatively high level of
precision will result.
The two most important reasons why cluster sampling is so widely used in practice,
especially in sample surveys of human populations and in sample surveys covering large
geographic areas, are feasibility and economy. Cluster sampling may be the only
feasible method since the only frames readily available for the target population may be lists
of clusters. If that is the case, it is almost never feasible, in terms of time and resources, to
compile a list of individuals (or even households) for the sole purpose of conducting a
survey. However, lists of blocks or other geographic units can be compiled relatively
86
easily, and these can serve as the sampling frame of clusters. Cluster sampling is also
often the most economical form of sampling since listing costs and travel costs are the
lowest of any potential method.
In general, if n1 =n 2 ==nm=n, standard errors obtained by cluster sampling are
approximately v'{1+8x(n-1)} times as large as those obtained from a simple random sample of
the same total number of listing units, where Bx is the intraclass correlation coefficient and n
is the number of listing units selected in each cluster. This coefficient ox can range from
very small negative values, when the elements within each cluster tend to be very diverse or
representative of the population of elements (this is termed "heterogeneity"), to a maximum
of one when the elements within each cluster are similar but differ from cluster to cluster
(this is termed "homogeneity"). It is clear that standard errors with cluster sampling will
equal those with simple random sampling when Bx=O (i.e., heterogeneous clusters), but can
be much larger when the clusters are homogeneous. The ratio of the variance with cluster
sampling to the variance with simple random sampling is termed the design effect.
Bibliography
Area of
emphasis
2.
Bloch DA: Sample size requirements and the cost of a randomized clinical trial
with repeated measurements. Stat in Med 5: 663667, 1986.
3.
Bohning D: Confidence interval estimation of a rate and the choice of sample size.
Stat in Med 7: 865875, 1988.
4.
Browne RH: Reducing sample sizes when comparing experimental and control groups.
Arch Environ Health May/June: 169170, 1976.
5.
6.
7.
1,3
2,4
Casagrande JT, Pike MC, Smith PG: An improved approximate formula for calculating
sample sizes for comparing two binomial distributions. Biometrics 34: 483-486, 1978.
2,4
8.
Connett JE, Smith JA, McHugh RB: Sample size and power for pair-matched case control
studies. Stat in Med 6: 5359, 1987.
2,4
9.
Connor RJ: Sample size for testing differences in proportions for the paired-sample design.
Biometrics 43: 207-211, 1987.
10.
11.
1 ,2,8
2,3,6
12.
13.
1,2,7
14.
15.
Feigl P: A graphical aid for determining sample size when comparing two
independent proportions. Biometrics 34: 111122, 1978.
16.
17.
Fleiss JL: Confidence intervals for the odds ratio in case-control studies:
the state of the art. J Chron Dis, 32: 6977, 1979.
The Area of emphasis column refers to that part of the reference of particular interest (see Key)
Key
1
2
3
4
One sample
Two samples
Cohort studies
Case-control studies
5
6
7
8
2,4
88
18.
Fleiss JL: Statistical Methods for Rates and Proportions (2nd ed.). New York,
John Wiley & Sons, 1981.
19.
Fleiss JL, Tytun A, Ury HK: A simple approximation for calculating sample
size for comparing independent proportions. Biometrics 36: 343-346, 1980.
20.
21.
22.
23.
24.
2,3
2,3
Gail M, Gart JJ: The determination of sample sizes for use with the exact
conditional test in 2 x 2 comparative trials. Biometrics 29: 441-448, 1973.
2,3
George SL, Desu MM: Planning the size and duration of a clinical trial studying
the time to some critical event. J Chron Dis 27: 15-24, 1977.
Gillum RF, Williams PT, Sondik E: Some considerations for the planning of
total-community prevention trials - when is sample size adequate?
J Comm Health 5: 270-278, 1980.
26.
28.
Haber M: Sample sizes for the exact test of 'no interaction' in 2 x 2 x 2 tables.
Biometrics 39: 493-498, 1983.
1,3
6
2,3
29.
Freiman JA, Chalmers TC, Smith HS Jr., Kuebler RR: The importance of beta,
the Type II error and sample size in the design and interpretation of the
randomized control trial. NEJM 299: 690-694, 1978.
25.
27.
1 ,2
2,3,8
Hall JC: A method for the rapid assessment of sample size in dietary studies.
Am J Clinical Nutrition 37: 473-477, 1983.
2,3
30.
Heilbrun LK, McGee DL: Sample size determination for the comparison of
normal means when one sample is fixed. Camp Stat & Data Analysis 3: 99-102, 1985.
2,3
31.
Hornick CW, Overall JE: Evaluation of three sample size formulae for 2 x 2
contingency tables. J Educ Stat 5: 351-362, 1980.
32.
33.
Johnson AF: Sample size: clues, hints or suggestions. J Chron Dis 38: 721-725, 1985.
34.
Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data.
New York, John Wiley & Sons, 1980.
35.
36.
The Area of emphasis column refers to that part of the reference of particular interest (see Key)
Key
1
2
3
4
One sample
Two samples
Cohort studies
Case-control studies
5
6
7
8
2,3
37.
38.
39.
89
2,6
2,3
40.
41.
42.
43.
3,4
44.
Lubin JH, Gail MH, Ershow AG: Sample size and power for case-control studies
when exposures are continuous. Stat in Med 7: 363-376, 1988.
45.
Lwanga SK, Lemeshow S: Sample Size Determination in Health Studies: A User's Manual.
World Health Organization, Geneva, 1989.
46.
2,3
2,3
47.
48.
Makuch RW, Simon RM: Sample size requirements for comparing time-to-failure
among k treatment groups. J Chron Dis 35: 861-867, 1982.
49.
50.
Meydrech EF, Kupper LL: Cost considerations and sample size requirements in
cohort and case-control studies. Am J Epidemio/1 07: 201-205, 1978.
51.
4
1-7
7
4
2,3,4
6
52.
53.
54.
Nam J-M: Optimum sample sizes for the comparison of the control and
treatment. Biometrics 20: 101-108, 1973.
2,3
Odeh RE, Fox M: Sample Size Choice; Charts for Experiments with Linear Models.
New York, Marcel Dekker, Inc., 1975.
1,2
55.
The Area of emphasis column refers to that part of the reference of particular interest (see Key)
Key
1
2
3
4
One sample
Two samples
Cohort studies
Case-control studies
5
6
7
8
90
56.
Oliphant TH, McHugh RB: Least significant relative risk determination in the case
of unequal sample sizes. Am J Epidemiol113: 711-715, 1981.
57.
58.
Overall JE, Dalal SN: Empirical formulae for estimating appropriate sample sizes
for analysis of variance designs. Perceptual and Motor Skills 27: 363-367, 1968.
59.
61.
62.
63.
64.
Palla M: Determining the required accrual rate for fixed-duration clinical trials.
2,3,4
2,8
2,3,8
2,3,4,8
2,4
65.
Rao BR: Sample size determination in case-control studies: the influence of the
distribution of exposure. J Chron Dis 39: 941-943, 1986.
66.
Rubenstein LV, Gail MH, Santner TJ: Planning the duration of a comparative
clinical trial with loss to follow-up and a period of continued observation.
J Chron Dis 34: 469-479, 1981.
2,8
67.
1 ,a
68.
69.
70.
72.
Taulbee JD, Symons MJ: Sample size and duration for cohort studies
of survival time with covariables. Biometrics 39: 351-360, 1983.
74.
2,3,4
71.
73.
Tygstrup N, Lachin JM, Juhl E: The Randomized Clinical Trial and Therapeutic
Decisions. Vol. 43, Statistics: Textbooks and Monographs. New York,
Marcel Dekker, Inc., 1982.
United States American Public Health Association: On the use of sampling in the
field of public health. Am J Pub Hlth 44:719-740, 1954.
The Area of emphasis column refers to that part of the reference of particular interest (see Key)
Key
1
2
3
4
One sample
Two samples
Cohort studies
Case-control studies
5
6
7
8
2,3,7
2,7
75.
Ury HK, Fleiss JL: On approximate sample sizes for comparing two independent
proportions with the use of Yates' correction. Biometrics 36: 347-351, 1980.
91
2
8
2,3,7
78.
1,7
79.
Young MJ, Bresnitz EA, Strom BL: Sample size nomograms for interpreting negative
clinical studies. Annals Intern Med 99: 248-251, 1983.
2,3
The Area of emphasis column refers to that part of the reference of particular interest (see Key)
Key
1
2
3
4
One sample
Two samples
Cohort studies
Case-control studies
5
6
7
8
Part Ill
Table 1a: Sample Size Necessary to Estimate P to Within d Absolute Percentage Points
with 99% Confidence
Anticipated Population Proportion (P)
d
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
0.14
0.15
0.20
0.25
0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 0.55 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95
3152 5972
8461 10617 12442 13935 15096 15926 16424 16589 16424 15926 15096 13935 12442 10617 8461
5972 3152
3111
3484
3774 3981
4106 4147
4106 3981
3774 3484
3111
2654 2115
1493
788
350
664
940 1180
1382 1548
1677 1770
1825 1843
1825 1770
1677 1548
1382
1180
940
664
350
197
373
529
1026 1037
1026
778
664
529
373
197
126
239
338
88
64
166
122
235
173
49
93
132
166
39
74
104
131
32
60
85
106
26
49
70
88
103
22
41
59
74
86
19
35
50
63
16
30
43
14
27
15
10
664
778
871
944
995
995
944
871
425
498
557
604
637
657
664
657
637
604
557
498
425
338
239
126
295
217
346
387
419
442
456
461
456
442
419
387
346
295
235
166
88
254
284
308
325
335
339
335
325
308
284
254
217
173
122
64
194
218
236
249
257
259
257
249
236
218
194
166
132
93
49
154
172
186
197
203
205
203
197
186
172
154
131
104
74
39
124
139
151
159
164
166
164
159
151
139
124
106
85
60
32
115
125
132
136
137
136
132
125
115
103
88
70
49
26
97
105
111
114
115
114
111
105
97
86
74
59
41
22
74
82
89
94
97
98
97
94
89
82
74
63
50
35
19
54
63
71
77
81
84
85
84
81
77
71
63
54
43
30
16
38
47
55
62
67
71
73
74
73
71
67
62
55
47
38
27
14
21
27
31
35
38
40
41
41
41
40
38
35
31
27
21
15
14
17
20
22
24
25
26
27
26
25
24
22
20
17
14
10
d
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
0.14
0.15
0.20
0.25
0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 0.55 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95
1825 3457
4898 6147
7203 8067
8740 9220
9508 9604
9508 9220
8740 8067
7203
6147 4898
1225 1537
1801
2017
2185 2305
2377 2401
2377 2305
2185 2017
1801
1537 1225
800
896
456
864
203
384
544
683
114
216
306
384
450
504
546
576
594
600
594
576
546
504
73
138
196
246
288
323
350
369
380
384
380
369
350
323
51
96
136
171
200
224
243
256
264
267
264
256
243
224
37
71
100
125
147
165
178
188
194
196
194
188
178
29
54
77
96
113
126
137
144
149
150
149
144
137
23
43
60
76
89
100
108
114
117
119
117
114
108
18
35
49
61
72
81
87
92
95
96
95
92
87
15
29
40
51
60
67
72
76
79
79
79
76
13
24
34
43
50
56
61
64
66
67
66
11
20
29
36
43
48
52
55
56
57
18
25
31
37
41
45
47
49
49
15
22
27
32
36
39
41
42
43
12
15
18
20
22
23
24
10
12
13
14
15
15
971
3457 1825
864
456
683
544
384
203
450
384
306
216
114
288
246
196
138
73
200
171
136
96
51
165
147
125
100
71
37
126
113
96
77
54
29
100
89
76
60
43
23
81
72
61
49
35
18
72
67
60
51
40
29
15
64
61
56
50
43
34
24
13
56
55
52
48
43
36
29
20
11
49
47
45
41
37
31
25
18
42
41
39
36
32
27
22
15
24
24
23
22
20
18
15
12
15
15
15
14
13
12
10
971
896
800
0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 0.55 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
0.14
0.15
0.20
0.25
1285 2435
3450 4330
5074 5683
6697 6494
6156 5683
5074
4330 3450
1268 1421
1539 1624
1674 1624
1539 1421
321
609
863 1082
1268
1082
863
609
321
143
271
383
481
564
631
684
722
744
752
744
722
684
631
564
481
383
271
143
80
152
216
271
317
355
385
406
419
423
419
406
385
355
317
271
216
152
80
51
97
138
173
203
227
246
260
268
271
268
260
246
227
203
173
138
97
51
36
68
96
120
141
158
171
180
186
188
186
180
171
158
141
120
96
68
36
26
50
70
88
104
116
126
133
137
138
137
133
126
116
104
88
70
50
26
20
38
54
68
79
89
96
101
105
106
105
101
96
89
79
68
54
38
20
16
30
43
53
63
70
76
80
83
84
83
80
76
70
63
53
43
30
16
13
24
35
43
51
57
62
65
67
68
67
65
62
57
51
43
35
24
13
11
20
29
36
42
47
51
54
55
56
55
54
51
47
42
36
29
20
11
17
24
30
35
39
43
45
47
47
47
45
43
39
35
30
24
17
14
20
26
30
34
36
38
40
40
40
38
36
34
30
26
20
14
12
18
22
26
29
31
33
34
35
34
33
31
29
26
22
18
12
11
15
19
23
25
27
29
30
30
30
29
27
25
23
19
15
11
11
13
14
15
16
17
17
17
16
15
14
13
11
10
10
11
11
11
10
10
1674 1691
2435 1285
0.10
0.85
0.90
0.95
0.011260798597220376027265431199073154835123236 99537 81104 66358 54293 44239 35731 28439 22119 16589 11710
7373
3493
0.02 315200149305 94007 66358 49769 38709 30809 24885 20276 16590 13574 11060
8933
7110
5530
4148
2928
1844
874
9012
5069
7374
4148
6033
3394
4916
2765
3971
2234
3160
1778
2458
1383
1844
1037
1302
732
820
461
389
219
0.05
7963
6194
4930
3982
3245
2655
2172
1770
1430
1138
885
664
469
295
140
0.06
737 4
5530
4301
3424
2765
225~
1844
1509
1229
993
790
615
461
326
205
98
0.07
0.08
25731 12189
19700 9332
7675
5876
5417
4148
4063
3111
3160
2420
2516
1926
2032
1556
1656
1268
1355
1037
1109
849
903
692
730
559
581
445
452
346
339
260
239
183
151
116
72
55
0.09
15566
7374
4643
3277
2458
1912
1522
1229
1002
820
671
547
442
352
274
205
145
92
44
0.10
12608
5973
3761
2655
1991
1549
1233
996
812
664
543
443
358
285
222
166
118
74
35
0.15
5604
2655
1672
1180
885
689
548
443
361
295
242
197
159
127
99
74
53
33
16
0.20
0.25
3152
2018
1494
956
941
602
664
425
498
319
388
248
309
198
249
160
203
130
166
107
136
87
111
71
90
58
72
46
56
36
42
27
30
19
19
12
9
6
0.30
1401
664
418
295
222
173
137
111
91
74
61
50
40
32
25
19
14
0.35
1030
488
307
217
163
127
101
82
67
55
45
37
30
24
19
14
10
0.40
0.50
788
505
374
239
236
151
166
107
125
80
97
62
78
50
63
40
51
33
42
27
34
22
28
18
23
15
18
12
14
9
11
7
8
5
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
9605
6780
4269
2022
9605
7858
6403
5172
4117
3202
2402
1695
1068
506
4269
3493
2846
2299
1830
1423
1068
754
475
225
2402
1965
1601
1293
1030
801
601
424
267
127
1537
1258
1025
828
659
513
385
272
171
81
1068
874
712
575
458
356
267
189
119
57
785
642
523
423
337
262
197
139
88
42
601
492
401
324
258
201
151
106
67
32
475
389
317
256
204
159
119
84
53
25
385
315
257
207
165
129
97
68
43
21
171
140
114
92
74
57
43
31
19
97
79
65
52
42
33
25
17
11
62
51
41
34
27
21
16
11
43
35
29
23
19
15
11
32
26
21
17
14
11
25
20
17
13
11
16
13
11
0.05
0.10
0.15
0.45
0.50
27061
0.20
0.25
0.30
0.35
0.40
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
11598
9021
6766
4776
3007
1425
6766
5536
4511
3643
2900
2256
1692
1194
752
357
3007
2461
2005
1619
1289
1003
752
531
335
159
1692
1384
1128
911
725
564
423
299
188
90
1083
886
722
583
464
361
271
192
121
57
752
616
502
405
323
251
188
133
84
40
553
452
369
298
237
185
139
98
62
30
423
346
282
228
182
141
i 06
75
47
23
335
274
223
180
144
112
84
59
38
18
271
222
181
146
116
91
68
48
31
15
7
121
99
81
65
52
41
31
22
14
68
56
46
37
29
23
17
12
44
36
29
24
19
15
11
31
25
21
17
13
11
23
19
15
12
10
17
14
12
10
11
P8
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
318
0.15
591
94
535
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
173
87
53
36
26
20
15
12
10
771
215
104
62
41
29
22
17
13
10
0.80
0.85
47
147
722
70
193
883
20
42
90
231
1018
14
28
52
106
263
1126
11
20
35
61
119
287
1208
15
24
40
68
130
306
1264
7
6
5
12
18
28
44
73
137
318
1294
14
21
31
47
77
141
323
1298
11
16
22
32
49
79
142
321
1275
12
17
23
33
50
79
140
313
1227
10
13
18
24
34
49
77
136
299
1152
6
5
8
6
10
13
18
24
33
48
74
128
278
1052
10
13
18
23
32
45
69
117
250
925
10
13
17
22
29
41
62
104
215
771
6
5
10
12
15
20
26
36
53
87
173
591
11
13
17
22
29
42
66
124
0.95
29
925
0.90
250
117
69
45
32
23
18
13
10
1052
278
128
74
48
33
24
18
13
10
1152
299
136
77
49
34
24
18
13
10
1227
313
140
79
50
33
23
17
12
1275
321
142
79
49
32
22
16
11
1298
323
141
77
47
31
21
14
1294
318
137
73
44
28
18
12
1264
306
130
68
40
24
15
1208
287
119
61
35
20
11
263
106
52
28
14
1018
231
90
42
20
193
70
29
722
147
47
1126
883
535
94
318
382
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
0.15
231
66
32
399
108
546
19
51
143
671
470
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
8
11
140
71
44
30
22
17
13
10
607
172
723
83
197
50
34
55
101
18
25
14
93
218
24
36
58
38
895
233
106
243
60
109
39
19
26
61
986
249
1001
819
13
30
10
20
66
38
174
79
777
199
862
14
25
46
90
219
927
6
5
11
18
30
51
98
234
972
21
15
33
23
56
36
105
59
244
997
13
10
1001
12
25
18
38
26
108
61
249
110
61
249
109
39
60
26
19
14
38
25
10
8
13
951
17
13
10
14
19
11
14
11
14
11
39
26
19
0.70
0.75
0.80
0.85
0.90
0.95
8
11
14
11
19
26
14
18
10
39
13
110
61
38
25
17
12
108
244
59
105
36
56
23
15
8
10
249
33
21
13
972
234
927
51
90
30
46
18
25
11
14
199
79
174
38
20
10
66
30
13
671
143
546
51
108
399
19
32
19
26
997
18
0.65
14
986
243
106
951
233
895
58
101
55
218
93
34
22
50
36
24
17
12
15
30
19
98
219
862
777
819
197
83
723
172
607
44
71
140
25
36
56
470
103
66
231
311
-0
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
103
26
12
7
5
0.10
195
49
22
13
8
6
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
276
87
347
46
102
406
29
51
114
455
20
31
55
124
493
15
21
33
58
130
520
11
15
22
34
60
134
536
9
12
16
22
34
61
136
542
7
9
11
15
22
34
60
134
536
6
7
9
11
15
21
33
58
130
520
5
5
7
8
11
14
20
31
55
124
493
276
69
31
18
12
8
6
5
347
87
39
22
14
10
8
6
5
406
102
46
26
17
12
9
7
6
5
455
114
51
29
19
13
10
8
6
5
493
124
55
31
20
14
11
8
7
5
5
520
130
58
33
21
15
11
9
7
6
5
536
134
60
34
22
15
11
9
7
6
542
136
61
34
22
16
12
9
7
536
134
60
34
22
15
11
9
520
130
58
33
21
15
11
493
124
55
31
20
14
0.70
5
6
8
10
13
19
29
51
114
455
455
114
51
29
19
0.75
5
6
7
9
12
17
26
46
102
406
406
102
46
26
0.80
5
6
8
10
14
22
39
87
347
347
87
39
0.85
5
6
8
12
18
31
69
276
276
69
0.90
0.95
>
0..
(1)
.0
c~
(")
6
8
13
22
49
195
195
'<!
0
.....,
Cll
5
7
12
26
103
"0
(P
Cll
N.
(1)
:=
(1)
e:..
g.
Cll
0..
(D"
[/)
;.,.
0..
(!>
..0
s::
""
(")
'<
0
....,
Pa
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
378
109
498
54
137
601
33
66
161
686
22
39
75
180
754
16
26
44
83
195
804
12
19
29
48
88
205
837
10
14
20
31
50
92
211
853
8
11
15
21
32
52
93
213
852
6
8
11
16
22
33
52
93
210
834
5
7
9
12
16
22
32
51
91
203
799
Vl
0.70
0.75
0.80
0.85
0.90
0.95
'E..
(!>
Vl
N.
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
221
67
34
21
15
11
8
7
5
362
102
49
30
20
14
11
9
7
6
5
485
131
62
36
24
17
13
10
8
6
5
589
156
72
42
27
19
14
11
8
7
5
676
176
80
46
30
21
15
11
9
7
5
746
191
87
49
31
22
16
12
9
7
5
799
203
91
51
32
22
16
12
9
7
5
834
210
93
52
33
22
16
11
8
6
852
213
93
52
32
21
15
11
8
5
853
211
92
50
31
20
14
10
6
837
205
88
48
29
19
12
8
804
195
83
44
26
16
10
754
180
75
39
22
13
(!>
5
7
9
12
16
22
31
49
87
191
746
686
161
66
33
18
5
7
9
11
15
21
30
46
80
176
676
601
137
54
25
s
:r:
(!>
5
7
8
11
14
19
27
42
72
156
589
498
109
40
....e:..
::r
5
6
8
10
13
17
24
36
62
131
485
378
76
Vl
2
5
6
7
9
11
14
20
30
49
102
362
0..
(1)"
"'
5
7
8
11
15
21
34
67
221
239
Ul
---------------------
-------
......
.j;:..
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
150
44
22
14
9
7
5
0.10
253
69
33
20
13
10
7
6
5
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
283
83
368
42
103
441
26
50
119
501
18
30
56
133
548
13
20
33
61
143
584
10
14
22
35
65
149
607
8
11
15
23
37
67
153
617
6
8
11
16
24
38
68
154
615
5
7
9
12
16
24
38
67
151
601
342
91
43
25
16
12
9
7
5
419
109
50
29
19
13
10
8
6
5
483
125
57
32
21
15
11
8
6
5
535
137
62
35
23
16
11
9
7
5
574
145
65
37
23
16
12
9
7
5
601
151
67
38
24
16
12
9
7
5
615
154
68
38
24
16
11
8
6
5
617
153
67
37
23
15
11
8
5
607
149
65
35
22
14
10
7
584
143
61
33
20
13
8
0.65
5
7
9
12
16
23
37
65
145
574
548
133
56
30
18
11
0.70
5
7
9
11
16
23
35
62
137
535
501
119
50
26
15
0.75
5
6
8
11
15
21
32
57
125
483
441
103
42
21
0.80
5
6
8
10
13
19
29
50
109
419
368
83
32
0.85
5
7
9
12
16
25
43
91
342
283
60
0.90
5
6
7
10
13
20
33
69
253
184
0.95
;l>
0.
(1)
.0
c::
"'
'<
(")
5
7
9
14
22
44
150
0.....,
(/)
'E.
(1)
(/)
No
(1)
s
:r:
(1)
e.
::r
(/)
c::
0.
(i)'
C/l
;:..
0..
('1)
..0
I'll
('")
'<
0
....,
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
en
0.70
0.75
0.80
0.85
0.90
0.95
"0
en
N.
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
52
13
6
139
98
25
11
7
139
35
16
9
6
44
174
174
44
20
11
7
5
23
51
203
203
51
23
13
9
6
5
15
26
57
228
228
57
26
15
10
7
5
10
16
28
62
247
247
62
28
16
10
7
6
8
11
17
29
65
260
260
65
29
17
11
8
6
5
6
8
11
17
30
67
268
268
67
30
17
11
8
6
5
5
6
8
11
17
31
68
271
271
68
31
17
11
8
6
5
('1)
5
6
8
11
17
30
67
268
268
67
30
17
11
8
6
5
s
5
6
8
11
17
29
65
260
260
65
29
17
11
8
6
:I:
('1)
::r
6
7
10
16
28
62
247
247
62
28
16
10
7
5
7
10
15
26
57
228
228
57
26
15
10
en
....
c
0..
n
(/)
5
6
9
13
23
51
203
203
51
23
13
5
7
11
20
44
174
174
44
20
6
9
16
35
139
139
35
7
11
25
98
6
13
52
98
Ul
0\
Pa
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
177
55
28
18
13
9
7
6
5
0.10
284
81
40
24
16
12
9
7
6
5
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
284
81
377
40
103
457
24
49
122
523
16
29
57
137
576
12
19
33
63
148
615
9
14
22
36
67
157
641
7
10
15
23
38
70
162
655
6
8
11
16
25
40
72
163
655
5
6
9
12
17
25
40
72
162
641
377
103
49
29
19
14
10
8
6
5
457
122
57
33
22
15
11
9
7
5
523
137
63
36
23
16
12
9
7
5
576
148
67
38
25
17
12
9
7
5
615
157
70
40
25
17
12
9
7
5
641
162
72
40
25
17
12
9
6
5
655
163
72
40
25
16
11
8
6
655
162
70
38
23
15
10
7
5
641
157
67
36
22
14
9
6
615
148
63
33
19
12
7
0.65
5
7
9
12
17
25
40
70
157
615
576
137
57
29
16
9
0.70
5
7
9
12
17
25
38
67
148
576
523
122
49
24
13
0.75
5
7
9
12
16
23
36
63
137
523
457
103
40
18
0.80
5
7
9
11
15
22
33
57
122
457
377
81
28
0.85
5
6
8
10
14
19
29
49
103
377
284
55
0.90
5
6
7
9
12
16
24
40
81
284
177
0.95
>0..
(1>
5
6
7
9
13
18
28
55
177
.0
~
P>
'<
0
....,
en
"0
~
en
N.
(1>
s
::r::
(1>
a
:;.
en
2
0..
(D.
(/}
>
Q.
.g
"'
0
'<
.....
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
202
59
265
29
74
319
18
36
86
363
12
21
40
96
398
9
14
24
44
103
425
7
10
16
26
47
109
442
0.55
0.60
0.65
u:l
0.70
0.75
0.80
0.85
0.90
0.95
s
'E..
0
u:l
N.
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
114
34
17
11
8
6
188
53
25
15
10
8
6
5
253
68
32
19
13
9
7
5
308
81
38
22
14
10
8
6
5
355
92
42
24
16
11
8
6
5
392
100
46
26
17
12
8
6
5
420
107
48
27
17
12
9
6
5
439
111
49
28
17
12
9
6
5
449
112
50
28
17
12
8
6
11
17
27
49
111
450
450
111
49
27
17
11
8
5
6
8
12
17
28
50
112
449
442
109
47
26
16
10
7
5
5
6
9
12
17
28
49
111
439
425
103
44
24
14
9
6
5
6
9
12
17
27
48
107
420
398
96
40
21
12
8
s
::r:
0
e:..
5
6
8
12
17
26
46
100
392
363
86
36
18
10
s5
6
8
11
16
24
42
92
355
319
74
29
14
u:l
a
5
6
8
10
14
22
38
81
308
265
59
22
e:
0
"'
5
7
9
13
19
32
68
253
202
42
5
6
8
10
15
25
53
188
6
8
11
17
34
114
130
....
00
0.05
32
8
0.10
60
15
7
0.15
0.20
0.25
0.30
0.35
0.40
84
27
106
14
31
124
9
16
35
139
6
10
17
38
150
5
7
10
18
40
158
84
21
10
6
106
27
12
7
5
124
31
14
8
5
139
35
16
9
6
150
38
17
10
6
5
158
40
18
10
7
5
0.45
5
7
11
19
41
163
163
41
19
11
7
5
0.50
5
7
11
19
42
165
165
42
19
11
7
5
0.55
0.60
5
7
11
19
41
163
4
5
7
10
18
40
158
163
41
19
11
7
5
158
40
18
10
7
5
0.65
0.70
0.75
0.80
0.85
0.90
0.95
2
5
6
10
17
38
150
150
38
17
10
6
5
6
9
16
35
139
139
35
16
9
6
5
8
14
31
124
124
31
14
8
>
.g~
5
7
12
27
106
106
27
12
"'
(')
'<
....,
6
10
21
84
84
21
Cl:l
"0
7
15
60
60
(1)
Cl:l
~-
8
32
s
:I:
(1)
e.
So
Cl:l
8.
en
>
~
.g
!!i
'<
....,
til
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
"0
0
til
0.70
0.75
0.80
0.85
0.90
0.95
7498 13781 19316 24105 28150 31450 34005 35816 36883 37206 36784 35618 33708 31054 27655 23512 18623 12989
1974 3537 4910 6096 7095 7908 8535 8975 9230 9298 9180 8876 8386 7710 6848 5799 4563 3140
919 1611 2217 2739 3178 3534 3807 3998 4105 4130 4072 3932 3708 3402 3013 2541 1985 1345
539
927 1266 1557 1801 1998 2149 2253 2310 2321 2286 2203 2074 1899 1677 1407 1091
726
358
606
821 1006 1160 1285 1379 1444 1479 1484 1459 1404 1320 1205 1061
443
886
681
104
166
218
262
299
328
349
363
369
368
359
287
248
201
60
343
319
144
52
79
101
120
136
147
161
156
161
163
156
147
135
120
101
77
101
79
32
47
77
59
69
83
88
88
62
47
90
90
85
79
72
49
27
59
22
31
39
45
50
53
56
57
56
55
52
48
35
20
45
31
42
39
16
22
27
35
37
32
38
39
38
37
34
16
22
31
26
35
32
27
12
17
25
20
23
27
27
27
25
27
17
27
23
20
13
25
23
20
9
13
16
18
19
20
20
18
16
20
19
10
20
20
19
18
16
13
8
10
12
14
15
15
15
15
14
13
14
15
15
15
14
12
10
15
6
12
8
10
11
12
12
7
12
8
12
11
10
10
11
12
11
10
6604
1522
610
297
127
104
52
32
22
16
12
9
8
6
~-
::r
:I:
e.
ertil
a
e:
0
f/.l
-0
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
5798 10739 15093 18861 22046 24646 26662 28094 28941 29204 28884 27979 26489 24416 21758 18516
14689 10278
1507 2738 3820 4756 5545 6188 6685 7036 7241 7299 7212 6978 6599 6073 5401
4583 3618 2507
694 1239 1718 2131 2479 2762 2979 3132 3220 3243 3201 3094 2922 2685 2383
2016 1583 1084
403
709
977 1208 1402 1559 1680 1764 1812 1823 1798 1736 1637 1502 1330 1121
876
592
266
461
632
779
902 1002 1078 1131 1160 1166 1148 1108 1043
955
844
709
550
366
75
124
165
201
231
254
272
284
290
290
284
272
254
231
201
165
122
60
36
58
76
92
104
114
121
126
128
127
124
118
109
98
84
66
76
58
22
34
44
53
59
65
68
71
71
71
68
64
59
52
43
27
44
34
15
23
29
34
38
41
44
45
45
44
42
40
36
30
20
34
29
23
11
16
20
24
27
29
30
31
31
30
28
26
23
16
27
24
20
16
8
12
15
18
20
21
22
22
22
21
20
18
13
21
20
18
15
12
7
9
12
14
15
16
16
16
16
15
14
10
16
16
15
14
12
9
5
8
9
11
12
12
13
13
12
11
12
13
13
12
12
11
9
8
6
7
9
9
10
10
10
9
7
9
10
10
10
9
9
7
6
0.95
5277
1243
513
261
127
75
36
22
15
11
8
7
.g~
P5
'<
0
.......
en
en
N.
0
s
~
e.
ET
en
a
..,e0
>
.g~
'<
....,
til
"0
G
til
0.10
3152 5973
788 1494
351
664
197
374
127
239
32
60
15
27
15
8
6
10
7
5
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
8461 10618 12443 13936 15097 15926 16424 16590 16424 15926 15097 13936 12443 10618
2116 2655 3111 3484 3775 3982 4106 4148 4106 3982 3775 3484 3111 2655
941 1180 1383 1549 1678 1770 1825 1844 1825 1770 1678 1549 1383 1180
871
778
664
778
529
871
944
996
944
664
996 1027 1037 1027
558
498
425
339
425
498
558
604
657
664
657
638
604
638
140
125
125
165
166
165
160
151
107
85
107
140
151
160
62
48
56
62
73
74
73
71
68
56
38
48
71
68
35
32
42
42
40
27
22
27
32
35
38
40
42
38
23
20
14
20
23
27
27
27
26
25
17
26
17
25
16
14
16
19
19
19
18
17
14
12
10
12
17
18
14
14
14
12
11
9
7
11
12
13
14
14
13
9
11
11
11
10
10
9
8
7
6
7
8
9
10
10
7
7
9
9
8
7
6
5
6
7
8
8
9
8
7
6
5
5
5
6
7
7
7
7
7
7
5
0.85
0.90
0.95
8461 5973
2116 1494
664
941
529
374
239
339
60
85
27
38
15
22
10
14
7
10
5
7
6
5
3152
788
351
197
127
32
15
8
6
N.
G
::r
~
e.
Er
til
e:
G
"'
--
-N
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
5353
1423
668
395
264
79
40
25
17
12
10
8
6
5
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
9784 13686 17061 19911 22234 24032 25305 26052 26273 25968 25138 23783 21902 19495 16562 13104
2524 3490 4324 5026 5597 6036 6344 6521 6565 6479 6261 5912 5431 4818 4074
3198
1155 1580 1947 2255 2504 2695 2827 2901 2916 2873 2771 2611 2393 2116 1780 1385
667
905 1109 1279 1417 1522 1594 1633 1639 1612 1552 1459 1334 1175
983
758
438
589
718
826
912
978 1022 1045 1047 1029
989
928
845
742
617
471
122
158
189
214
233
248
257
261
259
252
240
223
200
171
137
96
59
74
87
97
105
111
114
115
113
109
103
94
82
68
51
74
35
43
50
56
60
62
64
63
62
59
49
55
42
32
16
43
24
29
33
36
38
40
40
40
38
36
33
28
23
12
33
29
17
20
23
25
26
27
27
27
25
23
21
17
9
25
23
20
13
15
17
18
19
19
19
19
17
16
13
8
19
18
17
15
10
12
13
14
14
14
14
13
12
10
6
14
14
14
13
12
8
9
10
11
11
11
10
10
8
10
10
11
11
11
10
9
6
7
8
8
8
8
8
7
7
8
8
8
8
8
7
9119
2190
931
498
301
35
59
35
24
17
13
10
8
6
4603
1043
409
193
73
79
40
25
17
12
10
8
6
5
>
Q..
~
.0
s=
~
'<
0.....,
tn
'E.
~
tn
t::i'
~
s
~
ET
tn
9:
~
"'
>
ft'
,.c
c~
(")
'<
0
....,
til
"0
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
3933
1031
478
280
185
53
26
16
11
8
6
5
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
;"
0.70
0.75
0.80
7250 10172 12701 14837 16580 17930 18888 19453 19626 19406 18794 17789 16391 14601 12418
1856 2582 3209 3737 4167 4499 4732 4868 4905 4844 4685 4428 4072 3619 3067
844 1164 1440 1673 1861 2006 2107 2165 2179 2149 2076 1959 1798 1594 1346
888
747
947 1052 1132 1188 1219 1225 1207 1164 1097 1005
664
485
818
676
727
742
698
563
471
430
528
610
761
780
783
771
638
316
195
194
182
169
133
108
172
114
137
157
184
191
190
153
86
42
78
82
86
85
79
72
64
54
83
53
63
71
85
41
16
44
46
48
48
47
45
43
39
34
27
31
36
41
24
24
30
29
28
26
23
19
12
28
20
24
26
30
30
16
20
17
14
17
9
17
18
20
21
20
20
19
18
14
12
12
15
14
13
11
8
14
13
14
15
15
11
12
13
9
11
11
11
10
11
11
9
11
10
9
6
10
8
9
7
7
8
8
7
8
8
8
8
7
7
8
8
8
8
6
7
7
6
7
6
6
6
7
6
5
6
5
6
6
0.85
9842
2416
1053
580
363
79
53
31
20
14
11
8
7
5
0.90
6872
1667
717
389
239
35
41
24
16
12
9
7
6
5
0.95
3507
815
331
164
73
53
26
16
11
8
6
5
til
N.
(I)
::I:
(I)
~
::;.
til
2'
9:
(I)
"'
......
......
w
.......
.......
.j::>.
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
3458
865
385
217
139
35
16
9
6
4899
1225
545
307
196
49
22
13
8
6
6147
1537
683
385
246
62
28
16
10
7
6
7204
1801
801
451
289
73
33
19
12
9
6
5
8068
2017
897
505
323
81
36
21
13
9
7
6
8740
2185
972
547
350
88
39
22
14
10
8
6
5
9220
2305
1025
577
369
93
41
24
15
11
8
6
5
9508 9605
2377 2402
1057 1068
595
601
381
385
97
96
43
43
24
25
16
16
11
11
8
8
7
6
5
5
9508
2377
1057
595
381
96
43
24
16
11
8
6
5
9220
2305
1025
577
369
93
41
24
15
11
8
6
5
8740
2185
972
547
350
88
39
22
14
10
8
6
5
8068
2017
897
505
323
81
36
21
13
9
7
6
7204
1801
801
451
289
73
33
19
12
9
6
5
6147
1537
683
385
246
62
28
16
10
7
6
4899
1225
545
307
196
49
22
13
8
6
3458
865
385
217
139
35
16
9
6
1825
457
203
115
73
19
9
5
1825
457
203
115
73
19
9
5
>
0..
("0
.0
c:
I>'
n
'<
0
.....,
Cll
"0
("0
Cll
N.
("0
s
:I:
("0
e:..
:;.
Cll
0..
('p"
"'
6:
(1)
..c
c
~
'<
0
....,
Cl.l
"0
(1)
.....
N
Cl.l
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
*
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.55
0.60
21415 21163
5351 5279
2377 2340
1335 1313
837
853
211
205
92
88
48
50
31
29
20
19
14
12
10
8
6
8
5
20483
5100
2256
1263
804
195
83
44
26
16
10
5
8
6
0.50
0.90
0.95
3718
833
322
148
52
67
34
21
15
11
8
7
5
0.65
0.70
0.75
0.80
0.85
(1)
s
:I:
(1)
e:.
g.
Cl.l
Q..
~
"'
.....
.....
0'1
0.10
0.15
0.75
0.80
0.85
0.90
0.95
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
5730
1472
671
386
253
69
33
20
13
10
7
6
5
8030 10020 11700 13071 14132 14885 15328 15461 15286 14801 14007 12903 11490
2042 2535 2950 3287 3548 3730 3836 3864 3815 3688 3485 3203 2845
922 1139 1321 1469 1583 1662 1706 1717 1692 1634 1541 1413 1252
648
749
937
527
831
893
960
965
950
916
862
789
696
342
419
483
535
574
601
615
617
607
584
548
501
441
109
125
151
91
137
145
154
153
149
143
133
119
103
43
57
67
50
62
65
68
67
65
61
56
50
42
25
29
32
37
38
35
38
37
35
33
30
26
21
21
16
19
23
23
24
24
23
22
20
15
9
18
15
12
13
16
16
16
16
15
14
13
11
7
15
9
10
11
11
12
12
11
11
10
8
11
11
6
8
7
5
8
9
9
8
8
9
9
8
7
9
6
7
7
7
6
7
7
5
6
6
5
7
6
5
5
5
5
5
5
5
5
5
5
5
9768
2409
1055
585
368
83
32
11
19
13
10
8
6
5
7737
1895
824
453
283
60
43
25
16
12
9
7
5
5395
1303
558
301
184
25
33
20
13
10
7
6
5
2741
631
253
123
52
44
22
14
9
7
5
3120
822
383
225
150
44
22
14
9
7
5
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
>
0..
('1>
.0
~
'<
a.
Vl
('1>
Vl
N.
('1>
::r::
('1>
a
g.
Vl
....
5.
~
"'
>-
ft
.g
~
'<
0
.......
c;n
(1)
c;n
N.
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
(1)
s
::I:
(1)
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
1286
322
143
81
52
13
6
2436
609
271
153
98
25
11
7
3451
863
384
216
139
35
16
9
6
4330
1083
482
271
174
44
20
11
7
5074
1269
564
318
203
51
23
13
9
5683
1421
632
356
228
57
26
15
10
6157
1540
685
385
247
62
28
16
10
6495
1624
722
406
260
65
29
17
11
6698
1675
745
419
268
67
30
17
11
6766
1692
752
423
271
68
31
17
11
6698
1675
745
419
268
67
30
17
11
6495
1624
722
406
260
65
29
17
11
6157
1540
685
385
247
62
28
16
10
5683
1421
632
356
228
57
26
15
10
5074
1269
564
318
203
51
23
13
9
4330
1083
482
271
174
44
20
11
7
6
5
7
5
7
6
8
6
5
8
6
5
8
6
5
8
6
5
8
6
5
7
6
7
5
6
5
3451
863
384
216
139
35
16
9
6
2436
609
271
153
98
25
11
7
1286
322
143
81
52
13
6
-e
::r
c;n
z0..
(;)"
"'
-..J
=P1(1-P 1) + P2 (1-P2 )]
00
P2 or (1-P 2 )
P1 or (1-P1)
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.12
0.14
0.16
0.18
0.20.
0.22
0.24
0.26
0.28
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.08
0.09
0.10
0.12
0.13
0.14
0.16
0.17
0.18
0.19
0.20
0.21
0.22
0.23
0.23
0.24
0.25
0.25
0.25
0.26
0.26
0.26
0.26
0.03
0.04
0.05
0.06
0.07
0.08
0.08
0.09
0.10
0.11
0.13
0.14
0.15
0.17
0.18
0.19
0.20
0.21
0.22
0.23
0.24
0.24
0.25
0.26
0.26
0.26
0.27
0.27
0.27
0.27
0.04
0.05
0.06
0.07
0.08
0.09
0.09
0.10
0.11
0.12
0.13
0.15
0.16
0.18
0.19
0.20
0.21
0.22
0.23
0.24
0.25
0.25
0.26
0.26
0.27
0.27
0.28
0.28
0.28
0.28
0.05
0.06
0.07
0.08
0.09
0.09
0.10
0.11
0.12
0.13
0.14
0.16
0.17
0.19
0.20
0.21
0.22
0.23
0.24
0.25
0.26
0.26
0.27
0.27
0.28
0.28
0.28
0.29
0.29
0.29
0.06
0.07
0.08
0.09
0.10
0.10
0.11
0.12
0.13
0.14
0.15
0.17
0.18
0.20
0.21
0.22
0.23
0.24
0.25
0.26
0.27
0.27
0.28
0.28
0.29
0.29
0.29
0.30
0.30
0.30
0.10
0.11
0.12
0.13
0.14
0.15
0.16
0.16
0.17
0.18
0.20
0.21
0.22
0.24
0.25
0.26
0.27
0.28
0.29
0.30
0.31
0.31
0.32
0.33
0.33
0.33
0.34
0.34
0.34
0.34
0.14
0.15
0.16
0.17
0.18
0.18
0.19
0.20
0.21
0.22
0.23
0.25
0.26
0.28
0.29
0.30
0.31
0.32
0.33
0.34
0.35
0.35
0.36
0.36
0.37
0.37
0.37
0.38
0.38
0.38
0.17
0.18
0.19
0.20
0.21
0.22
0.23
0.23
0.24
0.25
0.27
0.28
0.29
0.31
0.32
0.33
0.34
0.35
0.36
0.37
0.38
0.38
0.39
0.40
0.40
0.40
0.41
0.41
0.41
0.41
0.20
0.21
0.22
0.23
0.24
0.24
0.25
0.26
0.27
0.28
0.29
0.31
0.32
0.34
0.35
0.36
0.37
0.38
0.39
0.40
0.41
0.41
0.42
0.42
0.43
0.43
0.43
0.44
0.44
0.44
0.22
0.23
0.24
0.25
0.26
0.27
0.28
0.28
0.29
0.30
0.32
0.33
0.34
0.36
0.37
0.38
0.39
0.40
0.41
0.42
0.43
0.43
0.44
0.45
0.45
0.45
0.46
0.46
0.46
0.46
0.24
0.25
0.26
0.27
0.28
0.28
0.29
0.30
0.31
0.32
0.33
0.35
0.36
0.38
0.39
0.40
0.41
0.42
0.43
0.44
0.45
0.45
0.46
0.46
0.47
0.47
0.47
0.48
0.48
0.48
0.25
0.26
0.27
0.28
0.29
0.30
0.31
0.31
0.32
0.33
0.35
0.36
0.37
0.39
0.40
0.41
0.42
0.43
0.44
0.45
0.46
0.46
0.47
0.48
0.48
0.48
0.49
0.49
0.49
0.49
0.26
0.27
0.28
0.29
0.30
0.30
0.31
0.32
0.33
0.34
0.35
0.37
0.38
0.40
0.41
0.42
0.43
0.44
0.45
0.46
0.47
0.47
0.48
0.48
0.49
0.49
0.49
0.50
0.50
0.50
0.26
0.27
0.28
0.29
0.30
0.31
0.32
0.32
0.33
0.34
0.36
0.37
0.38
0.40
0.41
0.42
0.43
0.44
0.45
0.46
0.47
0.47
0.48
0.49
0.49
0.49
0.50
0.50
0.50
0.50
:x>
0.
~
.0
""
(")
'<
....,
0
Vl
'"0
~
Vl
N.
s
::I:
~
e:.
Er
Vl
a.
0.
(;)'
VJ
Table 5b: Sample Size to Estimate the Risk Difference Between Two Proportions,
P1 and P2 , to Within d Percentage Points with 99% Confidence [Using v =P 1(1-P 1) + P2(1-P2)]
;J;>
0..
.0
(D
~
(")
d%
v
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
10
664
1328
1991
2655
3318
3982
4646
5309
5973
6636
7963
9291
10618
11945
13272
14599
15926
17254
18581
19908
21235
22562
23889
25216
26544
27871
29198
30525
31852
33179
166
332
498
664
830
996
1162
1328
1494
1659
1991
2323
2655
2987
3318
3650
3982
4314
4646
4977
5309
5641
5973
6304
6636
6968
7300
7632
7963
8295
74
148
222
295
369
443
517
590
664
738
885
1033
1180
1328
1475
1623
1770
1918
2065
2212
2360
2507
2655
2802
2950
3097
3245
3392
3540
3687
42
83
125
166
208
249
291
332
374
415
498
581
664
747
830
913
996
1079
1162
1245
1328
1411
1494
1576
1659
1742
1825
1908
1991
2074
27
54
80
107
133
160
186
213
239
266
319
372
425
478
531
584
638
691
744
797
850
903
956
1009
1062
1115
1168
1221
1275
1328
7
14
20
27
34
40
47
54
60
67
80
93
107
120
133
146
160
173
186
200
213
226
239
253
266
279
292
306
319
332
r:
15
'<
20
25
30
35
40
45
50
....,
(.1)
"0
6
9
12
15
18
21
24
27
30
36
42
48
54
59
65
71
77
83
89
95
101
107
113
118
124
130
136
142
148
;"
5
7
9
10
12
14
15
17
20
24
27
30
34
37
40
44
47
50
54
57
60
64
67
70
73
77
80
83
(.1)
5
6
7
8
9
10
11
13
15
17
20
22
24
26
28
30
32
34
37
39
41
43
45
47
49
51
54
No
(D
s
5
6
6
7
8
9
11
12
14
15
17
18
20
21
23
24
26
27
29
30
31
33
34
36
37
:I:
(D
5
5
6
7
8
9
10
11
12
14
15
16
17
18
19
20
21
22
23
24
25
27
28
e:..
....
::r
(.1)
5
5
6
7
8
9
10
10
11
12
13
14
15
15
16
17
18
19
20
20
21
0..
(ii"
Vl
5
6
6
7
8
8
9
10
10
11
12
12
13
14
14
15
16
16
17
5
5
6
6
7
7
8
8
9
10
10
11
11
12
12
13
13
14
\0
Table 5c: Sample Size to Estimate the Risk Difference Between Two Proportions,
P1 and P , to Within d Percentage Points with 95% Confidence [Using v =P (1-P ) + P 2(1-P2)]
2
.......
N
0
d%
v
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
10
15
20
25
30
35
385
769
1153
1537
1921
2305
2690
3074
3458
3842
4610
5379
6147
6915
7684
8452
9220
9989
10757
11525
12294
13062
13830
14599
15367
16135
16904
17672
18440
19209
97
193
289
385
481
577
673
769
865
961
1153
1345
1537
1729
1921
2113
2305
2498
2690
2882
3074
3266
3458
3650
3842
4034
4226
4418
4610
4803
43
86
129
171
214
257
299
342
385
427
513
598
683
769
854
940
1025
1110
1196
1281
1366
1452
1537
1623
1708
1793
1879
1964
2049
2135
25
49
73
97
121
145
169
193
217
241
289
337
385
433
481
529
577
625
673
721
769
817
865
913
961
1009
1057
1105
1153
1201
16
31
47
62
77
93
108
123
139
154
185
216
246
277
308
339
369
400
431
461
492
523
554
584
615
646
677
707
738
769
8
12
16
20
24
27
31
35
39
47
54
62
70
77
85
93
100
108
116
123
131
139
146
154
162
170
177
185
193
6
7
9
11
12
14
16
18
21
24
28
31
35
38
41
45
48
52
55
59
62
65
69
72
76
79
82
86
5
6
7
8
9
10
12
14
16
18
20
22
24
25
27
29
31
33
35
37
39
41
43
45
47
49
5
5
6
7
8
9
10
12
13
14
15
16
18
19
20
21
23
24
25
26
28
29
30
31
5
6
6
7
8
9
10
11
12
12
13
14
15
16
17
18
18
19
20
21
22
5
6
6
7
7
8
9
9
10
11
11
12
12
13
14
14
15
16
16
40
45
50
>-0.
('1)
5
6
6
7
7
8
8
9
9
10
10
11
11
12
12
13
.0
5
5
5
6
6
7
7
7
8
8
8
9
9
10
10
c
I>'
('")
'<
0
......,
5
5
5
6
6
6
7
7
7
8
8
8
C/:l
"d
0
C/:l
N.
('1)
::r:
('1)
e:..
s-
...c
C/:l
0.
o
"'
Table Sd: Sample Size to Estimate the Risk Difference Between Two Proportions,
P 1 and P 2 , to Within d Percentage Points with 90% Confidence [Using v P1(1-P1) + P2(1-P2)]
>-
Q.
~
..0
s::
I
(')
d%
v
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
'-<
0
.....,
10
271
542
812
1083
1354
1624
1895
2165
2436
2707
3248
3789
4330
4871
5413
5954
6495
7036
7577
8119
8660
9201
9742
10283
10825
11366
11907
12448
12989
13531
68
136
203
271
339
406
474
542
609
677
812
948
1083
1218
1354
1489
1624
1759
1895
2030
2165
2301
2436
2571
2707
2842
2977
3112
3248
3383
31
61
91
121
151
181
211
241
271
301
361
421
482
542
602
662
722
782
842
903
963
1023
1083
1143
1203
1263
1323
1384
1444
1504
17
34
51
68
85
102
119
136
153
170
203
237
271
305
339
373
406
440
474
508
542
576
609
643
677
711
745
778
812
846
11
22
33
44
55
65
76
87
98
109
130
152
174
195
217
239
260
282
304
325
347
369
390
412
433
455
477
498
520
542
6
9
11
14
17
19
22
25
28
33
38
44
49
55
60
65
71
76
82
87
93
98
103
109
114
120
125
130
136
15
20
25
30
35
40
45
50
C/)
"0
~
C/)
N.
5
7
8
9
10
11
13
15
17
20
22
25
27
29
32
34
37
39
41
44
46
49
51
53
56
58
61
5
5
6
7
7
9
10
11
13
14
15
17
18
19
21
22
24
25
26
28
29
30
32
33
34
s
:r:
~
e:..
.....
::r
C/)
5
6
7
7
8
9
10
11
12
13
13
14
15
16
17
18
19
20
20
21
22
8'
Q.
~
5
5
6
7
7
8
8
9
10
10
11
11
12
13
13
14
14
15
16
"'
5
5
6
6
7
7
8
8
8
9
9
10
10
11
11
12
5
5
5
6
6
6
7
7
7
8
8
8
9
9
5
5
5
5
6
6
6
6
7
7
7
5
5
5
5
5
6
6
......
......
N
N
p2
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
721
0.15
1137
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
330
165
102
71
52
40
32
26
22
18
15
13
11
1502
415
200
120
81
59
45
35
28
23
19
16
13
11
486
229
135
90
64
48
37
30
24
20
16
13
11
2075
545
252
146
96
68
50
38
30
24
20
16
13
11
232
1137
125
330
1502
81
165
415
58
102
200
486
2075
44
71
120
229
545
2283
35
52
81
135
252
590
1814
1814
2283
590
269
154
100
70
51
39
30
24
19
15
12
2439
623
281
159
102
70
51
38
30
23
18
14
2543
643
287
161
102
70
50
37
28
22
17
649
287
159
100
68
48
35
26
20
2595
643
281
154
96
64
45
32
24
2439
29
40
59
90
146
269
623
2543
24
32
45
64
96
154
281
643
2595
2595
2543
623
269
146
90
59
40
29
2439
590
252
135
81
52
35
545
229
120
71
44
2075
486
200
102
58
1814
415
165
81
1502
330
125
1137
232
20
26
35
48
68
100
159
287
649
2595
17
22
28
37
50
70
102
161
287
643
2543
14
18
23
30
38
51
70
102
159
281
623
2439
12
15
19
24
30
39
51
70
100
154
269
590
2283
11
13
16
20
24
30
38
50
68
96
146
252
545
2075
11
13
16
20
24
30
37
48
64
90
135
229
486
1814
8
7
6
9
8
7
11
13
16
19
23
28
35
45
59
81
120
200
415
1502
9
8
11
13
15
18
22
26
32
40
52
71
102
165
330
1137
11
12
14
17
20
24
29
35
44
58
81
125
232
2283
721
721
p2
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
556
0.10
0.15
877
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
8
9
255
128
79
55
41
32
25
21
17
15
12
11
1158
320
155
93
63
46
35
28
22
18
15
13
11
180
877
97
255
1158
63
128
320
1399
46
79
155
376
1600
35
55
93
177
421
1761
28
41
63
105
195
456
23
32
46
70
113
208
481
1961
19
25
35
50
74
120
217
496
2001
16
21
28
38
53
78
123
222
501
2001
14
17
22
29
39
54
79
125
222
496
1961
12
15
18
23
30
40
55
79
123
217
481
1881
10
12
15
19
24
30
40
54
78
120
208
456
1761
11
13
16
19
24
30
39
53
74
113
195
421
1600
8
7
6
11
13
16
19
23
29
38
50
70
105
177
376
1399
8
7
11
13
15
18
22
28
35
46
63
93
155
320
1158
11
12
15
17
21
25
32
41
55
79
128
255
877
10
12
14
16
19
23
28
35
46
63
97
180
1399
0.95
376
177
105
70
50
38
29
23
19
16
13
11
1600
421
195
113
74
53
39
30
24
19
16
13
11
8
9
1761
456
208
120
78
54
40
30
24
19
15
12
10
1881
481
217
123
79
55
40
30
23
18
15
12
1961
496
222
125
79
54
39
29
22
17
14
501
222
123
78
53
38
28
21
16
2001
496
217
120
74
50
35
25
19
481
208
113
70
46
32
23
1881
456
195
105
63
41
28
1761
421
177
93
55
35
1600
376
155
79
46
1881
2001
1961
1399
320
128
63
1158
255
97
877
180
556
556
......
N
w
p2
0.05
0.10
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
301
98
53
35
25
20
16
13
11
10
474
138
70
44
31
23
18
15
12
10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
474
138
625
70
174
755
44
84
203
863
31
51
96
228
950
23
35
57
106
247
1015
18
26
38
62
113
260
15
20
28
41
65
118
12
16
21
29
43
67
120
271
1080
10
13
17
22
30
44
68
120
268
1058
625
174
84
51
35
26
20
16
13
11
755
203
96
57
38
28
21
17
14
11
7
6
5
863
228
106
62
41
29
22
17
14
11
9
8
7
950
1058
268
1080
247
113
65
43
30
23
1015
260
118
67
44
31
1058
268
120
68
44
1080
271
120
67
1080
268
118
17
14
11
9
8
7
23
17
14
11
9
7
30
22
17
13
10
8
43
29
21
16
12
10
65
41
28
20
15
11
1058
260
113
62
38
26
18
13
1015
247
106
57
35
23
16
0.65
0.70
11
14
17
23
31
44
67
118
260
1015
950
228
96
51
31
20
0.75
0.80
0.85
0.90
11
8
9
14
17
23
30
43
65
113
247
950
11
14
17
22
29
41
62
106
228
8
9
11
863
863
203
84
44
25
755
174
70
35
11
14
17
21
28
38
57
96
203
755
625
138
53
13
16
20
26
35
51
84
174
625
474
98
9
10
12
15
18
23
31
44
70
138
474
301
0.95
10
11
13
16
20
25
35
53
98
301
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.10
474
0.15
748
153
748
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
217
109
67
46
34
26
21
17
14
12
10
988
273
131
79
53
39
29
23
18
15
12
10
82
217
988
53
109
273
1194
1194
38
67
131
320
1365
29
46
79
150
358
320
150
89
59
42
31
24
19
16
13
10
358
166
96
63
44
33
25
20
16
13
10
1502
1502
388
177
101
66
46
33
25
20
16
12
10
1605
410
185
105
67
46
33
25
19
15
12
1674
423
189
106
67
46
33
24
18
14
11
1708
427
189
105
66
44
31
23
17
13
15
34
53
89
166
388
1605
19
26
39
59
96
177
410
1674
15
21
29
42
63
101
185
423
1708
13
17
23
31
44
66
105
189
427
1708
11
14
18
24
33
46
67
106
189
423
1674
12
15
19
25
33
46
67
105
185
410
1605
10
12
16
20
25
33
46
66
101
177
388
1502
10
13
16
20
25
33
44
63
96
166
358
1365
7
6
10
13
16
19
24
31
42
59
89
150
320
1194
12
15
18
23
29
39
53
79
131
273
988
9
7
10
10
12
14
17
21
26
34
46
67
109
217
748
11
13
15
19
23
29
38
53
82
153
1365
23
0.95
1708
423
185
101
63
42
29
21
1674
410
177
96
59
39
26
19
1605
388
166
89
53
34
23
1502
358
150
79
46
29
1365
320
131
67
38
1194
273
109
53
988
217
82
748
153
474
474
Ul
......
N
0\
p2
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
343
0.10
0.15
541
0.20
0.25
0.30
157
79
714
197
111
541
60
157
714
39
79
197
28
21
49
34
95
862
231
57
17
25
14
20
12
10
16
13
8
7
6
5
39
28
22
862
0.35
0.40
49
34
25
20
16
13
95
231
57
109
39
28
22
64
43
31
17
23
32
48
24
33
76
986
0.45 0.50
259
120
70
46
1085
281
1159
128
296
74
134
1209
306
1233
0.60
0.65
0.70
11
14
18
11
137
77
49
24
18
14
11
309
1233
137
306
76
33
48
32
23
17
13
10
134
74
46
31
22
16
12
296
1159
128
281
70
120
43
64
28
20
14
1085
259
109
39
57
25
34
17
21
95
197
714
49
28
79
39
137
77
309
137
1233
306
1209
49
76
134
296
1159
48
74
46
128
70
281
120
31
43
28
20
14
12
10
15
12
19
15
10
12
19
14
18
32
23
11
14
17
11
13
22
16
10
12
33
24
76
48
1233
11
306
49
134
49
10
74
34
25
12
1209
33
25
14
1159
296
19
128
24
12
14
281
14
10
70
18
15
19
120
11
0.95
12
64
0.90
19
25
43
31
11
0.85
15
1085
23
0.80
19
109
17
14
0.75
25
34
986
259
46
32
0.55
1209
1085
986
231
64
259
109
986
231
862
862
39
57
25
17
34
95
49
197
79
714
157
541
21
28
39
60
111
157
60
541
111
343
343
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.10
0.15
151
237
0.20
0.25
0.30
0.35
0.40
70
35
313
87
378
0.45
22
16
12
42
26
18
13
102
48
29
19
432
114
53
475
124
0.50
0.55
0.60
0.65
10
14
11
31
21
15
11
57
33
22
15
130
59
34
530
134
60
540
136
540
49
237
27
70
313
18
35
87
378
13
22
42
102
432
10
16
26
48
114
475
12
18
29
53
124
508
13
19
31
57
130
530
10
14
21
33
59
134
540
11
15
22
34
60
136
540
11
15
22
34
60
134
530
508
0.75
0.80
6
7
5
6
12
22
16
12
22
15
11
60
34
22
15
11
6
7
8
34
134
59
33
21
14
10
530
0.70
0.85
0.95
130
57
31
19
13
508
124
53
29
18
12
114
48
26
16
10
432
102
42
22
13
378
87
35
18
70
27
12
16
22
34
59
130
508
12
15
22
33
57
124
475
11
15
21
31
53
114
432
11
14
19
29
48
102
378
6
5
10
13
18
26
42
87
313
12
16
22
35
70
237
10
13
18
27
49
0.90
475
313
237
49
151
151
......
N
00
p2
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
364
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
574
166
83
51
36
26
20
16
13
11
758
117
574
63
166
758
209
101
60
41
30
22
18
14
11
916
245
115
68
45
32
24
19
15
12
10
1047
0.95
275
127
74
48
34
25
19
15
12
10
1153
298
136
78
50
35
26
19
15
12
41
83
209
916
29
51
101
245
1047
22
36
60
115
275
1153
18
26
41
8'8
127
298
1231
14
20
30
45
74
136
314
1284
12
16
22
32
48
78
142
324
1310
10
13
18
24
34
50
80
145
328
1310
11
14
19
25
35
51
81
145
324
1284
11
15
19
26
35
51
80
142
314
1231
1231
314
142
80
51
35
26
19
15
11
1284
324
145
81
51
35
25
19
14
11
8
10
1310
328
145
80
50
34
24
18
13
1310
324
142
78
48
32
22
16
12
1284
314
136
74
45
30
20
14
1231
298
127
68
41
26
18
1153
275
115
60
36
22
1047
245
101
51
29
916
209
83
41
12
15
19
26
35
50
78
136
298
1153
10
12
15
19
25
34
48
74
127
275
1047
10
12
15
19
24
32
45
68
115
245
916
11
14
18
22
30
41
60
101
209
758
11
13
16
20
26
36
51
83
166
574
10
12
14
18
22
29
41
63
117
0.90
758
166
63
574
117
364
364
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
394
115
57
36
25
18
14
11
144
70
42
28
21
16
12
10
629
169
80
47
31
22
17
13
10
719
189
88
51
33
24
18
14
11
791
205
94
54
35
24
18
14
11
18
14
10
6
7
250
521
81
394
43
115
521
28
57
144
629
20
36
70
169
719
16
25
42
80
189
791
12
18
28
47
88
205
845
10
14
21
31
51
94
216
882
11
16
22
33
54
98
223
845
216
882
98
55
36
25
0.80
0.85
223
100
56
36
24
18
13
10
225
100
55
35
24
17
12
900
223
98
54
33
22
16
11
216
94
51
31
21
14
10
845
205
88
47
28
18
12
791
189
80
42
25
16
719
169
70
36
20
629
144
57
28
900
12
17
24
35
55
100
225
900
10
13
18
24
36
56
100
223
882
10
14
18
25
36
55
98
216
845
6
5
11
14
18
24
35
54
94
205
791
11
14
18
24
33
51
88
189
719
10
13
17
22
31
47
80
169
629
10
12
16
21
28
42
70
144
521
11
14
18
25
36
57
115
394
10
12
16
20
28
43
81
900
0.95
0.90
882
521
115
43
394
81
250
250
......
w
p1
p2
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
92
30
16
11
8
6
5
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
144
42
190
22
53
230
14
26
62
263
10
16
30
70
289
7
11
18
33
75
309
6
8
12
19
35
79
322
5
6
9
13
20
36
82
328
144
42
22
14
10
7
6
5
190
53
26
16
11
8
6
5
230
62
30
18
12
9
7
5
263
70
33
19
13
9
7
6
5
289
75
35
20
13
10
7
6
5
309
79
36
21
14
10
7
6
322
82
37
21
14
10
7
5
328
83
37
21
13
9
7
5
328
82
36
20
13
9
6
5
0.55
5
7
9
13
21
37
83
328
322
79
35
19
12
8
6
0.60
5
7
10
14
21
37
82
322
309
75
33
18
11
7
5
0.65
0.70
6
7
10
14
21
36
79
309
5
6
7
10
13
20
35
75
289
289
70
30
16
10
6
263
62
26
14
8
0.75
5
6
7
9
13
19
33
70
263
230
53
22
11
0.80
5
7
9
12
18
30
62
230
190
42
16
0.85
5
6
8
11
16
26
53
190
144
30
0.90
0.95
>-
0..
('1>
5
6
7
10
14
22
42
144
92
,.0
1::::
po
0
'<
5
6
8
11
16
30
92
0
.....,
(/)
'1::1
;"
(/)
N.
('1>
s
:I:
('1>
e:..
.....
::r
(/)
.....
s::
0..
(P"
"'
>-
0..
(1)
.0
c:
""
'<
()
0
....,
en
IP2-P11
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
"0
(D
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
15470
4195
2008
1209
824
266
143
93
67
51
40
33
27
23
27973
7284
3364
1963
1300
378
189
117
81
60
46
37
30
25
38987
10000
4555
2623
1717
474
229
138
93
67
51
40
32
26
48513
12344
5580
3191
2074
556
262
154
102
73
55
43
34
27
56550
14317
6440
3665
2372
623
288
167
110
77
57
44
35
28
63099
15917
7135
4047
2610
675
308
177
114
80
59
44
35
27
68160
17145
7664
4335
2789
712
321
182
117
81
59
44
34
26
71732
18000
8028
4530
2908
735
328
184
117
80
57
43
32
25
73816
18484
8226
4633
2967
742
328
182
114
77
55
40
30
23
74411
18596
8260
4642
2967
735
321
177
110
73
51
37
27
20
en
N.
(1)
s
::z:::
(1)
:;.
en
2
0..
(p"
(/)
......
w
IP2-P11
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
12143
3294
1577
950
647
209
113
74
53
41
32
26
22
19
21957
5718
2641
1541
1021
297
149
93
64
48
37
30
24
20
30602
7850
3576
2060
1348
373
180
109
74
54
41
32
26
21
38079
9690
4381
2505
1629
437
206
122
81
58
44
34
27
22
44388
11238
5056
2877
1862
490
227
132
87
61
46
35
28
22
49528
12494
5601
3177
2049
531
242
139
90
63
47
36
28
22
53500
13458
6016
3403
2190
560
253
144
92
64
47
35
27
21
56304
14129
6302
3556
2283
577
258
145
92
63
46
34
26
20
57940
14509
6458
3637
2330
583
258
144
90
61
44
32
24
19
58407
14597
6484
3644
2330
577
253
139
87
58
41
30
22
16
0..
(1)
..0
cpo
('")
'<
0
.....,
C/)
3
'"0
(p
C/)
No
(1)
=
a
8(1)
C/)
.....
0..
o
"'
>
.8=
~
'<
0
....,
(I)
C1>
(I)
N.
IP2-P11
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
6898
1872
897
540
369
120
65
43
31
24
19
16
14
12
12472
3249
1501
876
581
170
86
54
38
28
22
18
15
13
17383
4460
2032
1171
767
213
103
63
43
31
24
19
16
13
21630
5505
2489
1424
926
249
118
70
47
34
26
20
17
14
25213
6384
2873
1635
1059
279
130
76
50
36
27
21
17
14
28133
7097
3182
1805
1165
302
139
80
52
37
28
21
17
14
30389
7645
3418
1934
1245
319
145
83
53
37
28
21
17
13
31982
8026
3581
2021
1298
329
148
83
53
37
27
20
16
13
32911
8242
3669
2067
1324
332
148
83
52
36
26
19
15
12
33176
8292
3684
2071
1324
329
145
80
50
34
24
18
14
10
C1>
e:r
::z::
C1>
e.
g.
(I)
Q.
~
"'
IP2-P11
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
10924
2962
1418
854
582
188
101
65
47
36
28
23
19
16
19753
5143
2376
1386
918
266
133
82
57
42
33
26
21
17
27531
7062
3216
1852
1212
335
161
97
65
47
36
28
23
19
34258
8717
3940
2253
1465
393
185
109
72
52
39
30
24
19
39933
10110
4548
2588
1675
440
203
118
77
54
40
31
24
19
44558
11239
5038
2857
1843
477
217
125
81
56
41
31
24
19
48132
12107
5412
3061
1969
503
227
128
82
57
41
31
24
19
50654
12711
5669
3199
2053
519
231
130
82
56
40
30
23
17
52126
13053
5809
3271
2095
524
231
128
81
54
39
28
21
16
52546
13131
5832
3278
2095
519
227
125
77
52
36
26
19
14
>
~~
'<
0
.....,
Cll
Cll
t;l'
s
::I:
0
e.
g.
Cll
~
en
>
~
.g
~
'<
....,
til
.....
til
IP2-P11
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
8161
2213
1060
638
435
141
76
49
36
27
22
18
15
12
14756
3842
1775
1036
686
200
100
62
43
32
25
20
16
14
20566
5275
2403
1384
906
251
121
73
49
36
27
22
17
14
25590
6512
2944
1683
1095
294
138
82
54
39
29
23
18
15
29830
7552
3398
1934
1252
329
152
89
58
41
31
24
19
15
33284
8396
3764
2135
1377
357
163
94
61
42
31
24
19
15
35954
9044
4043
2287
1471
376
170
96
62
43
31
24
18
14
37838
9495
4235
2390
1534
388
173
97
62
42
31
23
17
14
38937
9751
4340
2444
1566
392
173
96
61
41
29
22
16
12
39251
9809
4357
2449
1566
388
170
94
58
39
27
20
15
11
s
~
e:..
s-
til
K
.....
("1)
"'
.....
0\
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
3994
1084
519
313
214
70
38
25
18
14
11
10
8
7
7221
1881
869
508
337
98
50
31
22
17
13
11
9
7
10064
2582
1177
678
444
123
60
37
25
18
14
11
9
8
12522
3187
1441
825
536
145
69
41
27
20
15
12
10
8
14597
3696
1663
947
613
162
75
44
29
21
16
12
10
8
16287
4109
1843
1045
675
175
81
47
31
22
16
13
10
8
17593
4426
1979
1120
721
185
84
48
31
22
16
12
10
8
18515
4647
2073
1170
752
191
86
49
31
22
16
12
9
7
19053
4772
2124
1197
767
193
86
48
31
21
15
11
9
7
19207
4801
2133
1199
767
191
84
47
29
20
14
11
8
6
>
c.
0>
.0
c::
'<
0
.......
1:/.l
-3
"0
0>
1:/.l
N.
0>
s
:r:
0>
e.
So
1:/.l
e:
0>
"'
Q..
('1)
..c
$::=
"'
'<
('")
0.....,
Cl.l
"0
('1)
Cl.l
No
IP2-P11
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
8904
2415
1156
696
474
153
82
53
38
29
23
19
15
13
16101
4192
1936
1130
748
217
109
67
46
34
26
21
17
14
22441
5756
2622
1510
988
273
131
79
53
39
29
23
18
15
27924
7105
3212
1836
1194
320
150
89
59
42
31
24
19
16
32550
8240
3707
2109
1365
358
166
96
63
44
33
25
20
16
36320
9161
4107
2329
1502
388
177
101
66
46
33
25
20
16
39233
9868
4411
2495
1605
410
185
105
67
46
33
25
19
15
41289
10361
4621
2607
1674
423
189
106
67
46
33
24
18
14
42488
10639
4735
2666
1708
427
189
105
66
44
31
23
17
13
42831
10704
4754
2672
1708
423
185
101
63
42
29
21
15
11
('1)
Ei"
::I:
('1)
e
g.
Cl.l
Q..
o
"'
VJ
00
IP2-P11
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
6429
1744
835
503
343
111
60
39
28
21
17
14
12
10
11624
3027
1398
816
541
157
79
49
34
25
20
16
13
11
16202
4156
1893
1090
714
197
95
57
39
28
22
17
14
11
20160
5130
2319
1326
862
231
109
64
43
31
23
18
14
12
23500
5950
2677
1523
986
259
120
70
46
32
24
19
15
12
26221
6614
2965
1682
1085
281
128
74
48
33
25
19
15
12
28324
7125
3185
1802
1159
296
134
76
49
34
25
19
14
11
29809
7480
3336
1883
1209
306
137
77
49
33
24
18
14
11
30675
7681
3419
1925
1233
309
137
76
48
32
23
17
13
10
30922
7728
3433
1929
1233
306
134
74
46
31
22
16
12
9
>
Q..
~
.g
~
'<
0
......
t;n
-3
"0
~
t;n
N.
s
~
:;.
t;n
Q..
(D"
"'
>
~
.g
I
(')
'<
0
....,
c;n
"0
(1>
c;n
t;i'
(1>
IP2-P11
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
2813
764
366
221
151
49
27
18
13
10
8
7
6
5
5086
1325
613
358
237
70
35
22
16
12
9
8
6
5
7089
1819
829
478
313
87
42
26
18
13
10
8
7
6
8821
2245
1015
581
378
102
48
29
19
14
11
9
7
6
10282
2604
1172
667
432
114
53
31
21
15
11
9
7
6
11473
2895
1298
737
475
124
57
33
22
15
12
9
7
6
12393
3118
1394
789
508
130
59
34
22
16
12
9
7
6
13042
3273
1460
824
530
134
60
34
22
15
11
9
7
5
13421
3361
1496
843
540
136
60
34
22
15
11
8
6
5
13529
3382
1502
845
540
134
59
33
21
14
10
8
6
5
s
::I:
(1>
e:..
g.
c;n
0..
(ii'
"'
.......
-!:>0
p1
p2
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
0.0001
379307
121433
65073
42589
13915
4064
1763
1106
801
374
242
178
140
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
379307
121433
644148
65073
189625
906247
42589
96331
256118
1167438
13915
21289
31800
48149
75817
4064
5056
6087
7223
8508
19240
1763
2030
2278
2525
2778
4248
15119
1106
1236
1352
1463
1572
2145
4835
25612
801
880
948
1013
1075
1386
2588
7531
35946
374
399
419
438
456
535
771
1287
2137
3738
242
254
265
274
283
321
423
610
853
1191
6283
178
186
192
198
203
226
284
382
495
636
1841
8749
644148
189625
96331
21289
5056
2030
1236
880
399
254
186
146
906247
256118
31800
6087
2278
1352
948
419
265
192
150
1167438
48149
7223
2525
1463
1013
438
274
198
154
75817
8508
2778
1572
1075
456
283
203
158
19240
4248
2145
1386
535
321
226
173
15119
4835
2588
771
423
284
211
25612
7531
1287
610
382
272
35946
2137
853
495
338
3738
1191
636
414
6283
1841
931
8749
2461
>
c..
CT>
.0
s::
~
'<
0
.....,
en
-.....
"0
CT>
en
N
CT>
11155
er
:I:
CT>
~
9en
e:
CT>
"'
Q.
..8
=
~
'<
0
.....,
(ll
(1)
p1
(ll
t::l"
(1)
p2
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
s
::I:
(1)
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
292434
292434
93621
50169
32835
10728
3133
1359
853
617
288
186
137
108
496619
146195
74268
16413
3898
1565
953
678
307
196
143
112
93621
496619
698689
197459
24517
4693
1757
1042
731
323
204
148
116
50169
146195
698689
900059
37122
5568
1947
1128
781
338
211
153
119
32835
74268
197459
900059
58452
6560
2142
1212
829
351
218
157
122
10728
16413
24517
37122
58452
14834
3275
1654
1068
413
247
174
133
3133
3898
4693
5568
6560
14834
11656
3728
1996
594
326
219
163
1359
1565
1757
1947
2142
3275
11656
19746
5806
992
470
294
210
853
953
1042
1128
1212
1654
3728
19746
27714
1648
657
382
260
617
678
731
781
829
1068
1996
5806
27714
2882
918
490
319
288
307
323
338
351
413
594
992
1648
2882
4844
1419
718
186
196
204
211
218
247
326
470
657
918
4844
6745
1897
137
143
148
153
157
174
219
294
382
490
1419
6745
8600
ET
(ll
Q.
"'
......
~
p1
p2
0.0001
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
157644
50469
27045
17700
5783
1689
733
460
333
155
100
74
58
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
157644
50469
267715
27045
78810
376646
17700
40036
106445
485199
5783
8848
13216
20011
31510
1689
2101
2530
3002
3536
7996
733
844
947
1050
1154
1766
6283
460
514
562
608
653
892
2009
10645
333
366
394
421
447
576
1076
3130
14940
155
166
174
182
189
222
320
535
888
1553
100
106
110
114
118
133
176
253
354
495
2611
74
77
80
82
84
94
118
159
206
264
765
3636
..c
4636
267715
78810
40036
8848
2101
844
514
366
166
106
77
61
376646
106445
13216
2530
947
562
394
174
110
80
62
485199
20011
3002
1050
608
421
182
114
82
64
31510
3536
1154
653
447
189
118
84
66
7996
1766
892
576
222
133
94
72
6283
2009
1076
320
176
118
88
10645
3130
535
253
159
113
14940
888
354
206
140
1553
495
264
172
2611
765
387
3636
1023
>
Q..
s::
""
'<
(")
0
.....,
Cll
~
0
Cll
No
::I:
0
e?..
g.
Cll
E'
9:
0
"'
>
0..
~
.g
II'
('")
'<
0.....,
en
"0
p1
p2
0.000'1
en
N.
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
249634
79919
423934
42827
124798
596429
28029
63398
168559
768327
9158
14011
20928
31688
49897
2675
3328
4006
4753
5600
12662
1160
1336
1500
1662
1828
2796
9950
728
813
890
963
1035
1412
3182
16856
527
579
624
667
708
912
1703
4957
23657
246
262
276
288
300
352
507
847
1407
2460
159
167
174
180
186
211
278
401
561
784
4135
117
122
126
130
134
149
187
251
326
418
1212
5758
s
:I:
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
249634
79919
42827
28029
9158
2675
1160
728
527
246
159
117
92
423934
124798
63398
14011
3328
1336
813
579
262
167
122
96
596429
168559
20928
4006
1500
890
624
276
174
126
99
768327
31688
4753
1662
963
667
288
180
130
101
49897
5600
1828
1035
708
300
186
134
104
12662
2796
1412
912
352
211
149
114
9950
3182
1703
507
278
187
139
16856
4957
847
401
251
179
23657
1407
561
326
222
2460
784
418
273
4135
1212
613
5758
1619
7341
:;.
en
a
e:
~
"'
-t
Table Se: Sample Size for Two-Sample Test of Small Proportions
(Level of significance: 5%; Power: 80%; Alternative hypothesis: 1-sided)
p1
p2
0.0001
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
180223
57697
30919
20236
6611
1931
837
526
380
178
115
84
67
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
180223
57697
306058
30919
90098
430591
20236
45770
121691
554693
6611
10115
15109
22877
36023
1931
2402
2892
3432
4043
9142
837
964
1083
1200
1320
2019
7183
526
587
642
695
747
1019
2297
12169
380
418
451
481
511
658
1230
3578
17079
178
189
199
208
216
254
366
611
1015
1776
115
121
126
130
134
152
201
290
405
566
2985
84
88
91
94
97
107
135
181
235
302
875
4157
306058
90098
45770
10115
2402
964
587
418
189
121
88
69
430591
121691
15109
2892
1083
642
451
199
126
91
71
554693
22877
3432
1200
695
481
208
130
94
73
36023
4043
1320
747
511
216
134
97
75
9142
2019
1019
658
254
152
107
82
7183
2297
1230
366
201
135
100
12169
3578
611
290
181
129
17079
1015
405
235
161
1776
566
302
197
2985
875
442
4157
1169
>-
0.
~
..0
s::
1'5
"<:
0
....,
Cll
'0
~
Cll
N.
5300
::r
:I::
~
:;.
Cll
s::
0.
G.
"'
>
Q..
(1>
..0
s::
'<
0
....,
C/.l
-3
"0
p1
(1>
C/.l
N.
p2
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
(1>
s
::I:
(1>
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
78848
78848
25243
13527
8853
2893
845
366
230
166
78
50
37
29
133901
39418
20025
4425
1051
422
257
183
83
53
39
30
25243
133901
188385
53240
6610
1265
474
281
197
87
55
40
31
13527
39418
188385
242679
10009
1501
525
304
211
91
57
41
32
8853
20025
53240
242679
15760
1769
577
327
224
95
59
42
33
2893
4425
6610
10009
15760
4000
883
446
288
111
67
47
36
845
1051
1265
1501
1769
4000
3143
1005
538
160
88
59
44
366
422
474
525
577
883
3143
5324
1566
267
127
79
57
230
257
281
304
327
446
1005
5324
7472
444
177
103
70
166
183
197
211
224
288
538
1566
7472
777
248
132
86
78
83
87
91
95
111
160
267
444
777
1306
383
194
50
53
55
57
59
67
88
127
177
248
1306
1819
512
37
39
40
41
42
47
59
79
103
132
383
1819
2319
e:..
g.
C/.l
a
Q..
(;)'
"'
+:>.
0'1
p1
p2
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
0.0001
191555
61325
32863
21508
7027
2052
890
559
404
189
122
90
71
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
191555
61325
325303
32863
95763
457667
21508
48648
129343
589572
7027
10751
16059
24316
38288
2052
2554
3074
3648
4297
9717
890
1025
1151
1275
1403
2145
7635
559
624
683
739
794
1083
2442
12935
404
444
479
511
543
700
1307
3803
18153
189
201
212
221
230
270
389
650
1079
1888
122
128
134
138
143
162
214
308
431
602
3173
90
94
97
100
103
114
144
193
250
321
930
4419
325303
95763
48648
10751
2554
1025
624
444
201
128
94
74
457667
129343
16059
3074
1151
683
479
212
134
97
76
589572
24316
3648
1275
739
511
221
138
100
78
38288
4297
1403
794
543
230
143
103
80
9717
2145
1083
700
270
162
114
87
7635
2442
1307
389
214
144
107
12935
3803
650
308
193
137
18153
1079
431
250
171
1888
602
321
209
3173
930
470
4419
1243
>
0..
('1l
.0
t::
I>'
(')
'-<
0
.....
C/)
"'('1l
C/)
N.
('1l
5633
s
:I:
('1l
e:..
Er
C/)
('1l
CIJ
>
0.
("p
.0
c::
"'
(")
'<
....,
(/)
'1:::)
("p
p1
(/)
N.
("p
p2
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
s
:I:
("p
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
131452
131452
42084
22552
14760
4822
1408
611
383
277
130
84
62
49
223235
65716
33384
7378
1752
703
428
305
138
88
64
50
42084
223235
314067
88760
11021
2110
790
468
329
145
92
67
52
22552
65716
314067
404585
16686
2503
875
507
351
152
95
69
53
14760
33384
88760
404585
26275
2949
963
545
373
158
98
70
55
4822
7378
11021
16686
26275
6668
1472
743
480
186
111
78
60
1408
1752
2110
2503
2949
6668
5239
1676
897
267
147
98
73
611
703
790
875
963
1472
5239
8876
2610
446
211
132
94
383
428
468
507
545
743
1676
8876
12457
741
295
172
117
277
305
329
351
373
480
897
2610
12457
1295
413
220
144
130
138
145
152
158
186
267
446
741
1295
2177
638
323
84
88
92
95
98
111
147
211
295
413
2177
3032
853
62
64
67
69
70
78
98
132
172
220
638
3032
3866
n
e:..
::r
(/)
c::
0.
"'
-....
00
p1
p2
0.0001
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
0.0500
0.0001
47889
15331
8216
5377
1757
513
223
140
101
47
31
22
18
0.0002
0.0003
0.0004
0.0005
0.0010
0.0025
0.0050
0.0075
0.0100
0.0200
0.0300
0.0400
47889
15331
81326
8216
23941
114417
5377
12162
32336
147393
1757
2688
4015
6079
9572
513
638
769
912
1074
2429
223
256
288
319
351
536
1909
140
156
171
185
198
271
610
3234
101
111
120
128
136
175
327
951
4538
47
50
53
55
58
68
97
162
270
472
31
32
33
35
36
40
53
77
108
150
793
22
23
24
25
26
29
36
48
63
80
232
1105
81326
23941
12162
2688
638
256
156
111
50
32
23
18
114417
32336
4015
769
288
171
120
53
33
24
19
147393
6079
912
319
185
128
55
35
25
19
9572
1074
351
198
136
58
36
26
20
2429
536
271
175
68
40
29
22
1909
610
327
97
53
36
27
3234
951
162
77
48
34
4538
270
108
63
43
472
150
80
52
793
232
118
1105
311
>--
0..
~
.0
1:::
P>
0
'<
0
....,
Cll
"0
Cll
N.
~
1408
s
:I:
~
e:.
....
::r
Cll
....
1:::
0..
o;
"'
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
95405
48454
32815
25005
20326
11028
8005
6560
5758
5288
5021
4897
4885
4975
5169
5484
6630
9202
17291
91179
46364
31439
23986
19522
10661
7789
6427
5679
5252
5022
4932
4955
5082
5317
5679
6960
9789
18631
87893
44740
30370
23195
18899
10378
7627
6331
5630
5239
5041
4982
5036
5198
5473
5881
7295
10378
19972
85264
43441
29515
22564
18402
10156
7503
6262
5600
5241
5072
5042
5126
5321
5633
6088
7632
10970
21314
83114
42379
28817
22048
17997
9977
7406
6213
5584
5254
5112
5109
5222
5448
5798
6297
7971
11562
22657
81322
41495
28236
21620
17661
9831
7330
6177
5580
5276
5159
5181
5322
5580
5966
6510
8312
12155
24000
79806
40747
27745
21258
17378
9709
7270
6154
5584
5304
5211
5258
5426
5714
6136
6724
8655
12749
25343
78507
40106
27325
20949
17136
9608
7221
6138
5594
5338
5267
5338
5532
5850
6308
6939
8998
13344
26687
77381
39551
26962
20682
16927
9522
7183
6130
5610
5375
5327
5420
5640
5988
6482
7156
9341
13939
28030
76396
39066
26644
20449
16746
9449
7153
6128
5630
5416
5389
5505
5750
6128
6656
7373
9686
14534
29374
75527
38638
26364
20245
16587
9386
7130
6130
5653
5460
5453
5591
5862
6268
6831
7591
10031
15129
30718
74755
38259
26116
20063
16446
9332
7112
6136
5679
5505
5519
5679
5975
6410
7008
7810
10376
15725
32063
74065
37919
25895
19902
16321
9286
7099
6145
5708
5553
5586
5768
6088
6552
7185
8030
10722
16321
33407
73443
37614
25696
19757
16210
9246
7089
6158
5739
5602
5655
5859
6203
6696
7362
8250
11068
16917
34751
Vl
p*2
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1.50
1. 75
2.00
2.25
2.50
2.75
3.00
10908
5566
3788
2900
2369
1319
984
829
749
708
692
695
714
749
801
874
1115
1631
3220
3.25
3.50
3. 75
4.00
4.25
4.50
4.75
5.00
10027
5132
3503
2692
2206
1252
954
823
762
739
741
762
802
860
940
1048
1392
2110
4301
9935
5087
3474
2670
2190
1246
953
825
766
745
750
774
817
879
964
1077
1439
2190
4481
9851
5046
3447
2650
2175
1241
951
826
770
752
759
786
832
899
988
1107
1485
2270
4662
......
Ut
......
Vt
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
2791
1410
950
720
582
307
217
173
148
132
122
116
112
111
112
116
132
173
307
2517
1275
861
654
530
283
202
163
141
127
119
114
112
112
114
119
139
186
338
2335
1184
801
610
495
267
192
156
136
124
117
113
112
113
117
123
146
200
369
2205
1120
759
578
470
255
185
152
134
123
117
114
113
115
120
127
154
213
400
2107
1072
727
555
452
247
180
149
132
122
117
114
115
118
123
132
161
227
431
2031
1034
702
536
437
240
177
147
131
122
117
116
117
121
127
136
169
240
462
1971
1004
682
522
426
235
174
145
130
122
118
117
119
123
131
141
177
254
493
1921
980
666
510
416
231
172
144
130
122
119
119
121
126
134
146
185
268
524
1879
959
653
500
409
228
170
143
129
122
120
120
123
129
138
151
193
281
555
1844
942
642
492
402
225
168
143
129
123
121
122
126
133
142
156
200
295
586
1814
927
632
485
396
222
167
142
130
124
122
124
128
136
146
161
208
309
617
1788
914
623
478
392
220
166
142
130
125
124
126
131
139
150
166
216
323
648
1766
903
616
473
387
219
166
142
131
126
125
128
133
142
154
171
224
336
679
1746
893
610
468
384
217
165
142
131
127
126
130
136
145
158
176
232
350
710
1728
884
604
464
380
216
165
142
132
128
128
132
139
149
162
181
240
364
741
1712
877
599
460
378
215
165
142
132
129
130
134
141
152
166
186
248
378
772
1697
870
594
457
375
214
164
143
133
130
131
136
144
155
171
191
256
391
803
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
69912
35313
23785
18025
14572
7691
5429
4326
3692
3296
3043
2884
2797
2769
2797
2884
3296
4326
7691
63061
31923
21550
16367
13261
7078
5052
4071
3513
3172
2961
2838
2783
2786
2846
2968
3469
4655
8462
58494
29664
20061
15263
12389
6672
4806
3908
3403
3101
2922
2827
2798
2827
2914
3067
3651
4990
9235
55232
28051
18998
14476
11767
6385
4634
3798
3333
3062
2907
2835
2828
2880
2993
3175
3838
5327
10010
52786
26842
18201
13886
11302
6172
4510
3721
3288
3041
2908
2856
2869
2942
3078
3288
4030
5667
10786
50883
25901
17582
13429
10941
6009
4416
3665
3259
3033
2919
2884
2916
3009
3168
3405
4223
6009
11563
49361
25149
17087
13063
10654
5880
4344
3626
3242
3034
2937
2919
2968
3080
3262
3525
4419
6351
12340
48116
24535
16683
12765
10419
5776
4288
3597
3233
3042
2960
2958
3023
3154
3357
3646
4615
6694
13117
47079
24023
16347
12516
10225
5691
4244
3576
3230
3055
2987
3000
3081
3230
3454
3769
4812
7037
13894
46202
23589
16063
12307
10061
5621
4209
3563
3233
3071
3017
3044
3141
3308
3553
3893
5011
7381
14672
45449
23219
15819
12128
9921
5562
4181
3554
3239
3090
3050
3090
3203
3387
3652
4017
5209
7725
15450
44798
22897
15609
11974
9800
5513
4159
3549
3248
3112
3084
3138
3265
3467
3752
4143
5408
8070
16228
44228
22616
15425
11839
9695
5470
4141
3548
3259
3136
3120
3187
3329
3548
3854
4269
5608
8414
17006
43725
22369
15263
11720
9603
5434
4128
3549
3273
3161
3157
3237
3394
3629
3955
4395
5807
8759
17784
43278
22149
15120
11615
9521
5403
4117
3552
3288
3187
3195
3288
3459
3711
4057
4522
6007
9104
18562
42878
21952
14991
11522
9449
5376
4110
3558
3305
3215
3234
3340
3525
3794
4160
4649
6207
9449
19340
42518
21776
14876
11438
9384
5353
4104
3565
3323
3244
3274
3392
3591
3876
4262
4776
6408
979~
20118
p*2
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
10301 10133
5259
5177
3581
3527
2744
2704
2243 2212
1254 1240
939
932
793
795
722
721
689
685
673
680
679
689
714
701
755
738
815
792
896
868
1117 1162
1646 1723
3445
3271
9988
5105
3480
2670
2185
1229
928
792
724
694
688
700
728
773
837
924
1206
1799
3618
9860
5042
3439
2640
2162
1220
924
791
727
699
696
711
743
791
859
952
1251
1876
3792
9748
4987
3403
2613
2141
1212
921
792
730
705
704
722
757
809
882
980
1295
1953
3965
9649
4938
3371
2590
2123
1205
918
792
733
711
713
733
772
828
905
1008
1340
2030
4139
9560
4894
3343
2569
2107
1199
917
794
737
717
721
745
786
846
928
1037
1384
2107
4312
9479
4855
3317
2550
2093
1194
915
795
741
724
730
757
801
865
951
1065
1429
2184
4486
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
9378
8459
7846
7409
7081
6825
6621
6454
6315
6198
6097
6009
5933
5865
5805
5752
5703
4737
4282
3763
2549
3601
2442
3475
2359
3374
2292
3223
3072
3034
3001
2971
2945
2921
2196
1942
1863
1802
1753
2193
1679
2122
1627
2094
1606
2069
1588
2048
1572
2028
2418
1955
2238
1713
3165
2155
1651
3115
2891
3979
2691
2048
3291
3191
2011
1546
1996
1535
1662
895
1579
857
1516
828
1468
806
1429
789
1398
1372
1315
1301
747
740
734
1278
725
1259
764
1288
729
1268
775
1350
754
1331
1032
1779
950
722
729
678
645
622
605
593
583
576
570
565
561
558
554
553
552
718
551
581
496
546
472
525
457
510
448
499
441
492
438
487
435
483
434
480
434
478
434
477
435
476
436
556
476
476
439
424
477
441
478
444
1558
479
446
436
443
426
416
411
408
407
407
408
410
412
415
418
438
421
428
432
409
398
392
390
390
392
394
383
385
387
392
392
399
435
406
414
409
422
419
428
434
381
380
414
421
429
380
376
409
415
424
381
374
401
403
405
387
376
372
397
397
430
438
447
456
441
464
448
473
374
382
380
391
387
402
395
404
414
424
434
444
455
465
412
426
438
473
451
489
464
506
477
523
498
545
399
425
457
487
531
509
413
441
476
517
573
590
607
624
641
490
670
515
541
567
593
619
646
1135
1239
806
1551
852
1656
898
1760
944
1864
833
1268
1032
761
1447
806
1222
860
715
1343
753
1129
779
581
466
625
2490
2595
376
387
443
490
504
672
539
699
556
726
990
1968
1037
2073
1083
2177
2281
1175
2386
558
440
455
482
520
572
1314
2699
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
1616
816
550
417
337
178
126
100
86
77
71
67
65
64
65
67
77
100
178
1458
738
498
379
307
164
117
95
82
74
69
66
65
65
66
69
81
108
196
1352
686
464
353
287
155
112
91
79
72
68
66
65
66
68
71
85
116
214
1277
649
439
335
272
148
108
88
78
71
68
66
66
67
70
74
89
124
232
1220
621
421
321
262
143
105
86
76
71
68
66
67
68
72
76
94
131
250
1176
599
407
311
253
139
103
85
76
71
68
67
68
70
74
79
98
139
268
1141
582
395
302
247
136
101
84
75
71
68
68
69
72
76
82
103
147
286
1112
567
386
295
241
134
100
84
75
71
69
69
70
73
78
85
107
155
304
1088
556
378
290
237
132
99
83
75
71
70
70
72
75
80
88
112
163
322
1068
546
372
285
233
130
98
83
75
71
70
71
73
77
83
90
116
171
339
1051
537
366
281
230
129
97
83
75
72
71
72
74
79
85
93
121
179
357
1036
530
361
277
227
128
97
82
76
72
72
73
76
81
87
96
125
187
375
1022
523
357
274
224
127
96
82
76
73
73
74
1011
517
353
271
222
126
96
82
76
74
73
75
79
84
92
102
135
203
411
1000
512
350
269
220
125
96
83
76
74
74
76
80
86
94
105
139
211
429
991
508
347
267
219
125
95
83
77
75
75
78
82
88
97
108
144
219
447
983
504
344
265
217
124
95
83
77
75
76
79
83
90
99
111
149
227
465
77
82
90
99
130
195
393
p*2
1.00
1.25
1.50
1.75
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
49246
24875
16754
12697
10264
5418
3824
3048
2601
2322
2144
2032
1970
1951
1970
2032
2322
3048
5418
44421
22487
15180
11529
9341
4986
3559
2868
2475
2234
2086
1999
1961
1963
2005
2091
2443
3279
5961
41203
20896
14131
10752
8727
4700
3385
2753
2398
2185
2058
1991
1971
1991
2053
2161
2572
3515
6505
38906
19759
13382
10197
8289
4498
3265
2675
2348
2157
2048
1997
1992
2029
2108
2236
2704
3753
7051
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
32545
16617
11315
8669
7087
3960
2965
2510
2277
2163
2125
2144
2213
2330
2503
2742
3530
5199
10335
32015
16355
11143
8543
6988
3918
2945
2503
2281
2177
2148
2177
2256
2386
2573
2830
3669
5442
10883
31556
16129
10995
8434
6903
3883
2930
2500
2288
2192
2172
2211
2300
2442
2643
2918
3810
5684
11431
31154
15931
10866
8339
6829
3853
2917
2499
2296
2209
2198
2245
2345
2499
2715
3007
3950
5927
11979
30800
15757
10752
8256
6764
3828
2908
2500
2306
2227
2224
2280
2391
2556
2786
3096
4091
6170
12527
30485
15602
10650
8182
6707
3806
2900
2503
2316
2245
2251
2316
2437
2614
2858
3185
4232
6413
13075
30203
15463
10560
8116
6656
3787
2895
2506
2328
2265
2278
2353
2483
2672
2930
3275
4373
6656
13623
29950
15339
10479
8057
6610
3771
2891
2511
2341
2285
2306
2389
2530
2731
3003
3364
4514
6899
14172
_.
VI
00
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
10979
5546
3736
2831
2289
1208
853
680
580
518
478
453
440
435
440
453
518
680
1208
9903
5014
3385
2571
2083
1112
794
640
552
499
465
446
437
438
447
467
545
731
1329
9186
4659
3151
2397
1946
1048
755
614
535
487
459
444
440
444
458
482
574
784
1451
8674
4406
2984
2274
1848
1003
728
597
524
481
457
446
445
453
470
499
603
837
1572
8290
4216
2859
2181
1775
970
709
585
517
478
457
449
451
462
484
517
633
890
1694
7991
4068
2761
2109
1719
944
694
576
512
477
459
453
458
473
498
535
664
944
1816
7752
3950
2684
2052
1673
924
683
570
510
477
462
459
466
484
513
554
694
998
1938
7557
3853
2620
2005
1637
907
674
565
508
478
465
465
475
496
528
573
725
1052
2060
7394
3773
2567
1966
1606
894
667
562
508
480
470
471
484
508
543
592
756
1106
2182
7256
3705
2523
1933
1580
883
661
560
508
483
474
478
494
520
558
612
787
1160
2304
7138
3647
2485
1905
1558
874
657
559
509
486
479
486
503
532
574
631
818
1214
2427
7035
3596
2452
1881
1539
866
654
558
510
489
485
493
513
545
590
651
850
1268
2!?49
6946
3552
2423
1860
1523
859
651
558
512
493
490
501
523
558
606
671
881
1322
2671
6867
3513
2397
1841
1508
854
649
558
514
497
496
509
533
570
622
691
912
1376
2793
6797
3479
2375
1824
1496
849
647
558
517
501
502
517
544
583
638
711
944
1430
2915
6734
3448
2355
1810
1484
845
646
559
519
505
508
525
554
596
654
730
975
1484
3038
6677
3420
2337
1797
1474
841
645
560
522
510
515
533
564
609
670
750
1007
1538
3160
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
6606
3337
2248
1703
1377
727
513
409
349
312
288
273
265
262
265
273
312
409
727
5959
3017
2037
1547
1253
669
478
385
332
300
280
269
263
264
269
281
328
440
800
5527
2803
1896
1443
1171
631
455
370
322
293
277
268
265
268
276
290
345
472
873
5219
2651
1795
1368
1112
604
438
359
315
290
275
268
268
273
283
300
363
504
946
4988
2537
1720
1312
1068
584
427
352
311
288
275
270
271
278
291
311
381
536
1020
4808
2448
1662
1269
1034
568
418
347
308
287
276
273
276
285
300
322
399
568
1093
4664
2377
1615
1235
1007
556
411
343
307
287
278
276
281
292
309
333
418
600
1166
4547
2319
1577
1206
985
546
406
340
306
288
280
280
286
298
318
345
436
633
1240
4449
2270
1545
1183
966
538
401
338
306
289
283
284
292
306
327
357
455
665
1313
4366
2229
1518
1163
951
532
398
337
306
291
286
288
297
313
336
368
474
698
1387
4295
2194
1495
1146
938
526
395
336
306
292
289
292
303
320
346
380
493
730
1460
4233
2164
1475
1132
926
521
393
336
307
294
292
297
309
328
355
392
511
763
1534
4179
2137
1458
1119
916
517
392
336
308
297
295
302
315
336
365
404
530
795
1607
4132
2114
1443
1108
908
514
390
336
310
299
299
306
321
343
374
416
549
828
1681
4089
2093
1429
1098
900
511
389
336
311
302
302
311
327
351
384
428
568
861
1754
4052
2075
1417
1089
893
508
389
337
313
304
306
316
333
359
393
440
587
893
1828
4018
2058
1406
1081
887
506
388
337
314
307
310
321
340
367
403
452
606
926
1901
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
Q15
0.20
. 0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1138
575
388
294
238
126
89
71
61
54
50
47
46
46
46
47
54
71
126
1027
520
351
267
216
116
83
67
58
52
49
47
46
46
47
49
57
76
138
952
483
327
249
202
109
79
64
56
51
48
46
46
46
48
50
60
82
151
899
457
310
236
192
104
76
62
55
50
48
47
47
47
49
52
63
87
163
860
437
297
226
184
101
74
61
54
50
48
47
47
48
51
54
66
93
176
829
422
287
219
179
98
72
60
54
50
48
47
48
49
52
56
69
98
189
804
410
279
213
174
96
71
59
53
50
48
48
49
51
54
58
72
104
201
784
400
272
208
170
94
70
59
53
50
49
49
50
52
55
60
76
109
214
767
391
267
204
167
93
70
59
53
50
49
49
51
53
57
62
79
115
227
752
384
262
201
164
92
69
58
53
50
50
50
52
54
58
64
82
121
239
740
378
258
198
162
91
69
58
53
51
50
51
53
56
60
66
85
126
252
730
373
255
195
160
90
68
58
53
51
51
52
54
57
62
68
89
132
265
720
369
252
193
158
90
68
58
54
52
51
52
55
58
63
70
92
137
277
712
365
249
191
157
89
68
58
54
52
52
53
56
60
65
72
95
143
290
705
361
247
190
155
88
68
58
54
52
52
54
57
61
67
74
98
149
303
698
358
244
188
154
88
67
58
54
53
53
55
58
62
68
76
102
154
315
692
355
243
187
153
88
67
59
55
53
54
56
59
64
70
78
105
160
328
Table 10a: Sample Size for a Hypothesis Test of the Odds Ratio
(Level of significance: 1%; Power: 90%; Alternative hypothesis: 2-sided)
Odds Ratio (OR)
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.25
1.50
1.75
2.00
2.25
2.50
2. 75
3.00
3.25
3.50
3.75
50273
25496
17242
13119
10648
5733
4128
3355
2919
2657
2500
2415
2386
2407
2476
2601
3082
4192
7718
13092
6046
3089
2104
1613
1319
736
548
461
414
389
377
375
382
396
418
451
562
801
1544
3525
1808
1236
950
780
442
335
2334
1201
824
635
523
301
231
1674
864
595
460
380
222
173
1000
519
360
280
232
139
111
813
423
294
229
191
116
94
200
184
177
151
141
137
137
141
148
99
95
94
96
100
106
115
126
141
84
81
81
677
353
246
193
161
99
81
73
71
72
74
78
84
92
102
115
156
240
493
574
301
210
165
285
260
247
243
244
251
263
281
306
389
564
1102
1269
657
453
352
291
173
136
120
113
111
113
117
123
132
144
161
212
319
643
6665
4524
3456
2815
1544
1132
936
829
767
733
720
722
740
772
823
1003
1401
2646
176
179
186
197
212
233
300
441
873
158
171
189
247
367
735
188
284
578
83
87
94
102
112
126
170
259
530
138
86
71
65
63
64
67
71
77
84
94
106
145
224
464
4.00
4.25
4.50
4.75
5.00
495
432
227
160
126
106
67
56
53
52
54
381
340
180
127
101
85
55
47
45
45
46
49
53
59
65
74
85
118
186
390
305
162
260
182
143
120
75
63
58
57
58
61
65
71
78
87
99
136
212
440
56
61
66
73
82
94
129
202
421
201
142
112
94
61
51
48
48
50
53
57
62
69
78
89
123
193
404
115
91
77
50
43
41
42
44
47
51
56
62
71
81
114
179
378
Table 10b: Sample Size for a Hypothesis Test of the Odds Ratio
(Level of significance: 1%; Power: 80%; Alternative hypothesis: 2-sided)
Odds Ratio (OR
p*2
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
o.70
0.80
0.90
39067
19817
13405
10202
8283
4465
3218
2618
2281
2078
1957
1893
1872
1890
1947
2047
2429
3310
61 04
10082
5135
3488
2665
2173
1195
878
728
646
599
574
564
567
582
608
649
794
1112
21 05
4617
2361
1610
1235
1011
566
424
357
322
303
295
294
300
312
330
357
446
638
1233
2672
1372
939
723
594
339
257
221
202
193
190
192
198
208
223
243
309
450
884
1757
905
622
481
396
230
177
154
143
138
138
141
147
156
168
185
239
353
702
1252
647
446
346
286
169
132
116
109
107
108
111
117
125
136
151
198
295
592
943
489
338
263
219
131
104
93
88
87
88
92
97
105
115
128
170
256
519
739
385
267
209
174
105
85
77
73
73
75
79
84
91
100
113
151
229
468
598
312
217
170
142
88
71
65
63
63
65
69
74
81
90
101
137
209
430
495
259
181
142
119
74
61
57
55
56
58
62
67
73
82
92
126
194
400
418
220
154
121
102
64
54
50
49
50
53
56
61
67
75
85
117
182
377
358
189
133
105
88
57
48
45
44
46
48
52
56
62
70
80
110
172
358
312
165
116
92
78
50
43
41
41
42
45
48
53
58
66
75
105
164
343
274
145
103
82
69
45
39
37
37
39
42
45
50
55
62
72
100
157
329
243
129
92
73
62
41
36
34
35
36
39
42
47
52
59
68
96
151
318
218
116
83
66
56
38
33
32
33
34
37
40
45
50
57
66
92
146
309
Table 10c: Sample Size for a Hypothesis Test of the Odds Ratio
(Level of significance: 1%; Power: 50%; Alternative hypothesis: 2-sided)
Odds Ratio (OR)
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
21557
10943
7407
5641
4583
5416
2763
1880
1439
1175
651
482
402
359
335
323
319
322
332
349
374
461
651
1241
2420
1241
848
652
535
303
230
196
178
169
166
167
171
179
191
207
262
378
736
1368
705
484
374
309
179
138
120
111
107
'107
880
456
315
244
202
120
94
83
79
77
78
277
147
103
82
226
120
85
67
57
37
32
30
30
31
33
36
39
43
49
56
77
120
250
188
100
71
57
48
32
28
27
27
28
30
33
36
40
45
52
72
113
236
159
85
61
49
42
28
25
24
25
26
28
30
33
37
42
49
68
107
225
136
73
53
42
36
25
22
22
23
24
26
28
31
35
40
46
65
102
216
118
64
46
37
32
22
20
20
21
22
24
27
30
33
38
44
62
98
208
103
56
41
33
29
20
19
19
19
21
23
25
28
32
36
42
91
50
36
30
26
19
17
80
84
90
98
109
143
213
427
454
237
165
130
100
67
55
50
48
48
50
53
56
61
68
76
349
184
129
101
109
113
120
129
142
183
269
533
614
320
222
173
1
87
70
63
60
60
61
63
67
73
80
89
119
179
362
2479
1793
1464
1279
1169
1104
1071
1062
1075
1111
1171
1397
1912
3541
103
157
320
54
44
41
40
41
43
45
49
54
60
67
92
141
290
44
37
35
35
36
37
40
43
48
54
61
83
129
267
60
95
201
17
18
20
22
24
27
30
35
40
58
92
196
Table 10d: Sample Size tor a Hypothesis Test of the Odds Ratio
(Level of significance: 5%; Power: 90%; Alternative hypothesis: 2-sided)
Odds Ratio (OR)
p*2
1.25
1.50
0.01
0.02
0.03
0.04
0.05
0.1 0
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
35761
18133
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
9375
4355
2554
1700
1225
4771
2224
1308
873
12261
9327
3237
2472
1514
894
598
631
434
932
738
602
482
332
383
264
313
1160
687
461
335
257
205
7569
2013
948
563
379
276
213
170
318
240
217
161
125
101
166
124
98
80
85
68
204
185
143
108
71
61
101
97
86
81
79
68
67
58
58
3.75
4.00
4.25
4.50
4.75
5.00
503
428
370
324
287
257
262
224
194
170
151
135
231
122
217
182
156
169
140
142
118
122
102
135
106
119
94
106
83
95
75
89
79
70
63
72
63
55
49
45
40
58
51
46
41
37
34
53
51
47
42
35
32
30
45
46
41
42
38
37
34
35
32
30
31
40
43
37
35
40
4072
11 02
527
2929
807
392
2379
666
329
2068
1881
589
544
295
276
176
131
126
1769
519
267
172
125
97
80
68
59
52
47
43
1707
509
265
173
127
50
46
269
177
131
70
75
55
510
82
87
62
1686
1699
100
104
59
54
50
46
43
522
279
138
111
48
46
149
120
78
64
71
51
294
317
80
88
55
544
579
93
101
59
1747
185
198
66
71
38
41
61
57
215
163
132
112
98
88
80
66
74
69
65
54
62
59
704
982
1851
394
560
1076
272
393
209
307
172
255
148
221
130
197
118
179
108
166
94
146
89
139
85
133
82
128
766
606
509
445
399
366
340
303
289
278
268
1834
2170
2948
5421
51
101
155
319
38
33
51
86
68
57
37
32
33
36
39
43
49
56
78
123
259
Table 10e: Sample Size for a Hypothesis Test of the Odds Ratio
(Level of significance: 5%; Power: 80%; Alternative hypothesis: 2-sided)
Odds Ratio (OR)
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01 26421
0.02 13400
0.03 9063
0.04 6896
0.05 5598
0.10 3016
0.15 2172
0.20 1766
0.25 1537
0.30 1400
0.35 1318
0.40 1273
0.45 1259
0.50 1270
0.55 1307
0.60 1373
0.70 1629
0.80 2216
0.90 4083
6858
3492
2371
1811
1476
810
595
492
436
404
387
380
381
391
408
435
531
742
1403
3157
1614
1100
843
690
386
288
242
218
205
199
198
202
209
221
239
298
425
820
1836
942
644
496
407
231
175
150
137
130
128
129
133
139
149
162
206
300
586
1213
624
429
331
272
157
121
105
97
94
93
95
98
104
112
123
159
235
465
868
448
309
239
198
116
90
79
74
72
73
75
78
84
91
100
131
196
392
656
340
235
183
151
90
71
63
60
59
60
62
65
70
516
269
186
145
121
73
58
52
50
50
51
53
56
61
67
75
100
152
309
419
219
152
119
99
61
49
44
43
43
44
46
50
54
60
67
91
138
283
348
182
127
100
83
52
42
39
38
38
39
42
45
49
54
61
83
128
264
295
155
108
85
71
45
37
34
33
34
36
38
41
45
50
57
78
120
248
254
134
94
74
62
39
33
31
30
31
32
35
38
42
47
53
73
113
236
221
117
82
65
55
35
30
28
28
28
30
32
35
39
44
50
69
108
225
195
103
73
58
49
32
27
26
26
26
28
30
33
37
42
48
66
103
216
174
92
65
52
44
29
25
24
24
25
26
29
31
35
40
45
63
99
209
156
83
59
47
40
26
23
22
22
23
25
27
30
33
38
44
61
96
203'
77
85
113
170
343
0\
0\
Table 10f: Sample Size for a Hypothesis Test of the Odds Ratio
(Level of significance: 5%; Power: 50%; Alternative hypothesis: 2-sided)
Odds Ratio (OR)
p*2
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
12480
6335
3136
1600
1401
718
792
408
510
264
356
185
263
138
202
106
161
85
131
109
92
79
4289
1089
491
281
182
129
96
75
60
49
41
35
31
3266
833
378
217
142
100
75
59
47
39
33
28
2654
1436
680
179
104
117
70
84
51
63
377
310
176
39
49
31
40
26
33
22
28
19
24
17
1038
279
133
22
19
13
24
20
65
46
35
24
20
18
18
16
14
14
13
103
29
28
16
16
15
113
41
37
26
233
208
55
49
32
848
741
80
70
13
677
194
187
98
96
62
62
45
45
35
28
29
21
22
17
18
15
16
63
66
47
35
37
24
25
23
21
19
21
70
640
19
31
26
39
42
46
33
36
29
25
31
35
28
23
25
31
29
52
69
44
39
53
35
48
33
82
75
45
70
168
155
145
620
185
97
615
623
643
187
193
99
104
202
111
75
52
57
678
217
120
82
63
809
1107
267
377
152
219
106
156
83
123
104
60
91
2050
718
426
309
247
210
185
49
18
40
4.75
5.00
68
60
53
27
24
21
25
22
19
17
21
15
19
17
15
13
12
11
12
11
10
12
12
11
10
11
11
14
15
13
14
12
13
12
13
18
17
16
15
14
20
22
18
17
16
16
25
21
23
19
22
19
21
18
20
30
42
28
27
26
25
24
40
35
55
34
62
130
38
59
36
66
117
113
23
26
137
4.00
4.25
125
4.50
57
121
53
Table 10g: Sample Size for a Hypothesis Test of the Odds Ratio
(Level of significance: 10%; Power: 90%; Alternative hypothesis: 2-sided)
Odds Ratio (OR)
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0. 70
0.80
0.90
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
29293
7713
3924
3598
1414
726
1022
526
780
619
506
424
362
313
275
197
403
321
115
104
740
497
361
277
221
189
131
144
1250
221
153
164
2662
263
182
244
128
218
1836
2117
1084
114
101
90
81
73
2032
1655
957
782
568
383
~79
119
103
71
64
58
117
99
85
89
75
79
230
133
172
142
142
315
180
215
177
59
37
53
14852
10041
7638
6197
3332
905
434
466
262
104
84
70
60
52
46
66
41
34
49
31
2396
661
322
198
137
103
81
66
56
48
42
38
34
31
28
26
1944
1690
546
482
270
118
89
50
44
39
56
48
42
37
31
31
29
28
25
83
35
34
27
108
71
67
59
241
168
152
26
25
1536
445
226
144
55
47
42
37
34
31
29
27
25
424
415
218
217
141
103
102
80
1443
1393
55
57
48
50
43
45
39
35
416
425
61
65
53
48
52
44
38
41
35
48
1423
443
58
53
49
46
39
44
37
41
1493
1765
471
572
52
72
50
47
2396
796
111
68
107
66
102
4402
1499
220
227
239
257
319
453
870
31
33
27
29
1374
1385
37
40
30
32
28
41
44
33
35
231
222
214
141
144
103
80
81
85
65
65
67
71
151
107
113
161
121
90
97
174
220
318
132
169
107
139
247
206
119
178
618
488
409
357
75
82
91
71
58
64
79
105
71
95
65
87
60
81
158
321
144
133
124
56
76
117
293
272
256
242
32
35
40
45
63
99
207
0\
Table 10h: Sample Size for a Hypothesis Test of the Odds Ratio
00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
20906
5448
2518
10603
7170
2774
1883
1286
876
1469
973
699
240
207
181
160
142
128
361
248
217
340
177
283
501
344
530
274
418
753
515
148
126
109
95
84
76
189
150
123
103
88
76
67
59
68
48
117
96
81
69
60
53
47
53
42
38
97
58
80
49
67
42
58
36
50
32
44
28
40
26
36
23
21
5455
1438
672
396
265
192
4428
2384
1172
643
549
307
325
184
218
126
159
147
122
93
72
1716
1395
471
390
228
192
140
119
1214
345
173
32
97
72
57
47
24
22
20
18
42
31
25
22
20
19
108
50
47
30
27
26
63
59
39
35
34
83
77
40
34
30
27
24
22
20
19
18
18
39
40
27
28
25
26
23
24
21
22
20
21
20
30
21
1105
319
162
103
74
57
47
1039
1004
305
299
157
156
101
102
73
75
57
47
59
49
992
1000
1029
300
308
321
159
165
174
105
11 0
117
78
62
51
82
88
66
71
1081
342
188
127
1281
417
234
162
97
125
79
103
1742
582
333
234
183
153
3206
1099
641
458
362
305
34
30
42
35
37
31
33
44
39
55
60
48
53
42
47
35
38
43
67
53
71
48
88
59
78
132
267
118
240
18
27
25
24
22
32
30
28
26
25
23
35
31
29
27
26
39
33
37
34
32
31
30
44
42
39
37
35
60
93
57
54
84
51
49
77
34
47
108
65
100
75
220
205
193
162
157
88
183
175
80
168
Table 10i: Sample Size for a Hypothesis Test of the Odds Ratio
(Level of significance: 10%; Power: 50%; Alternative hypothesis: 2-sided)
Odds Ratio (OR)
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
8791
4463
3021
2301
1869
1011
732
597
522
2209
1127
767
587
479
266
197
164
147
137
132
130
132
136
143
153
188
266
506
987
506
346
266
219
124
94
80
73
69
68
68
70
73
78
85
107
154
300
558
288
198
153
126
73
57
49
46
44
44
45
46
49
53
58
75
110
218
359
186
129
100
83
49
39
34
32
32
32
33
35
37
40
45
58
87
174
251
131
91
71
59
36
29
26
25
25
25
26
28
30
33
37
49
73
148
185
97
68
53
44
28
23
21
20
20
21
22
23
25
28
31
42
64
131
143
75
53
42
35
22
18
17
17
17
18
19
20
22
25
28
38
58
118
113
60
42
34
28
18
15
15
14
15
16
17
18
20
22
25
34
53
109
92
49
35
28
24
16
13
13
13
13
14
15
16
18
20
23
32
49
102
77
41
29
23
20
13
12
11
11
12
13
14
15
17
19
21
30
46
97
65
35
25
20
17
12
10
10
10
11
12
13
14
16
18
20
28
56
30
22
18
15
10
48
26
19
15
13
42
23
17
14
12
37
21
15
12
11
8
9
9
8
8
7
8
10
11
12
14
16
18
26
40
85
10
11
12
13
15
17
25
39
82
10
11
13
14
17
24
38
80
477
451
437
434
439
453
478
570
780
1444
44
92
10
11
12
13
15
17
19
27
42
88
-.l
1.00
1.25
1.50
1.75
2.00
92741 88471
45773 43638
30117 28694
22289 21221
17592 16738
8199
7772
4783
5067
3502
3288
2392
2562
1936
1794
1489
1367
1153 1047
892
798
684
598
513
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
>
~
..c
c:
!:
('")
'<
0
....,
Vl
"0
~
Vl
N.
::r
::I:
~
~
....
::r
....c:Vl
0..
c;;
"'
>
0..
('1)
..c
c::
~
'<
....,
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
Cll
3.50
3.75
4.00
4.25
4.50
4.75
5.00
3
"S!..
('1)
Cll
t:::i'
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
17503
8618
5657
4176
3288
1511
919
622
445
326
16392
8063
5287
3899
3066
1400
845
567
400
16196
7965
5221
3850
3026
1380
831
557
('1)
s
:I:
('1)
...::re:..
Cll
0..
~
Cll
--....)
......
-...)
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
15876
7858
5185
3849
3047
1444
909
642
482
375
298
241
196
161
132
107
69
41
18
14273
13203
6522
4295
3181
2513
1176
731
508
375
286
222
174
137
107
83
63
12440
6140
4040
2990
2360
1100
680
470
344
260
200
155
120
92
69
11867
5854
3849
2847
2246
1043
642
441
321
241
184
141
107
81
11422
5631
3701
2736
2156
998
612
419
303
226
171
130
11065
5453
3582
2646
2085
963
588
401
289
214
161
121
10774
5307
3485
2574
2027
934
569
387
277
205
153
10531
5185
3404
2513
1978
909
553
375
268
196
10325
5083
3335
2461
1937
889
539
364
260
190
10149
4995
3276
2417
1902
871
527
356
252
9996
4918
3226
2379
1871
856
517
348
246
9863
4851
3181
2346
1845
842
508
341
241
9745
4792
3142
2316
1821
831
500
335
9640
4740
3107
2290
1800
820
493
330
9546
4693
3075
2267
1781
811
487
325
9462
4651
3047
2246
1764
802
482
321
70~6
4651
3448
2727
1283
802
562
417
321
252
201
161
129
103
81
46
21
>
0..
('l>
..0
c::
""
'<:
(")
0
.....,
Cll
""
a
"0
Cll
N.
('l>
s
::c:
e:.
....
::r
Cll
....
c::
('l>
0..
(ii"
00
;..
p..
(!>
..0
cpo
(")
'<
....,
1/P2 )
Cll
po
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
a
"0
~
Cll
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
2735
1354
894
663
525
249
157
111
83
65
52
42
34
28
23
19
12
7
2459
1216
802
594
470
221
139
97
72
56
44
35
28
23
18
14
8
2275
1124
740
548
433
203
126
88
65
50
39
30
24
19
15
11
2143
1058
696
515
407
190
118
81
60
45
35
27
21
16
12
2045
1009
663
491
387
180
111
76
56
42
32
25
19
14
1968
970
638
472
372
172
106
73
53
39
30
23
1906
940
617
456
360
166
102
70
50
37
28
21
1856
915
601
444
350
161
98
67
48
36
27
1814
894
587
433
341
157
96
65
47
34
1779
876
575
424
334
153
93
63
45
33
1749
861
565
417
328
150
91
62
44
1722
848
556
410
323
148
90
60
43
1699
836
548
404
318
146
88
59
42
1679
826
542
399
314
143
87
58
1661
817
536
395
310
142
85
57
1645
809
530
391
307
140
84
56
1630
802
525
387
304
139
83
56
N.
(!>
::r:
(!>
So
Cll
p..
~
Vl
......
-.)
u.:>
-..)
~
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1/P2 )
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
53690
26499
17436
12904
10185
4747
2934
2027
1484
1121
862
668
517
396
297
51218
25263
16612
12286
9690
4499
2769
1904
1385
1039
792
606
462
347
49295
24302
15971
11805
9306
4307
2641
1808
1308
975
737
558
47757
23533
15458
11421
8998
4153
2538
1731
1246
923
693
520
46499
22904
15039
11106
8746
4027
2454
1668
1196
881
657
45450
22379
14689
10844
8537
3923
2384
1615
1154
44563
21936
14393
10622
8359
3834
2325
1571
1119
817
43802
21555
14140
10432
8207
3758
2275
1533
1088
3.75
4.00
43143 42566
21226 20937
13920 13728
10267 10123
8075
7960
3692
3634
2231
2192
1500
1471
1062
1039
4.25
4.50
42057 41605
20683 20457
13558 13407
9996 9883
7858
7768
3583 3538
2158 2128
1446
1423
4.75
5.00
41200 40836
20254 20072
13272 13151
9781
9690
7687
7614
3498 3461
2101
2077
1403
1385
>-
0..
(1)
..0
~
1>0
(")
'<
0
.....,
en
3
"0
(i"
en
N.
(1)
s
:I:
(1)
e:.
....
::r
en
....
~
0..
~-
00
>
0..
(1)
..c
c
I>'
0
'<
....,
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
1.25
1.50
en
I>'
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
10133
4990
3275
2418
1904
875
532
361
258
189
9935
4891
3209
2368
1864
855
519
351
250
182
9766
4806
3153
2326
1830
838
507
342
243
9619
4732
3104
2289
1801
823
498
335
237
9490
4668
3061
2257
1775
811
489
328
232
9377
4611
3023
2229
1752
799
482
323
9276
4561
2989
2204
1732
789
475
318
9186
4516
2959
2181
1714
780
469
313
9104
4475
2932
2161
1698
772
463
309
1.75
2.00
2.25
2.50
3
"0
en
N.
(1)
::c.
(1)
e:..
g.
en
....
c
0..
('6'
en
- .1
VI
-.J
0\
1/P2 )
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
9191
4549
3002
2229
1764
836
527
372
279
217
173
140
114
93
76
62
40
24
11
8263
4085
2693
1996
1579
743
465
325
242
186
146
117
93
75
60
47
27
12
7644
3776
2486
1842
1455
681
423
294
217
166
129
101
80
62
48
37
7202
3555
2339
1731
1367
637
394
272
199
151
116
90
70
54
40
6870
3389
2229
1648
1300
604
372
256
186
140
107
82
62
47
6612
3260
2143
1584
1249
578
355
243
176
131
99
75
6406
3157
2074
1532
1207
558
341
233
168
124
93
70
6237
3073
2018
1490
1174
541
330
224
161
119
89
6097
3002
1971
1455
1145
527
320
217
155
114
5978
2943
1931
1425
1122
515
312
211
150
110
5876
2892
1897
1400
1101
504
306
206
146
5787
2847
1868
1378
1084
496
300
202
143
5710
2809
1842
1358
1068
488
294
198
140
5642
2775
1819
1341
1054
481
290
194
5581
2744
1799
1326
1042
475
286
191
5527
2717
1781
1312
1031
470
282
189
5478
2693
1764
1300
1022
465
279
186
>
0..
~
..c~.
~
'<
0
....,
(/)
'E..
~
(/)
No
s
::r:
~
-e:
a
::r
(/)
"'
;.:.
0..
("1)
.0
1:::
'-<
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
0
.....,
1/P2 )
3.00
3.25
(/)
3.50
3.75
4.00
4.25
4.50
4.75
5.00
3
'E..
("1)
(/)
N.
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1584
784
518
384
304
144
91
64
48
38
30
24
20
16
14
11
7
1424
704
464
344
272
128
80
56
42
32
26
20
16
13
11
8
5
1317
651
429
318
251
118
73
51
38
29
23
18
14
11
9
7
1241
613
403
299
236
110
68
47
35
26
20
16
12
10
7
1184
584
384
284
224
104
64
44
32
24
19
14
11
8
1139
562
369
273
215
100
62
42
31
23
18
13
1104
544
358
264
208
96
59
40
29
22
16
12
1075
530
348
257
203
94
57
39
28
21
16
1051
518
340
251
198
91
56
38
27
20
1030
507
333
246
194
89
54
37
26
19
1013
499
327
242
190
87
53
36
26
997
491
322
238
187
86
52
35
25
984
484
318
234
184
84
51
34
24
972
478
314
231
182
83
50
34
962
473
310
229
180
82
50
33
952
468
307
226
178
81
49
33
944
464
304
224
176
80
48
32
("1)
::r
::r:
("1)
e:.
.....
::r
(/)
.....
1:::
0..
n;
Cll
-l
-l
......
-....)
00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1.00
48266
23890
15764
11701
9264
4388
2763
1951
1463
1138
906
732
596
488
399
326
209
122
55
1.25
1.50
43391 40141
21452 19827
14139 13056
10483 9670
8289 7639
3901
3576
2438 2221
1707 1544
1268 1138
976
867
767
674
610
529
488
416
391
326
311
252
244
190
140
61
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
>
0..
~
.0
s::
~
'<
0
.....,
Cl:l
$l.l
"0
Cl:l
N.
~
::r
:I:
~
e:.
....
::rCl:l
....
s::
0..
(;;"
"'
>
0..
(1)
,D
::::
1'0
(")
'-<
0.....,
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
CJj
1'0
3.50
3.75
4.00
4.25
4.50
4.75
5.00
"0
(;
CJj
;::;
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
10761
5326
3515
2609
2066
979
616
435
327
254
202
164
133
109
89
73
47
28
13
9674
4783
3153
2337
1848
870
544
381
283
218
171
136
109
87
70
55
32
14
8949
4421
2911
2156
1703
798
496
345
254
194
151
118
93
73
56
43
8432
4162
2738
2027
1600
746
461
319
233
176
136
105
82
63
47
8044
3968
2609
1930
1522
707
435
299
218
164
125
96
73
55
7742
3817
2508
1854
1462
677
415
284
206
153
116
88
7500
3696
2428
1794
1413
653
399
272
196
145
109
82
7303
3597
2362
1744
1374
633
386
262
188
139
104
7138
3515
2307
1703
1341
616
375
254
182
133
6999
3445
2261
1668
1313
602
366
247
176
129
6879
3385
2221
1639
1289
591
358
241
171
6776
3334
2186
1613
1269
580
351
236
167
6685
3288
2156
1590
1250
571
345
231
164
6605
3248
2130
1570
1234
563
339
227
6534
3213
2106
1552
1220
556
335
224
6470
3181
2085
1536
1208
550
330
221
6413
3153
2066
1522
1196
544
327
218
(1)
::r::
(1)
e:..
sCJj
0..
(p"
en
>-'
-...)
\0
00
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
6474
3205
2115
1570
1243
589
371
262
197
153
122
99
80
66
54
44
29
17
8
5821
2878
1897
1406
1112
524
327
229
171
131
103
82
66
53
42
33
19
9
5385
2660
1752
1297
1025
480
298
208
153
117
91
71
56
44
34
26
5073
2504
1648
1220
963
449
278
192
141
106
82
64
49
38
29
4840
2387
1570
1161
916
426
262
180
131
99
75
58
44
33
4658
2297
1509
1116
880
407
250
171
124
93
70
53
4513
2224
1461
1079
851
393
240
164
118
88
66
50
4394
2164
1421
1050
827
381
232
158
113
84
62
4295
2115
1388
1025
807
371
226
153
109
80
4211
2073
1360
1004
790
363
220
149
106
78
4139
2037
1336
986
776
355
215
145
103
4077
2006
1316
971
763
349
211
142
101
4022
1979
1297
957
753
344
208
139
99
3974
1955
1281
945
743
339
204
137
3931
1933
1267
934
734
335
202
135
3893
1914
1254
925
727
331
199
133
3859
1897
1243
916
720
327
197
131
>-
0..
0
.0
I::
::>l
('")
'<:
0
....,
en
::>l
"0
n'
en
t::i.
0
s
::r:
0
e:..
:r
en
....
I::
0..
(ii"
"'
>0.
(1l
..0
~
po
(")
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
'-<:
0
....,
1/P2 )
3.00
Cll
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
"0
Cll
N.
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
0.90
1116
552
365
271
215
102
64
46
34
27
21
17
14
12
10
8
5
1003
496
327
243
192
91
57
40
30
23
18
15
12
10
8
6
928
459
302
224
177
83
52
36
27
21
16
13
10
8
6
5
874
432
284
211
166
78
48
33
25
19
15
11
9
7
5
834
412
271
200
158
74
46
31
23
17
13
10
8
6
803
396
260
193
152
71
43
30
22
16
12
10
778
383
252
186
147
68
42.
29
21
16
12
9
757
373
245
181
143
66
40
28
20
15
11
740
365
240
177
139
64
39
27
19
14
726
357
235
173
137
63
38
26
19
14
713
351
231
170
134
62
38
25
18
703
346
227
168
132
61
37
25
18
693
341
224
165
130
60
36
24
17
685
337
221
163
128
59
36
24
678
333
219
161
127
58
35
24
671
330
217
160
126
57
35
23
665
327
215
158
124
57
34
23
(1l
s
::r:
(1l
e:..
....
::r
Cll
....
0.
n
rn
~
.....
00
.....
......
00
Table 12a: Sample Size for a Hypothesis Test of the Relative Risk
(Level of significance:1%; Power: 90%; Alternative hypothesis: 2-sided)
Relative Risk (RR::; 1/P2)
p*2
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
52978 14696
26187 7254
17256 4773
12791
3533
10112 2789
4754
1300
2967
804
2074
556
1539
407
1181
308
237
926
735
184
143
586
467
110
369
83
288
60
161
65
7175
3536
2324
1717
1353
626
383
262
189
141
106
80
60
43
30
4396
2164
1419
1047
824
378
229
154
110
80
59
43
30
20
3044
1496
980
722
567
257
154
102
72
51
36
25
2273
1115
729
536
421
189
112
73
50
35
24
15
1786
875
571
419
328
146
85
55
37
24
16
1457
712
464
340
266
117
67
43
28
18
1221
596
388
284
221
96
55
34
21
13
1046
510
331
242
188
81
45
27
17
911
443
287
210
163
69
38
22
13
804
391
253
184
143
60
32
19
10
718
349
225
164
127
53
28
15
648
314
202
147
113
46
24
13
589
285
183
133
102
41
21
11
539
260
167
121
93
37
18
9
5.00
Q.
(1)
.0
r::
r:>:>
(")
'<
....,
Cll
"0
Cll
t::i.
(1)
::r
::r:
e:..
g.
(1)
Cll
8Q.
VJ
>-
0.
('1)
Table 12b: Sample Size for a Hypothesis Test of the Relative Risk
.0
"'
'<
c::
('")
0
....,
Cll
"0
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
41584 11536
20555 5694
13545 3747
10040 2774
7937 2190
3732 1021
2330
632
1629
437
1208
320
928
242
728
187
577
145
461
113
367
87
291
65
227
48
127
52
5632
2776
1824
1348
1063
492
301
206
149
111
84
63
47
35
24
3451
1699
1115
823
647
297
180
122
87
63
47
34
24
16
2390
1175
770
567
446
203
122
81
57
41
29
20
1785
876
573
422
331
149
88
58
40
28
19
13
1403
688
449
330
258
115
68
44
29
20
13
1144
560
365
268
209
93
54
34
22
15
959
469
305
223
174
76
44
27
17
11
821
401
261
190
148
64
36
22
14
715
349
226
165
128
55
30
18
11
632
307
199
145
113
48
26
15
9
564
274
177
129
100
42
22
13
509
247
159
116
90
37
20
11
463
224
145
105
81
33
17
9
424
205
132
95
74
30
15
8
5.00
Cll
N.
('1)
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
s
:I:
('1)
::r
Cll
c::
0.
(ij.
Vl
00
~
......
00
.j:.
Table 12c: Sample Size for a Hypothesis Test of the Relative Risk
(Level of significance:1%; Power: 50%; Alternative hypothesis: 2-sided)
Relative Risk (RR:::;; 1/P2)
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
23621
11676
7695
5704
4510
2121
1324
926
687
528
414
329
263
210
166
130
73
30
6553
3235
2129
1576
1245
581
360
249
183
139
107
83
65
50
38
28
3200
1578
1037
767
605
280
172
118
86
64
49
37
28
21
15
1961
966
634
468
369
170
103
70
50
37
28
20
15
10
1358
668
438
323
254
116
70
47
33
24
18
13
1015
499
327
240
189
86
51
34
24
17
12
8
798
392
256
188
148
67
39
26
18
12
8
651
319
208
153
120
54
31
20
14
9
546
267
174
128
100
44
26
17
11
7
468
229
149
109
85
38
22
14
9
407
199
130
95
74
32
18
11
7
360
176
114
83
65
28
16
10
6
322
157
102
74
58
25
14
8
290
141
92
67
52
22
12
7
264
128
83
61
47
20
11
6
242
117
76
55
43
18
10
5
5.00
>
0..
(')
..c
:::::
~
(")
'<
0.....,
en
~
"0
en
N.
(')
s
::r:
(')
e:..
en
8"
0..
~-
"'
>
c.
t1>
Table 12d: Sample Size for a Hypothesis Test of the Relative Risk
..0
1'0
(")
'<
....,
C/:1
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5066
2497
1641
1212
955
442
270
185
133
99
75
56
42
30
21
3104
1528
1002
739
582
266
161
109
77
56
41
30
21
14
2149
1056
692
509
400
182
109
72
50
36
25
17
1605
787
515
379
297
133
79
52
35
24
16
11
1261
618
403
296
232
103
60
39
26
17
11
1028
503
328
240
188
82
47
30
19
12
862
421
274
200
156
68
38
24
15
9
738
360
234
171
133
57
32
19
12
643
313
203
148
115
49
27
16
9
568
276
178
130
101
42
23
13
7
507
246
159
115
89
37
19
11
457
221
143
103
80
33
17
9
416
201
129
93
72
29
15
7
381
184
118
85
65
26
13
6
5.00
'E.
t1>
C/:1
N.
t1>
s
::r::
t1>
[::.
:;.
C/:1
c.
~-
"'
.......
00
Ul
......
00
0\
Table 12e: Sample Size for a Hypothesis Test of the Relative Risk
(Level of significance:5%; Power: 80%; Alternative hypothesis: 2-sided)
Relative Risk (RR
1/P2)
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
27946
13814
9103
6747
5334
2508
1566
1095
812
623
489
388
309
247
195
152
85
35
7752
3827
2518
1864
1471
686
425
294
215
163
125
97
76
58
44
32
3785
1866
1226
906
714
330
202
138
100
74
56
42
32
23
16
2319
1142
749
553
435
200
121
82
58
42
31
23
16
11
1606
789
517
381
299
136
82
54
38
27
19
14
1199
589
385
283
222
100
59
39
27
19
13
8
943
462
302
222
174
77
45
29
20
13
9
769
376
245
180
141
62
36
23
15
10
644
315
205
150
117
51
29
18
12
7
552
269
175
128
100
43
24
15
9
481
234
152
111
86
37
20
12
7
425
207
134
97
76
32
17
10
6
379
184
119
87
67
28
15
8
342
166
107
78
60
25
13
7
311
151
97
70
54
22
11
6
285
138
89
64
49
20
10
5
5.00
>
fr
>
~
'<
....,
en
'0
0
en
N.
s
::r:
0
e:..
:;.
en
e:
0
"'
>
Q..
Table 121: Sample Size for a Hypothesis Test of the Relative Risk
(1)
.0
=
!=;
'<!
0
......
tn
-3
"0
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
(1)
tn
t::i"
(1)
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
13675
6760
4455
3302
2611
1228
767
536
398
306
240
191
152
122
96
75
42
18
3794
1873
1233
913
721
337
209
145
106
81
62
49
38
29
22
17
1853
914
601
444
350
162
100
69
50
37
28
22
16
12
9
1136
559
367
271
214
98
60
41
29
22
16
12
9
6
787
387
254
187
147
67
41
27
19
14
10
7
588
289
189
139
110
50
30
20
14
10
7
5
462
227
148
109
86
39
23
15
10
7
5
377
185
121
89
70
31
18
12
8
6
316
155
101
74
58
26
15
10
7
271
133
86
63
50
22
13
8
5
236
115
75
55
43
19
11
7
209
102
66
49
38
17
9
6
186
91
59
43
34
15
8
5
168
82
53
39
30
13
7
153
75
48
35
27
12
6
140
68
44
32
25
11
6
s
:I:
(1)
e:..
g.
tn
e:
(1)
"'
00
-.)
00
00
Table 12g: Sample Size for a Hypothesis Test of the Relative Risk
(Level of significance: 10%; Power: 90%; Alternative hypothesis: 2-sided)
Relative Risk (RR:::; 1/P2)
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
30494
15073
9932
7362
5820
2736
1708
1194
885
680
533
423
337
268
212
166
92
37
8459
4175
2747
2033
1605
748
463
320
234
177
136
106
82
63
47
34
4130
2035
1337
988
779
360
220
150
109
81
61
46
34
25
17
2530
1245
817
603
474
217
131
89
63
46
33
24
17
11
1752
861
564
415
326
148
88
59
41
29
21
14
1308
642
420
308
242
109
64
42
29
20
13
8
1028
503
329
241
189
84
49
31
21
14
9
838
410
267
196
153
67
39
24
16
10
703
343
223
163
127
55
31
19
12
7
602
293
190
139
108
46
26
16
9
524
255
165
120
93
40
22
13
7
463
225
145
106
82
34
18
10
6
413
200
129
94
73
30
16
9
373
180
116
84
65
26
14
7
339
164
105
76
59
24
12
6
310
150
96
69
53
21
10
5
5.00
>
Q..
.0
=
n
I)>
'<
0
.......
til
s
'E.
0
til
N.
s
:I:
0
a
:r
til
a
e:
0
"'
>
~
Table 12h: Sample Size for a Hypothesis Test of the Relative Risk
..cs::
'<
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
....,
0
1/P2)
3.00
(/l
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00
-N.
(1)
(/l
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
22016
10882
7171
5316
4202
1976
1233
862
640
491
385
306
244
194
154
120
67
27
6107
3015
1984
1468
1159
541
334
231
170
128
99
77
60
46
35
25
2982
1470
966
714
563
260
159
109
79
59
44
33
25
18
13
1827
899
590
436
343
157
95
64
46
33
25
18
13
9
1265
622
407
300
236
107
64
43
30
21
15
11
945
464
303
223
175
79
47
31
21
15
10
7
743
364
238
175
137
61
36
23
16
10
7
606
296
193
142
111
49
28
18
12
8
508
248
161
118
92
40
23
14
9
6
435
212
138
101
78
34
19
12
7
379
184
120
87
68
29
16
10
6
334
163
105
77
60
25
14
8
299
145
94
68
53
22
12
7
270
131
84
61
47
20
10
6
245
119
76
55
43
17
9
5
224
108
70
50
39
16
8
(1)
s
:I:
(1)
e?..
Et-
(/l
e:
(1)
"'
......
00
\C)
\0
Table 12i: Sample Size for a Hypothesis Test of the Relative Risk
1/P2 )
p*2
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
0.01
0.02
0.03
0.04
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.80
9633
4762
3138
2326
1839
865
540
378
281
216
169
134
107
86
68
53
30
13
2673
1320
869
643
508
237
147
102
75
57
44
34
27
21
16
12
1305
644
423
313
247
115
71
48
35
26
20
15
12
9
6
800
394
259
191
151
70
42
29
21
15
12
9
6
5
554
273
179
132
104
48
29
19
14
10
7
5
414
204
133
98
326
160
105
77
61
27
16
11
8
5
266
130
85
63
49
22
13
9
6
223
109
71
52
41
18
11
7
5
191
94
61
45
35
16
9
6
166
81
53
39
30
13
8
5
147
72
47
34
27
12
7
131
64
42
31
24
10
6
119
58
38
28
21
9
5
108
53
34
25
19
8
5
99
48
31
23
18
8
35
21
14
10
7
5
77
5.00
>-
Q..
~
..c
c::
i!5
'<
0
......
Cll
"0
Cll
N.
s
:I:
~
So
Cll
C'
e:
~
"'
>
0.
('1)
.g
Po'
('")
'<
0
.......
en
'E.
('1)
en
N.
Prevalence%
('1)
Population
90
80
70
60
50
40
30
20
10
2.5
1.25
s
::I:
-o
('1)
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
5
5
6
6
6
6
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7
7
7
9
9
9
9
9
10
10
10
10
10
10
10
13
13
13
13
13
13
13
13
13
13
14
14
19
20
21
21
21
21
21
21
21
21
21
21
36
40
43
44
44
44
44
44
44
44
45
45
59
73
86
88
89
89
90
90
90
90
91
91
90
120
167
174
176
179
181
181
182
182
182
182
98
182
307
335
341
354
360
361
364
365
365
367
::r
en
s::::
0.
"'
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
2.5
1.25
4
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
6
6
7
7
7
7
7
7
7
7
7
7
8
8
8
8
8
8
8
8
8
8
8
8
10
10
11
11
11
11
11
11
11
11
11
11
13
14
14
14
14
14
14
14
14
14
14
14
18
19
19
20
20
20
20
20
20
20
20
20
27
29
30
31
31
31
31
31
31
31
31
31
49
56
62
63
63
64
64
64
64
64
65
65
76
98
123
127
128
129
129
130
130
130
131
131
98
153
234
248
252
257
260
261
261
262
263
263
100
196
422
470
483
506
516
520
525
525
526
529
>-
~
s::
.0
'<
0
.....,
en
"0
0
en
No
0
:I:
0
e:..
:;.
en
8'
Q..
('p'
{/)
>
0.
(1>
.c
=
r
(")
'<
0.....,
U'l
"C
(i"
Prevalence%
U'l
No
(1>
Population
90
80
70
60
50
40
30
20
10
2.5
1.25
5
5
5
5
5
5
5
5
5
5
5
5
7
7
7
7
7
7
7
7
7
7
7
7
8
8
9
9
9
9
9
9
9
9
9
9
10
11
11
11
11
11
11
11
11
11
11
11
13
13
14
14
14
14
14
14
14
14
14
14
17
17
18
18
18
18
18
18
18
18
18
18
23
24
25
25
25
25
25
25
25
25
25
25
33
36
39
39
39
39
39
39
39
39
39
39
59
69
79
80
80
81
81
81
81
81
82
82
87
119
155
160
161
163
164
164
165
165
166
166
100
175
291
311
317
326
329
329
332
333
333
334
100
200
516
584
604
637
653
658
665
666
668
670
::r
::I:
(1>
-=e:..
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
U'l
0.
('6"
"'
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
2.5
1.25
7
7
7
7
7
7
7
7
7
7
7
7
8
8
9
9
9
9
9
9
9
9
9
9
10
10
11
11
11
11
11
11
11
11
11
11
13
13
13
13
13
13
13
13
13
13
13
13
16
16
17
17
17
17
17
17
17
17
17
17
20
21
22
22
22
22
22
22
22
22
22
22
27
29
30
30
30
30
30
30
30
30
30
30
39
43
46
47
47
47
47
47
47
47
47
47
67
81
94
96
96
97
97
97
97
97
98
98
95
136
183
191
192
195
197
197
197
198
198
198
100
190
342
369
377
388
393
394
396
397
397
399
100
200
597
687
713
757
778
785
793
794
794
801
>
0..
0
..0
=
~
'<
0.....,
til
'E..
0
til
N.
::r
::I:
0
~
So
til
2'
0..
Ci.
V>
>
~
..c
c
~
'<
....,
(IJ
~
(1)
(IJ
N.
Prevalence%
(1)
Population
90
80
70
60
50
40
30
20
10
2.5
1.25
::z::
(1)
e:..
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
8
8
8
8
8
8
8
8
8
8
8
8
10
10
10
10
10
10
10
10
10
10
10
10
12
12
12
12
12
12
12
12
12
12
12
12
15
15
15
15
15
15
15
15
15
15
15
15
18
19
19
19
19
19
19
19
19
19
19
19
23
24
25
25
25
25
25
25
25
25
25
25
31
33
35
35
35
35
35
35
35
35
35
35
45
49
54
54
54
54
54
55
55
55
55
55
75
92
109
111
111
112
112
112
113
113
113
113
100
151
210
220
222
225
227
227
228
228
230
230
100
199
390
424
434
447
454
455
457
460
460
461
100
200
669
781
816
871
897
906
912
917
917
925
So
(IJ
C'
0..
~
00
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
13
13
14
14
14
2.5
1.25
25
45
82
96
27
51
90
140
29
57
112
212
29
58
115
225
29
58
116
228
Q..
('1)
..0
14
29
58
118
234
14
29
59
118
236
14
29
59
118
237
0
....,
14
29
59
118
238
14
29
59
119
238
14
29
59
119
239
14
29
59
119
239
s::
~
'<
en
'1::::1
(D
en
N.
('1)
::r:
('1)
e:..
.....
::r
en
.....
s::
Q..
(;;"
Cll
>-
0..
(")
.0
c::
P>
(')
'-<
....,
(,/)
"0
( ")
(,/)
Prevalence%
t.:i.
(")
Population
90
80
70
60
50
40
30
20
10
2.5
1.25
::r
::r:
(")
e:..
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
8
8
8
8
8
8
8
8
8
8
8
8
10
10
10
10
10
10
10
10
10
10
10
10
14
14
14
14
14
14
14
14
14
14
14
14
20
21
22
22
22
22
22
22
22
22
22
22
38
42
45
46
46
46
46
46
46
46
46
46
64
77
90
92
92
93
93
93
93
93
94
94
95
127
174
181
183
186
187
187
188
188
188
188
100
191
324
348
356
367
372
374
376
379
379
379
:;.
(,/)
.....
c::
0..
(ii.
[JJ
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
2.5
1.25
4
5
5
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7
7
7
8
8
8
8
8
8
9
9
9
9
9
9
10
11
11
11
11
11
11
11
11
11
11
11
13
14
14
14
14
14
14
14
14
14
14
14
18
19
19
19
19
19
19
19
19
19
19
19
27
28
29
30
30
30
30
30
30
30
30
30
48
54
60
61
61
61
61
61
61
62
62
62
77
98
118
122
122
123
123
124
124
124
125
125
100
155
227
238
242
246
248
248
251
251
251
251
100
200
417
455
467
486
493
497
502
502
502
502
>-0.
(1)
..0
""
(")
'<
0
.......
(/)
"0
cr
(/)
No
(1)
::r
::r:
(1)
::r
(/)
0.
(;)"
00
>
0.
(1)
.0
c
::.0
('")
'<
0
.....
en
'E..
(1)
en
N.
Prevalence%
(1)
Population
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
2.5
1.25
:I:
(1)
e:..
....
::r
10
13
16
22
32
58
88
100
100
11
13
17
23
34
66
116
176
200
ze:en
11
13
17
24
36
74
145
275
501
"'
11
13
17
24
37
75
150
291
552
(1)
11
13
17
24
37
75
150
297
571
11
13
17
24
37
75
152
303
596
6
6
6
6
6
6
7
7
7
7
7
7
9
9
9
9
9
9
11
11
11
11
11
11
13
13
13
13
13
13
17
17
17
17
17
17
24
24
24
24
24
24
37
37
37
37
37
37
75
75
75
76
76
76
152
152
153
153
155
155
305
306
307
307
309
309
607
610
614
618
619
619
tv
0
0
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
2.5
1.25
10
12
15
19
26
38
66
95
100
100
10
13
16
20
27
41
77
132
191
200
10
13
16
20
28
43
87
170
321
578
10
13
16
21
28
43
88
176
342
643
10
13
16
21
28
43
89
177
349
669
10
13
16
21
28
43
89
179
357
701
7
7
7
7
7
7
9
9
9
9
9
9
10
10
10
10
10
10
13
13
13
13
13
13
16
16
16
16
16
16
21
21
21
21
21
21
28
28
28
28
28
2.8
44
44
44
44
44
44
89
89
89
90
90
90
180
180
180
181
181
181
361
361
362
363
363
364
715
720
724
728
728
730
>-
0..
(1)
.0
s::
""
0
"<:
....,
Cll
"0
G"
Cll
N.
(1)
::r
:I:
(1)
e:.
st
...s::
Cll
0..
n
"'
>0..
(1>
.0
""'
'<
('")
0
.....,
en
""'
a
"0
~
en
N.
Prevalence%
Population
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
(1>
2.5
20
37
78
94
11
21
41
78
120
11
22
44
87
168
50
40
30
20
10
10
90
80
70
60
1.25
11
22
45
89
175
11
22
45
90
177
11
22
45
91
181
11
22
45
91
182
11
22
45
91
182
11
22
45
91
184
11
23
45
92
184
11
23
46
92
184
11
23
46
92
184
s
::r:
....e:.
::r
(1>
en
....
c
0..
~-
"'
......
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
2.5
1.25
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
7
7
7
7
7
7
7
7
7
7
7
7
8
9
9
9
9
9
9
9
9
9
9
9
11
12
12
12
12
12
12
12
12
12
12
12
17
18
18
18
18
18
19
19
19
19
19
19
32
35
37
38
38
38
38
38
38
38
38
38
56
65
74
76
76
76
76
76
76
93
112
145
149
151
153
154
154
154
155
155
155
100
188
274
290
296
303
305
308
311
311
311
311
77
77
77
>
0..
(1>
..0
c::
()
'<
0
.....,
Cll
~
"0
Cll
N.
(1>
s
:I:
(1>
e:.
....
::r
Cll
....
c::
0..
~-
(/)
----
;..
0..
(j)
..0
::::
I"
()
'<
0
.....,
en
I"
8
"0
0
en
[:::i'
Prevalence%
Population
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
4
4
4
4
4
4
4
4
4
4
4
4
80
5
5
5
5
5
5
5
5
5
5
5
5
70
6
6
6
6
6
6
6
6
6
6
6
6
60
7
7
7
7
7
7
7
7
7
8
8
8
50
9
9
9
9
9
9
9
9
9
9
9
9
40
12
12
12
12
12
12
12
12
12
12
12
12
30
16
16
16
16
16
16
16
16
16
17
17
17
(j)
20
23
24
25
25
25
25
25
25
25
25
25
25
10
43
47
51
52
52
52
52
52
52
52
52
52
5
71
86
101
104
104
105
105
105
105
105
106
106
2.5
1.25
s
::r:
(j)
r=..
:;.
100
141
195
203
206
209
210
211
211
212
212
212
100
199
366
391
401
414
418
420
426
427
427
427
en
2
0..
(5'
00
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
90
80
70
60
50
40
30
20
10
2.5
1.25
5
5
5
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
7
7
8
8
8
8
8
8
8
8
8
8
8
8
9
9
9
9
9
9
10
10
10
10
10
10
11
12
12
12
12
12
12
12
12
12
12
12
14
15
15
15
15
15
15
15
15
15
15
15
19
20
21
21
21
21
21
21
21
21
21
21
29
30
32
32
32
32
32
32
32
32
32
32
52
58
64
65
65
65
65
65
65
66
66
66
82
104
126
130
130
131
132
132
132
132
135
135
100
164
241
253
258
262
264
265
265
267
267
267
100
200
449
484
500
518
526
527
531
535
535
535
~
0..
(1l
..0
=
po
'<:
0
....,
!ZJ
po
3
"d
0
!ZJ
N.
(1l
::r:
e:..
.....
(1l
::r
!ZJ
.....
=
(D"
0..
VJ
>
0.
(p
..0
s::
P>
'<
0
......
en
P>
"0
en
No
Prevalence%
(p
Population
90
80
70
60
50
40
30
20
10
2.5
1.25
s
::I:
(p
e:..
100
200
1000
2000
2500
5000
10000
15000
20000
25000
50000
Infinite
7
7
7
7
7
7
7
7
7
7
7
7
8
8
8
8
8
8
8
8
8
8
8
8
9
9
9
9
9
9
9
10
10
10
10
10
11
11
11
11
11
11
12
12
12
12
12
12
14
14
14
14
14
14
14
14
14
14
14
14
17
18
18
18
18
18
18
18
18
18
18
18
23
24
25
25
25
25
25
25
25
25
25
25
34
36
38
38
38
38
38
38
38
38
39
39
60
69
77
78
78
78
78
78
78
79
79
79
90
121
150
155
156
157
158
158
158
159
159
159
100
180
285
302
308
314
316
316
317
318
318
318
100
200
527
572
595
619
628
628
637
637
637
638
:;.
en
.....
s::
0.
(ij'
00
0\
Po%
55
50
Pa% n
5 11 ;
10 15;
15 22;
20 32;
25 48;
30 77;
35 140;
40 321;
45 1298;
50
55
60
65
70
75
80
85
60
d
65
d
.
.
75
70
d
80
d
9;
12;
10;
17;
13;
10;
8;
6;
23;
18;
13;
10;
a;
5;
6
5;
85
d
.
.
.
95
90
d
.
.
.
2
3
15
33;
11
24;
1a;
13;
10;
2a
49;
1a
34;
13
24;
10
1a;
13;
10;
56
79;
33
50;
21
33;
15
23;
10
17;
12;
9;
6;
607
142;
64
323; 156
1294; 670
79;
141;
37
49;
71
77;
317; 169
1264; 717
24
40
32;
47;
16
25
22;
31 ;
11
16;
17
21 ;
11 ;
12
14;
139
(D
a;
5;
9;
6;
76
73;
41
44;
26
2a;
17
18;
11
12;
7;
306; 179
129;
?a
6a;
42
40;
26
24;
16
15;
10
9;
287; 1a2
119;
?a
61 ; 41
35;
24
20;
14
11 ;
75
52;
38
2a;
21
14;
11
231; 170
90;
sa
42;
33
20;
16
192; 151
70;
57
29;
24
147; 123
47;
41
535; 465
94;
84
137;
120a; 746
1126; 752
262; 180
101a; 731
106;
aa3; 678
>-
0..
.0
'<
....,
en
'E.
(D
en
N.
(D
::r:
(D
722; 591
...e:..
::r
...enc
0..
"'
>-
0..
(1)
..0
c::
po
0
'<
0
....,
Cll
Po%
po
"0
50
Pa% n
5
9 ;
10
13 ;
15
18 ;
25;
20
25
38;
60;
30
35 109;
40 249;
45 1001;
50
55
60
65
70
75
80
85
60
55
d
8 ;
10 ;
14 ;
6
11
19 ;
26;
5
8
20
39;
42
61 ;
14
24
106
463
n
6 .
8 ;
11 ;
1
2
14 ;
19 ;
26;
'
110 ; 48
249; 118
997; 511
65
d
38;
6
9
15
61 ; 27
108; 52
244; 128
972; 547
8 ;
11 ;
5 ;
7 ;
3
4
8 ;
11 ;
7
11
14 ;
26;
38;
17
59;
29
105; 56
234; 135
927; 568
85
80
d
90
d
95
d
Cll
N.
(1)
:r
:r:
5 ;
7 ;
14 ;
19 ;
75
70
d
;-"
(1)
...::re:..
...c::
Cll
5 ;
6 ;
8 .
10 ;
13 ;
6
8
4
5
'
18 ;
25;
36;
8
12
18
17 ;
23;
56;
31
33;
98; 58
219; 137
862; 572
12
18
51 ; 31
90; 57
199; 135
777; 554
0..
5 ;
6 ;
7 ;
9;
5 .
'
7 .
12 ;
15 ;
6
8
8 ;
10 ;
21 ;
30;
12
18
46;
30
13 ;
18 ;
25;
79; 54
174; 126
38;
66;
cr
r/0
671 ; 512
'
2
3
4
5
8
11
17
27
49
143; 111
546; 444
5 ;
7 ;
8 .
'
11 ;
2
5
7
5 ;
6 .
3
4
14 ;
20;
7 ;
14
10 ;
13 ;
7
10
19 ;
32;
66;
27
58
30;
23
51 ; 40
108; 89
399; 345
'
15
0
-.J
00
50
Pa% n
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
7 ;
60
55
d
65
d
70
d
5 ;
9 ;
7;
6 ;
5 ;
12 ;
9 ;
5 ;
7 ;
9 .
16 ;
11 ;
7 ;
75
d
80
d
85
d
90
d
95
d
5 ;
22;
15 ;
11 ;
8 ;
34;
10
22;
15 ;
11 ;
8 ;
6 ;
61 ;
21
34;
11
21 ;
14 ;
10 ;
7 ;
136;
54
60 ;
24
33;
13
20;
13 ;
9 ;
6 ;
542; 243
134;
60
58;
26
31 ;
13
19 ;
12 ;
8 ;
5 ;
536; 268
130;
65
55;
27
29;
14
17 ;
10 ;
6 ;
520; 286
124;
68
51 ;
28
26;
14
14 ;
8 ;
114;
68
46;
27
22;
13
12 ;
6 ;
455; 295
102;
66
39;
25
18 ;
11
8 ;
406; 284
87;
60
31 ;
21
13 ;
69;
51
22;
49;
195 ; 165
493 ; 295
6 ;
5 ;
>-
5 ;
0..
(I)
347; 260
.0
276; 220
I
0
'<
0
.....,
Cl:l
"0
(i"
Cl:l
N.
5 ;
16
7 ;
39
12 ;
(I)
26;
22
(I)
:I:
e:..
.....
::r
Cl:l
.....
c
0..
(p"
"'
>
0..
('!)
,J;l
~
po
(')
'<
0
....,
Po%
(/)
po
"0
50
Pao/o
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
6 ;
10 ;
55
d
65
60
d
75
70
d
80
d
85
d
(p'
95
90
d
(/)
No
('!)
s
14 ;
20;
31 ;
50;
92;
0
2
5 ;
0
2
8 ;
11 ;
6
10
15 ;
21 ;
5
7
12
::r:
('!)
6;
a'
11 ;
16 ;
22;
19
38
32;
52;
22
33;
211 ; 93
853; 402
93;
43
52;
212; 104
852; 444
E:..
g.
5 ;
2
7 ;
9 ;
12 ;
3
5
6
9
15
25
93; 48
210; 114
834; 477
16 ;
22;
5 ;
7 ;
9 ;
12 ;
16 ;
22;
(/)
2
4
5
5 ;
7 ;
7;
'
"'
'
6 ;
5 ;
6 ;
7
8;
8
12
11 ;
8 ;
14 ;
19 ;
27;
8
12
18
10 ;
18
29
8
12
11 ;
53
176; 122
676; 488
42;
29
13 ;
17 ;
24;
72;
52
36;
17
27
14 ;
20 ;
10
15
156; 116
589; 455
62;
48
30 ;
24
15 ;
51 ; 27
91 ; 51
203; 120
31 ; 17
49; 29
87; 53
21 ;
30;
46;
798; 496
191 ; 123
746; 501
80;
10
16
0..
(ii'
3
4
9 ;
11 ;
8
11
32;
2
0
131 ; 104
484; 398
9 ;
3
4
4
6
49 ; 40
102; 86
362; 316
5 ;
7 ;
3
5
8 ;
11 ;
15 ;
6
9
12
21 ;
34;
18
30
67;
60
tv
0
\.0
N
,_...
50
Pa% n
55
d
5
5; 0
10
8 ; 1
15 11 ; 2
20 15 ; 4
25 23; 7
30 37; 13
35 67; 26
40 153; 66
45 617; 288
50
55
60
65
70
75
80
85
60
d
65
d
70
d
5 ;
6
0
1
5 ;
8 ;
11 ;
7 ;
3
5
9 ;
12 ;
2
4
16 ;
24;
6
10
17
23;
33
80
37;
65;
35
145;
84
16 ;
24;
38;
15
68;
30
74
154;
615; 317
38;
67;
151 ;
600; 340
5 ;
7 ;
9 ;
12 ;
16 ;
5
7
11
19
573; 353
5 ;
7;
9 ;
11 ;
75
d
5 ;
80
d
85
d
90
6 ;
5 ;
8 ;
6 ;
11 ;
5 ;
15 ;
21 ;
32;
8
12
8 ;
10 ;
19
13 ;
19 ;
8
12
7 ;
9;
57; 37
125; 85
483; 346
29;
19
50;
109;
35
80
136; 86
534; 356
95
d
5
8
16 ;
22; 11
35; 20
62; 37
419; 321
;J>
12 ;
16 ;
25;
43;
5
8
11
18
32
91 ; 71
342; 279
0..
(1)
.0
~
'<
5 ;
6 ;
3
4
7 ;
10 ;
13 ;
20;
5 ;
9
15
7 ;
9 ;
33;
26
14 ;
22;
11
19
::t
44;
39
:;.
69; 58
253; 219
....,
C/J
3
5
7
'"t:l
C/J
t:::i"
(1)
(1)
e:.
C/J
....
c
0..
(p"
"'
>
Q.
(1>
..c
~
'<
0
....,
Po%
50
Pao/o n
55
d
60
d
65
d
Vl
70
d
75
d
80
d
85
d
90
d
95
d
(1>
Vl
N.
(1>
5
10
5 ; 0
15
6 ; 0
20
8 ;
25
11 ; 2
17 ; 5
30
35
31 ; 10
40
68; 27
45 271 ; 121
50
55
60
65
70
75
80
85
s
:I:
(1>
a
g.
5 ;
6 ;
8 ;
11 ;
6 ;
17 ;
11
7 ;
Vl
a
Q.
o;
"'
2
30;
12
17 ;
10 ;
67;
30
29;
13
16 ;
5;
7 .
'
10 ;
268; 134
65;
32
28;
14
15 ;
6;
9 .
5 ;
260; 143
62;
34
26;
14
13 ;
7 ;
247; 148
57;
34
23;
13
11 ;
51 ;
33
20;
13
9 ;
203; 142
44;
30
16 ;
11
7 ;
174; 130
35 ;
26
11 ;
138 ; 110
25;
20
6 ;
98;
83
13 ;
11
5 ;
228; 148
'
6 ;
3
4
.....
50
Pa% n
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
55
d
60
d
65
d
70
d
75
d
80
d
85
d
90
d
95
d
5
7
5 ;
6 ;
10 ;
8 ;
6 ;
15 ;
11 ;
9 ;
7 ;
5 ;
12 ;
9 ;
5 ;
7 ;
5 ;
9 ;
7 ;
23;
16 ;
38;
15
25;
10
17 ;
12 ;
7;
9 .
70;
29
39;
17
25;
11
17 ;
12 ;
>
72
72;
34
40;
20
25 ;
13
17 ;
12 ;
9 ;
5;
6 .
..c
163;
81
72;
37
39 ;
21
25;
14
16 ;
11 ;
8 ;
5 ;
6 .
654; 310
1!5
161 ;
88
70 ;
40
38;
22
23;
14
15 ;
10
10 ;
7 ;
641 ; 368
156;
93
67;
42
36 ;
23
22;
15
14 ;
10
9 ;
148;
96
63;
42
33;
23
19 ;
14
12 ;
575; 388
137;
96
57 ;
41
29;
22
16 ;
12
121 ;
91
49;
38
24;
19
13 ;
11
C/}
.....
N
103;
82
40;
33
18 ;
15
81 ;
69
28;
25
:I:
(1)
284; 249
55;
50
161 ;
654; 343
615; 384
522; 378
456; 353
'
3
3
377; 311
Q..
(1)
'
s::
'<
5 .
'
6 .
0
.....,
9 ;
'
7 .
'
C/}
"0
(1)
(1)
;.
C/}
e:
(1)
<J}
>
.g
'<
....,
Po%
50
Pa% n
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
55
d
60
d
65
d
Ul
75
70
d
80
d
85
d
90
d
95
d
("'>
Ul
r::s
("'>
::r
::I:
("'>
5 ;
So
8 ;
6 ;
5 ;
11 ;
8 ;
6 ;
5 ;
17 ;
12 ;
9 ;
6 ;
5 ;
27;
10
17 ;
12 ;
9 ;
6 ;
5 ;
49;
20
27;
11
17 ;
12 ;
6 ;
48
49;
22
28 ;
13
17 ;
'
12 ;
111 ;
8 ;
6;
450; 211
112;
54
49;
25
27;
14
17 ;
11 ;
8 ;
5 ;
110 ;
59
48;
26
26;
15
16 ;
10 ;
7 ;
5 ;
439; 250
107;
63
45;
27
24;
15
14 ;
9 ;
6 ;
420; 260
100;
64
42;
27
22;
15
13 ;
8 ;
392; 262
92;
63
38;
27
19 ;
14
:10 ;
81 ;
60
32;
24
15 ;
308; 237
68;
54
25;
253; 207
53;
449; 233
Ul
9:
("'>
354; 255
"'
'
6;
12
8 ;
20
11 ;
44
17 ;
14
188; 163
34;
30
50
Pa% n
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
55
d
60
d
70
65
d
75
d
80
d
90
85
d
95
d
5;
7 ;
5 ;
11 ;
7 ;
19 ;
11 ;
42;
16
19 ;
5 ;
7 .
'
10 ;
5 ;
6 .
165;
74
41 ;
18
18 ;
10 ;
6 .
163 ;
81
40;
20
17 ;
9 ;
158;
86
'
>
0..
(1>
..0
""
(")
'<
5 ;
0
......
en
38;
20
16 ;
8;
150;
90
35;
21
14 ;
5 .
'
7 ;
138;
89
31 ;
20
12 ;
6 ;
124;
86
27;
18
10 ;
106;
79
21 ;
15
7 ;
84;
67
15 ;
12
::I:
(1>
60;
51
"C
(i'
en
N.
(1>
8 ;
...e:.
::r
en
a0..
(D'
"'
---
-~-
Table 15: Sample Size to Estimate the Incidence Rate to within percent,
with 99%, 95% or 90% Confidence Level
;.:.
0.
~
.0
~
'<
E
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
99%
66358
16590
7374
4148
2655
1844
1355
1037
820
664
461
339
260
205
166
138
116
99
85
74
65
58
52
46
42
38
35
32
29
27
95%
38417
9605
4269
2402
1537
1068
785
601
475
385
267
197
151
119
97
80
67
57
50
43
38
34
30
27
25
22
20
19
17
16
90%
27061
6766
3007
1692
1083
752
553
423
335
271
188
139
106
84
68
56
47
41
35
31
27
24
21
19
17
16
14
13
12
11
0
.....,
en
'E..
~
en
N.
~
s
::I:
~
g.
en
....
c
0.
(p'
V>
Ul
0\
A.8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
0.15
42
27
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.70
0.75
0.80
0.85
0.90
0.95
21
15
13
12
11
10
10
10
106
42
27
21
17
15
14
13
12
12
11
11
11
10
10
10
10
70
42
30
24
21
18
17
15
14
14
13
13
12
12
11
325
106
60
42
33
27
23
21
19
17
16
15
15
14
13
16
11
81
27
166
15
50
280
11
27
81
424
18
42
120
597
13
27
60
166
801
11
20
38
81
219
1034
15
27
50
106
280
1297
13
21
35
65
134
348
1589
11
17
27
45
81
166
424
1912
14
22
34
56
100
200
507
2264
12
18
27
42
68
120
239
597
0.65
201
479
150
82
55
42
34
29
25
23
21
19
18
17
662
201
106
70
52
42
35
30
27
24
22
21
19
876
259
135
88
64
51
42
36
32
28
26
24
1119
325
166
106
77
60
49
42
37
33
29
398
201
127
91
70
57
48
42
37
1694
479
239
150
106
82
66
55
48
1392
2027
567
280
174
123
94
75
63
2389
662
325
201
141
106
85
765
373
229
159
120
3203
876
424
259
179
2781
2646
11
15
22
33
50
81
142
280
695
3058
10
13
19
27
39
60
96
166
325
801
3499
12
16
23
32
47
70
112
192
372
914
3971
11
14
20
27
38
54
81
128
219
424
1034
4472
10
13
17
23
32
44
63
93
147
249
478
1162
3654
993
479
291
4136
1119
537
4647
1251
5187
5003
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0,75
0.80
0.85
0.90
0.95
0.10
0.15
36
19
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.80
0.85
0.90
0.95
19
14
12
11
10
10
10
36
24
19
16
14
13
12
12
11
11
10
10
10
10
10
60
36
27
22
19
17
15
14
13
13
12
12
11
11
11
264
89
51
36
29
24
21
19
17
16
15
14
14
13
13
387
124
69
47
36
30
26
23
21
19
18
17
16
15
533
1~
31
27
24
22
20
19
18
703
212
112
74
55
44
36
31
28
25
23
21
896
264
137
89
65
51
43
36
32
29
26
1112
323
165
106
77
60
49
42
36
32
165
19
124
10
36
211
19
59
322
12
30
89
456
19
43
124
614
13
27
59
164
795
10
19
36
78
211
999
14
25
47
100
264
1227
11
19
32
59
124
322
1478
15
24
40
73
150
386
12
19
30
49
89
179
456
2050
10
15
23
36
59
105
211
532
0.75
89
59
0.70
1352
387
196
124
89
69
56
47
41
1614
457
229
144
102
79
64
53
533
264
165
117
89
72
2210
615
303
188
132
100
703
344
212
148
2900
796
387
237
1901
1753
2543
2372
13
19
28
43
70
124
246
614
2716
11
16
22
33
51
82
143
282
702
5
5
10
13
19
27
39
59
95
164
322
795
3475
12
16
22
31
45
69
109
187
364
894
3280
3084
896
433
3683
1001
4109
3890
00
/..8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
0.15
0.20
0.25
0.30
0.35
27
15
60
12
27
107
11
19
42
166
10
15
27
60
239
10
14
21
37
82
326
27
7
60
15
7
107
27
12
7
166
42
19
11
7
239
60
27
15
10
7
326
82
37
21
14
10
0.40
0.45
9
11
15
22
12
17
27
48
107
425
425
107
48
27
17
12
9
34
60
135
538
538
135
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
9
10
13
17
23
33
51
90
201
803
8
10
12
14
18
23
32
8
10
11
14
17
21
27
8
9
11
13
15
19
24
45
71
125
281
1122
37
53
82
145
326
1301
31
42
60
94
166
374
1494
8
9
11
12
15
17
21
27
35
48
68
107
189
425
1699
8
9
10
12
14
16
20
24
30
40
54
77
120
214
480
1918
8
9
10
11
13
15
18
22
27
34
44
60
86
135
239
538
2150
10
12
15
20
27
39
60
107
239
11
14
19
27
42
74
166
664
664
166
74
42
27
19
14
11
60
34
22
15
11
956
803
201
90
51
33
23
17
13
956
239
107
60
39
27
20
1122
281
125
71
45
32
1301
326
145
82
53
1494
374
166
94
1699
425
189
1918
480
2150
9
10
11
13
15
17
20
24
30
38
49
67
96
150
267
599
2396
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.10
0.15
28
21
0.20
0.25
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
10
28
17
13
11
10
137
47
28
20
16
13
12
11
10
72
40
28
21
17
15
13
12
11
10
10
331
102
55
37
28
22
19
16
15
13
12
11
11
10
137
72
47
35
28
23
20
17
16
14
13
12
608
178
91
59
43
33
28
24
21
18
17
15
779
223
113
72
52
40
33
28
24
21
19
21
122
12
38
21
61
306
14
32
89
223
204
11
21
16
12
0.40
13
0.35
72
61
0.30
45
459
430
122
575
29
61
160
741
21
38
79
204
928
970
274
137
86
61
47
38
32
28
24
1182
331
163
102
72
55
44
37
31
10
16
27
49
99
252
1136
13
21
34
61
122
306
1365
1416
392
192
119
83
63
50
42
1670
459
223
137
95
72
57
531
257
157
108
81
2242
608
293
178
122
691
331
200
2898
779
371
3258
872
1946
11
17
26
42
74
147
366
1615
10
14
21
32
51
89
174
430
7
6
6
12
17
25
38
61
104
204
500
2179
11
15
21
30
45
71
122
236
575
2492
10
13
18
25
35
53
83
140
270
656
2826
12
16
21
29
41
61
95
160
306
741
3181
11
14
18
24
33
47
69
108
181
345
832
1886
2560
3639
3557
A.8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
23
14
6
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
12
58
23
15
12
10
108
38
174
23
58
17
14
23
12
18
10
15
10
13
12
11
10
44
30
58
139
23
19
16
23
35
13
17
12
15
11
14
10
13
29
48
14
20
10
38
73
11
28
23
20
18
16
12
15
13
595
174
89
58
42
33
27
739
213
899
108
256
69
128
50
81
38
58
23
31
20
27
18
23
16
21
44
36
30
26
1075
302
1267
150
353
94
174
67
108
51
76
41
1474
407
199
123
58
86
34
46
1697
466
1936
227
528
139
256
2190
595
42
14
86
26
146
14
42
221
21
62
312
31
19
86
42
419
14
10
114
541
14
11
26
18
55
34
146
70
680
181
14
23
42
29
86
35
26
20
0.50
256
33
81
353
11
17
14
108
466
52
834
221
104
1003
265
1188
62
124
312
1389
42
31
74
146
50
86
364
169
1606
419
36
28
23
58
42
32
99
67
48
194
11
10
21
17
14
12
16
24
10
14
12
19
16
114
76
1839
478
221
2087
541
2460
2350
129
250
609
2630
65
97
156
286
665
2746
>-
0..
(1>
..0
p;
()
'<
0
....,
~
A.a
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
en
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
a
'E..
(1>
16
9
35
16
35
9
7
16
62
62
16
7
7
11
25
97
97
25
11
7
6
9
16
35
139
139
35
16
9
6
6
8
12
21
48
189
189
48
21
12
8
6
6
7
10
16
28
62
246
246
62
28
16
10
7
6
5
7
9
13
20
35
78
312
312
78
35
20
13
9
7
5
5
7
8
11
16
25
43
97
385
385
97
43
25
16
11
8
7
5
5
6
8
10
13
19
30
52
117
465
465
117
52
30
19
13
10
8
5
6
7
9
12
16
23
35
62
139
554
554
139
62
35
23
16
12
5
6
7
9
11
14
19
26
41
73
163
650
650
163
73
41
26
19
5
6
7
8
10
12
16
21
31
48
84
189
753
753
189
84
48
31
5
6
7
8
9
11
14
18
25
35
55
97
217
865
865
217
97
55
5
6
6
7
9
10
13
16
21
28
40
62
110
246
984
984
246
110
5
5
6
7
8
10
12
14
18
23
31
45
70
124
278
1111
1111
278
5
5
6
7
8
9
11
13
16
20
26
35
50
78
139
312
1245
5
5
6
7
8
9
10
12
14
18
22
29
39
56
87
155
347
1387
en
N.
(1>
::c:
(1>
e:..
s-en
0..
~-
"'
1245
N
N
A.8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
0.15
21
18
8
6
5
51
18
11
0.20
0.25
10
57
21
109
6
13
37
179
102
0.30
0.35
0.40
0.45
5
10
21
57
266
15
31
81
369
12
21
43
109
490
10
33
18
13
10
169
51
27
18
14
11
6
6
9
8
38
25
18
14
12
10
6
6
5
356
102
51
33
23
18
15
13
11
10
474
133
66
42
29
23
18
15
13
12
6
6
10
254
74
16
29
57
142
629
610
169
83
51
36
27
22
18
16
14
12
764
209
102
62
43
33
26
21
18
16
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
6
9
13
21
37
72
179
784
6
8
12
17
27
46
90
220
956
5
7
10
14
21
33
57
109
266
1146
6
7
9
12
16
21
30
43
66
109
206
490
2075
6
7
9
11
14
19
25
34
50
76
125
235
557
2351
934
254
122
74
51
38
30
25
21
1121
303
145
88
60
45
35
29
1326
356
169
102
70
51
40
9
13
18
26
41
68
130
315
1352
1548
413
196
117
80
59
8
11
15
21
31
48
81
154
369
1576
1786
474
224
133
90
8
10
13
18
25
37
57
94
179
428
1817
2042
540
254
151
2315
610
286
2606
685
0.95
10
13
16
21
29
39
57
86
142
266
629
2643
12
15
19
24
33
45
64
97
160
298
704
2952
2913
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
12
5
0.10
0.15
18
9
44
34
12
7
69
21
12
8
0.20
0.25
0.30
0.35
0.40
11
29
135
5
9
18
83
18
44
199
13
25
62
275
10
18
34
83
364
117
34
18
12
9
7
177
50
25
16
12
249
69
34
21
15
12
334
92
45
27
19
15
12
10
431
117
56
34
24
18
14
12
10
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
14
23
44
108
465
11
18
29
56
135
578
10
14
22
36
69
165
704
12
18
27
44
83
199
842
11
15
21
32
53
99
235
992
10
13
18
25
38
62
116
275
1155
7
8
10
13
18
24
34
51
83
155
364
1518
6
8
10
12
15
20
28
39
58
95
176
412
1718
6
7
9
11
14
18
23
31
44
6
7
8
10
12
16
20
26
35
50
75
121
223
520
2154
540
145
69
42
29
21
17
14
12
10
662
177
84
50
34
25
20
16
13
796
211
100
60
40
30
23
19
942
249
117
69
47
34
27
1101
290
136
80
54
39
1272
334
155
92
61
11
15
21
29
44
72
135
318
1330
1456
381
177
104
1652
431
199
1860
484
66
108
199
465
1930
2081
N
N
+>-
Ao
A-a
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
0.15
0.20
0.25
11
7
25
5
11
44
5
8
17
68
11
25
7
44
11
5
68
17
8
5
0.30
0.35
0.40
0.45
0.50
0.55
7
11
25
98
6
9
15
34
133
5
7
11
20
44
174
5
7
9
14
25
55
220
5
6
8
11
17
31
68
271
5
6
7
10
14
21
37
82
328
98
25
11
7
133
34
15
9
6
174
44
20
11
7
5
220
55
25
14
9
7
5
271
68
31
17
11
8
6
5
328
82
37
21
14
10
7
6
0.60
0.65
0.70
0.75
0.80
5
7
8
11
16
25
44
98
390
5
6
8
10
13
19
29
51
115
458
5
6
7
9
11
15
22
34
59
133
531
5
6
7
8
10
13
17
25
39
68
153
609
5
5
6
7
9
11
15
20
28
44
77
174
693
390
98
44
25
16
11
8
458
115
51
29
19
13
531
133
59
34
22
609
153
68
39
693
174
77
0.85
0.90
0.95
5
6
7
8
10
13
16
22
32
49
87
196
783
5
6
7
8
9
11
14
18
25
36
55
98
220
877
5
5
6
7
9
10
13
16
20
28
40
62
109
245
977
783
196
877
>
0.
('D
.0
"'
(")
'<
0
.....,
Cll
'1:::1
(i"
Cll
N.
('D
s
::I:
('D
~
So
Cll
C'
0.
(D"
"'
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.10
70
70
0.15
0.20
0.25
33
24
20
17
16
15
189
70
43
33
27
24
368
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
14
14
13
13
13
13
12
12
12
12
12
21
20
18
17
17
16
16
15
15
14
14
122
70
49
39
33
29
26
24
22
21
20
19
18
17
17
606
189
103
70
53
43
37
33
29
27
25
24
22
21
20
33
189
24
70
368
20
43
122
606
17
33
70
189
903
16
27
49
103
271
1261
15
24
39
70
143
368
903
271
143
94
70
56
47
41
36
33
30
28
26
25
1261
368
189
122
89
70
58
49
43
39
35
33
30
1677
1677
479
242
154
110
86
70
59
52
46
41
38
2154
606
301
189
134
103
83
70
60
53
48
747
368
228
160
122
98
82
70
61
3285
903
440
271
189
143
114
94
80
1075
520
317
220
165
131
108
4654
1261
606
368
253
189
149
5428
1462
698
422
289
215
1677
798
479
327
7155
1908
903
541
8107
2154
1016
9120
2414
14
21
33
53
94
189
479
2154
14
20
29
43
70
122
242
606
2690
2690
13
18
26
37
56
89
154
301
747
3285
13
17
24
33
47
70
110
189
368
903
3940
13
17
22
29
41
58
86
134
228
440
1075
4654
13
16
21
27
36
49
70
103
160
271
520
1261
5428
12
16
20
25
33
43
59
83
122
189
317
606
1462
6262
12
15
19
24
30
39
52
70
98
143
220
368
698
1677
7155
12
15
18
22
28
35
46
60
82
114
165
253
422
798
1908
8107
12
14
17
21
26
33
41
53
70
94
131
189
289
479
903
2154
9120
12
14
17
20
25
30
38
48
61
80
108
149
215
327
541
1016
2414 10191
3940
6262
10191
A.8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
54
54
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
9
11
9
11
25
18
15
13
12
11
11
11
10
10
10
10
148
54
34
25
21
18
16
15
14
13
13
12
12
11
11
95
54
38
30
25
22
20
18
17
16
15
14
14
13
13
475
148
80
54
41
34
29
25
23
21
19
18
17
16
16
709
212
112
73
54
43
36
31
28
25
23
22
20
19
989
288
148
95
69
54
45
38
34
30
27
25
23
25
148
18
54
15
34
95
475
13
25
54
148
709
288
288
376
190
120
86
67
54
46
40
36
32
29
1690
475
236
148
105
80
65
54
47
41
37
2111
586
288
179
126
95
76
64
54
48
2578
709
345
212
148
112
89
73
63
3092
843
408
249
172
129
102
84
12
21
38
80
212
989
11
18
30
54
112
288
1316
11
16
25
41
73
148
376
1690
11
15
22
34
54
95
190
475
2111
10
14
20
29
43
69
120
236
586
10
13
18
25
36
54
86
148
288
709
3092
10
13
17
23
31
45
67
105
179
345
843
3653
10
12
16
21
28
38
54
80
126
212
408
989
4260
12
15
19
25
34
46
65
95
148
249
475
1147
4915
11
14
18
23
30
40
54
76
112
172
288
548
1316
5615
11
14
17
22
27
36
47
64
89
129
198
331
626
1497
6363
11
13
16
20
25
32
41
54
73
102
148
226
376
709
1690
7158
11
13
16
19
23
29
37
48
63
84
116
168
256
424
797
1895
1316
2578
3653
989
475
288
198
148
116
4260
1147
548
331
226
168
1316
626
376
256
5615
1497
709
424
6363
1690
797
7158
1895
4915
7999
7999
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
30
14
10
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
30
14
83
10
30
163
19
54
269
14
30
83
402
11
21
45
120
561
10
17
30
63
163
747
9
14
23
41
83
213
959
83
30
19
14
11
10
5
5
163
54
30
21
17
14
12
11
10
8
7
6
6
5
5
5
5
5
5
6
6
6
6
6
6
269
83
45
30
23
19
16
14
12
11
10
10
8
8
402
120
63
41
30
24
20
17
15
14
13
12
11
10
561
163
83
54
39
30
25
21
19
17
15
14
13
747
213
107
68
48
37
30
26
22
20
18
16
959
269
134
83
59
45
36
30
26
23
20
1198
332
163
101
71
54
43
36
30
27
12
19
30
54
107
269
1198
11
16
24
39
68
134
332
1464
10
14
20
30
48
83
163
402
1756
12
17
25
37
59
101
196
478
2074
11
15
21
30
45
71
120
231
561
2419
10
14
19
26
36
54
83
141
269
651
2791
10
13
17
22
30
43
63
97
163
311
747
3189
9
12
15
20
26
36
50
73
112
187
355
850
3614
7
9
11
14
18
23
30
41
57
83
128
213
402
959
4065
10
13
16
20
27
35
47
1464
402
196
120
83
63
50
41
35
1756
478
231
141
97
73
57
47
2074
561
269
163
112
83
66
2419
651
311
187
128
95
2791
747
355
213
145
3189
850
402
240
3614
959
452
4065
1075
4543
66
95
145
240
452
1075
4543
N
N
00
A.8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
50
50
24
17
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
24
17
14
13
12
11
11
10
10
10
10
134
50
31
24
20
17
15
14
13
13
12
12
11
11
11
11
10
260
87
50
35
28
24
21
19
17
16
15
14
14
13
13
12
428
134
73
50
38
31
27
24
21
20
18
17
16
15
15
134
50
260
14
31
87
428
13
24
50
134
12
20
35
73
192
891
11
17
28
50
101
260
1185
638
638
192
101
67
50
40
34
29
26
24
22
20
19
18
891
260
134
87
63
50
41
35
31
28
25
24
22
1185
339
171
109
78
61
50
42
37
33
30
27
1521
428
213
134
95
73
59
50
43
38
34
528
260
162
114
87
70
58
50
44
2320
638
311
192
134
101
81
67
57
759
368
225
156
117
93
76
3287
891
428
260
179
134
106
3834
1033
494
298
205
152
4422
1185
564
339
231
1348
638
382
5726
1521
718
6440
1705
11
15
24
38
67
134
339
1521
10
14
21
31
50
87
171
428
1900
1900
10
13
19
27
40
63
109
213
528
2320
10
13
17
24
34
50
78
134
260
638
2783
10
12
16
21
29
41
61
95
162
311
759
3287
12
15
20
26
35
50
73
114
192
368
891
3834
11
14
18
24
31
42
59
87
134
225
428
1033
4422
11
14
17
22
28
37
50
70
101
156
260
494
1185
5053
11
13
16
20
25
33
43
58
81
117
179
298
564
1348
5726
11
13
15
19
24
30
38
50
67
93
134
205
339
638
1521
6440
10
12
15
18
22
27
34
44
57
76
106
152
231
382
718
1705
2783
5053
7197
7197
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.10
37
37
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
6
8
17
13
10
100
37
23
17
14
13
11
10
10
17
100
13
37
10
23
64
320
17
37
100
477
14
26
54
143
665
13
21
37
75
194
885
11
17
28
50
100
253
1136
10
15
23
37
64
128
320
1419
10
14
20
30
47
81
159
394
13
17
25
37
58
100
194
477
2078
12
16
22
31
45
71
120
232
567
194
194
64
37
26
21
17
15
14
13
12
11
10
10
10
320
100
54
37
28
23
20
17
16
14
13
13
12
11
11
13
477
143
75
50
37
30
25
22
19
17
16
15
14
665
194
100
64
47
37
31
26
23
21
19
17
16
885
253
128
81
58
45
37
31
27
24
22
20
1136
320
159
100
71
54
44
37
32
28
25
1419
394
194
120
85
64
52
43
37
32
477
232
143
100
75
60
50
42
2078
567
274
168
116
87
69
57
1733
1733
2455
2455
665
320
194
134
100
79
2863
771
369
222
153
113
885
421
253
173
3774
1007
477
285
11
14
19
26
37
54
85
143
274
665
2863
10
13
17
23
31
44
64
100
168
320
771
3303
8
8
10
13
16
21
27
37
52
75
116
194
369
885
3774
10
12
15
19
24
32
43
60
87
134
222
421
1007
4277
3303
4277
11
14
17
22
28
37
50
69
100
153
253
477
1136
4811
11
13
16
20
25
32
42
57
79
113
173
285
536
1274
1136
536
4811
1274
5376
5376
\.#)
A-8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
0.15
18
18
0.20
0.25
49
18
11
0.30
0.35
0.40
0.45
0.50
0.55
0.70
0.75
0.80
0.85
0.90
0.95
31
18
13
10
49
26
18
13
11
233
70
37
24
18
14
12
10
325
95
49
31
23
18
15
13
11
10
123
62
39
28
22
18
15
13
12
10
10
556
156
78
49
34
26
21
18
15
13
12
694
193
95
59
41
31
25
21
18
16
848
233
113
70
49
37
29
24
20
1017
277
134
82
57
42
33
28
49
18
95
11
31
156
18
49
233
13
26
70
325
10
18
37
95
433
13
24
49
123
556
11
18
31
62
156
694
14
23
39
78
193
848
0.65
156
95
0.60
433
12
18
28
49
95
233
1017
10
15
22
34
59
113
277
1201
13
18
26
41
70
134
325
1401
11
15
21
31
49
82
156
377
10
13
18
25
37
57
95
180
433
1846
12
15
21
29
42
65
109
206
492
2092
10
13
18
24
33
49
74
123
233
556
2353
10
12
16
20
28
38
55
84
139
262
623
1201
325
156
95
65
49
38
1401
377
180
109
74
55
433
206
123
84
1846
492
233
139
556
262
1616
1616
2092
2353
623
2630
2630
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
41
19
14
41
12
11
10
11
10
109
41
19
212
109
14
41
212
12
26
71
41
26
16
13
12
15
13
12
18
16
15
521
157
83
55
41
33
28
24
21
19
18
17
16
109
71
52
41
34
29
26
23
21
19
18
35
30
27
24
22
49
41
35
31
28
726
521
13
19
31
55
109
277
13
13
19
10
14
966
11
15
212
11
22
726
11
14
17
83
26
157
19
41
31
60
22
41
23
15
8
10
23
29
11
11
10
10
10
8
10
60
16
0.95
29
14
26
11
0.90
41
17
12
0.85
109
19
12
13
0.80
71
11
10
14
0.75
0.70
349
349
109
19
0.65
41
33
71
52
212
966
140
89
277
140
89
64
50
41
1240
349
174
109
78
60
431
212
132
93
71
57
48
41
36
1891
521
254
157
109
83
66
55
47
2268
619
300
183
127
96
76
63
349
212
146
109
86
842
403
243
167
124
3605
966
460
277
189
1099
521
312
4667
1240
585
5250
1390
1549
1240
349
174
1549
431
1891
2680
19
28
41
64
109
212
521
13
18
24
34
50
78
132
254
619
2680
41
60
93
157
300
726
3125
35
49
71
109
183
349
842
3605
212
403
966
13
16
21
29
12
15
19
26
11
11
14
18
23
30
41
57
83
2268
726
14
127
3125
4119
4119
13
17
21
27
35
48
66
96
146
243
460
1099
4667
19
24
31
41
55
76
109
167
277
521
1240
5250
18
22
28
36
47
63
86
124
189
312
585
1390
11
13
16
10
12
15
5867
5867
A.8
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.05
0.10
29
29
14
79
10
29
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
14
10
79
29
18
14
12
10
5
6
51
29
21
16
14
12
11
10
252
79
43
29
22
18
16
14
13
12
11
10
10
39
29
24
20
17
15
14
13
12
11
11
13
153
153
376
113
60
524
153
79
51
37
29
24
21
18
16
15
14
697
199
101
64
46
36
29
25
22
19
17
16
895
252
126
79
56
43
35
29
25
22
20
1118
311
153
95
67
51
41
34
29
26
18
51
252
14
29
79
376
12
21
43
113
524
10
16
29
60
153
697
6
6
6
6
6
6
14
22
39
79
199
895
8
8
12
18
29
51
101
252
1118
11
16
24
37
64
126
311
1365
10
14
20
29
46
79
153
376
1638
13
17
24
36
56
95
183
447
1934
1365
376
183
113
79
60
48
39
34
1638
447
216
132
92
69
55
45
1934
524
252
153
106
79
62
2256
608
291
176
120
90
697
332
199
136
297 4
793
376
225
895
422
2602
12
15
21
29
43
67
113
216
524
2256
11
14
18
25
35
51
79
132
252
608
8
8
10
13
16
22
29
41
60
92
153
291
697
297 4
10
12
15
19
25
34
48
69
106
176
332
793
3369
11
14
17
22
29
39
55
79
120
199
376
895
3790
11
13
16
20
26
34
45
62
90
136
225
422
1004
2602
3369
3790 1004
4235
4235
0.05
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
0.50
0.55
10
17
13
10
67
34
22
16
13
305
87
44
28
392
110
489
0.15
0.20
0.25
0.30
0.35
13
6
34
13
22
13
34
19
13
164
49
26
229
13
6
0.40
0.10
0.45
34
13
67
22
110
13
34
164
19
49
229
13
26
67
305
10
17
34
87
392
13
22
44
110
489
10
16
28
55
136
597
67
110
0.70
0.75
10
20
16
13
11
55
34
24
19
15
13
136
67
41
29
22
18
15
164
80
49
34
26
21
17
15
716
195
94
58
40
30
24
20
846
229
110
67
46
34
27
987
266
127
77
53
39
59
597
0.60
0.65
0.80
0.85
0.90
6
8
6
7
11
10
13
11
13
20
34
67
164
716
10
16
24
41
80
195
846
29
49
94
229
987
6
5
13
11
19
15
22
34
58
110
266
1138
26
40
67
127
305
1301
13
11
18
15
21
30
46
77
145
347
1474
10
17
24
34
53
87
164
392
1658
13
11
15
20
27
39
59
98
185
439
1138
0.95
6
7
305
145
87
1301
347
164
98
1474
392
185
1658
439
1853
1853
Index
hypergeometric distribution
hypotheses 49
allocation, sample 82
alpha error 65
alternative hypothesis, definition of 64
balanced repeated replication 85
beta error 65
bias of an estimate 61
binomial distribution 25, 27
bootstrap 85
case-control design 71, 73
censored events 30
central limit theorem 57
characteristic variable 50
cluster sampling 3, 47, 83-6
definition 84
clusters 83
cohort study 71, 72
confidence 63
confidence intervals
advantages of 70
cross product ratio 73
dependent variables 49
design effect 3, 86
direct estimation 72
economy 85
elementary units 49, 50, 85
elements 49
enumeration units 52
equal allocation 45
expected value of sampling distribution
"experimental study" 49
explanatory variables 49
exposure variable 71
false negative rate 78
false positive rate 78
feasibility 85
finite population correction
follow-up study 71
force of morbidity 29
groups, definition
83
hazard 29
heterogeneity 86
heterogeneous clusters 84
homogeneity 86
homoskedastic variance 38
56
incidence 71
incidence density 29
one-sample test, 2-sided alternative
hypothesis
1% significance, 90% power 216
1% significance, 80% power 217
1% significance, 50% power 218
5% significance, 90% power 219
5% significance, 80% power 220
5% significance, 50% power 221
10% significance, 90% power 222
10% significance, 80% power 223
10% significance, 50% power 224
test of equality
1% significance, 90% power 225
1% significance, 80% power 226
1% significance, 50% power 227
5% significance, 90% power 228
5% significance, 80% power 229
5% significance, 50% power 230
10% significance, 90% power 231
10% significance, 80% power 232
10% significance, 50% power 233
incidence density ratio (IDR) 35
incidence rate
definition 29
estimation to within c: percent with 99%,
95% or 90% confidence level 215
single-sample studies 29-32
two-sample studies 29, 32-5
independent samples 68
independent variables 49
instantaneous incidence rate 29
jackknife 85
judgmental samples
42
24
52
linearization 85
listing units 52, 85
lot quality assurance sampling (LQAS)
24-8
consequences of hypothesis testing in 24
sample size and decision rule for, with
1-sided alternative hypothesis
1% significance, 90% power 206
1% significance, 80% power 207
1% significance, 50% power 208
5% significance, 90% power 209
236
lot quality assurance sampling (LQAS),
sample size and decision rule for, with
1-sided alternative hypothesis (cont.)
5% significance, 80% power 210
5% significance, 50% power 211
10% significance, 90% power 212
10% significance, 80% power 213
10% significance, 50% power 214
sample sizes
with 0 cases acceptable with 99%
confidence 191
with 1 case acceptable with 99%
confidence 192
with 2 cases acceptable with 99%
confidence 193
with 3 cases acceptable with 99%
confidence 194
with 4 cases acceptable with 99%
confidence 195
with 0 cases acceptable with 95%
confidence 196
with 1 case acceptable with 95%
confidence 197
with 2 cases acceptable with 95%
confidence 198
with 3 cases acceptable with 95%
confidence 199
with 4 cases acceptable with 95%
confidence 200
with 0 cases acceptable with 90%
confidence 201
with 1 case acceptable with 90%
confidence 202
with 2 cases acceptable with 90%
confidence 203
with 3 cases acceptable with 90%
confidence 204
with 4 cases acceptable with 90%
confidence 205
use of binomial distribution 25, 27
use of hypergeometric distribution 24
use of operating characteristic curve 26-7
maximum likelihood estimation, theory of 30
mean
population 50
sample 53
of the sampling distribution 57
multistage cluster sample 85
multistage sampling designs 52
nonprobability sample 52
normal distribution 57
null hypothesis, definition 64
Index
observational studies 49
odds of an event 72
odds ratio (OR) 49
in epidemiologic studies 71-4
estimating
to within 10% of true odds ratio, with
99% confidence 149
to within 20% of true odds ratio, with
99% confidence 150
to within 25% of true odds ratio, with
99% confidence 151
to within 50% of true odds ratio, with
99% confidence 152
to within 10% of true odds ratio, with
95% confidence 153
to within 20% of true odds ratio, with
95% confidence 154
to within 25% of true odds ratio, with
95% confidence 155
to within 50% of true odds ratio, with
95% confidence 156
to within 10o/o of true odds ratio, with
90% confidence 157
to within 20% of true odds ratio, with
90% confidence 158
to within 25% of true odds ratio, with
90% confidence 159
to within 50% of true odds ratio, with
90% confidence 160
with stated precision 16-19
sampling distribution of 74-7
two-sided hypothesis testing of 19-20
with power at 90%, 1% significance
level 161
with power at 80%, 1% significance
level 162
with power at 50%, 1% significance
level 163
with power at 90%, 5% significance
level 164
with power at 80%, 5% significance
level 165
with power at 50%, 5% significance
level 166
with power at 90%, 10% significance
level 167
with power at 80%, 10% significance
level 168
with power at 50%, 10% significance
level 169
one population mean, hypothesis testing
37-8
one-sample hypothesis test, sampling
distributions for 5
237
Index
one-sample test of proportion, sample size
for
one-sided
with power at 90%, 1% significance
level 100
with power at 80%, 1% significance
level 101
with power at 50%, 1% significance
level 102
with power at 90%, 5% significance
level 103
with power at 80%, 5% significance
level 104
with power at 50%, 5% significance
level 105
with power at 90%, 10% significance
level 106
with power at 80%, 10% significance
level 107
with power at 50%, 10% significance
level 108
two-sided
with power at 90%, 1% significance
level 109
with power at 80%, 1% significance
level 110
with power at 50%, 1% significance
level 111
with power at 90%, 5% significance
level 112
with power at 80%, 5% significance
level 113
with power at 50o/o, 5% significance
level 114
with power at 90%, 10% significance
level 115
with power at 80%, 10% significance
level 116
with power at 50%, 10% significance
level 117
one-sided alternative, definition 64
operating characteristic (OC) curve 26-7
outcome characteristic 71
PAP test 77
parameters, population 50--51
person-time incidence rate 29
point estimate 62
pooled variance 38
population mean 36-7, 50
estimates of 54
population parameters 50-51
population proportion 50
estimating 54
by one sample 1-4
quota surveys
52
random selection 85
random variable 50
rejection region 64
relative risk 49
confidence interval estimation of 21-2
in epidemologic studies 71-2, 73-4, 76
estimation
to within 10% of true risk with 99%
confidence 170
to within 20% of true risk with 99%
confidence 171
to within 25% of true risk with 99%
confidence 172
to within 50o/o of true risk with 99%
confidence 173
to within 10% of true risk with 95%
confidence 174
to within 20% of true risk with 95%
confidence 175
238
Index
sample mean 53
sample proportion 53
sample standard deviation 53
sample var:ance 53
sampling distribution 1
definition 55
mean of 56
standard deviation of 57
variance of 57
sampling error 61-2
sampling frame 52
sampling units 52
screening tests for disease prevalence
self-weighting estimates 83
sensitivity, test 78
simple one-stage clusters sample 85
simple random sample
definition 80
simple random sampling 3, 79-80
77-8
239
Index
with power at 90%,
level 131
with power at 80%,
level 132
with power at 50%,
level 133
with power at 90%,
level 134
with power at 80%,
level 135
with power at 50%,
level 136
with power at 90%,
level 137
with power at 80%,
level 138
with power at 50%,
level 139
two-sample test of small
one-sided
with power at 90%,
level 140
with power at 80%,
level 141
with power at 50%,
level 142
with power at 90%,
level 143
1% significance
1% significance
1% significance
5% significance
5% signifiacnce
5% significance
10% significance
10% significance
10% significance
proportions
60, 61
1% significance
1% significance
1% significance
5% significance
University of
and
Stephen K. Lwanga
For most research studies, especially those of human populations, all the people
cannot be studied. This may be due to constraints on time, finances or other
resources, or because the population cannot be defined uniquely in terms of either
space or time. In such situations only part of the population, a sample, would be
studied and the results generalized to the whole population. It is this need to
generalize that dictates which statistical technique should be used.
Over the past few years the essential value of sampling in many types of public
health investigations, and in many other areas of scientific research, has become
widely recognized. Adequacy of Sample Size in Health Studies looks mainly at
the determination of adequate sample sizes under different situations, and is
dividE!d into three parts: Part I provides solutions to typical problems and tabulations
for minimum sample sizes for various survey and study designs, while Part II
provides a concise exposition of the theory behind the process of determining
sample sizes. Part Ill comprises tables for sample size determination.
This book therefore aims to provide epidemiologists and health workers with a
good basic knowledge of sampling principles and methods and an acquaintance
with their potential applications in the medical field.
Epidemiologists, health workers and statisticians faced with the problem of deciding
how large a sample to survey or study will find this book invaluable as it provides
an insight into the methodology of solving problems of sample size needs.
ISBN 0-471-92517-9